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INTRODUCTION 
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Developmental timing, growth and homeostasis form the cornerstones that 
shape the genesis and subsequent maintenance of a healthy adult for all 
multicellular organisms. Understanding the mechanisms that regulate these 
processes has important implications both from the perspective of our 
understanding of basic biology and also for our understanding of complex 
biological disorders involving these processes. For instance, the age of onset of 
human puberty has advanced significantly in the last few decades and 
precocious puberty has been shown to cause lasting psychological and physical 
complications (Kaplowitz and Oberfield, 1999; Lazar and Phillip, 2012; Sonis et 
al., 1985; Walvoord, 2010). An in-depth understanding of the mechanisms that 
regulate developmental transitions can help us better evaluate the causes of 
precocious puberty and possibly devise strategies to prevent them. Similarly, 
deregulation of homeostatic mechanisms leads to disorders like obesity and 
diabetes, that have become a worldwide health concern and combating these 
multifaceted disorders will require an extensive understanding of the regulatory 
networks that regulate homeostasis (Bruce and Hanson; Kirk and Klein, 2009; 
Tseng et al., 2010). Understanding growth, on the other hand, has significant 
applications in translational research involving cancer biology and regeneration 
(Tennessen et al., 2011).  
My thesis work explores the mechanisms regulating developmental timing, 
homeostasis and growth using the model organism Drosophila melanogaster. 
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The fast generation time of this model organism and presence of defined 
developmental transitions, that manifest as clear physiological events like molting 
and metamorphosis, make Drosophila an excellent model to study 
developmental timing (Thummel, 2001; Yamanaka et al., 2013). Additionally, the 
exceptional growth observed during the larval stages, along with the fact that the 
larva grows in close contact with its environment necessitating robust 
homeostatic mechanisms, provides a unique opportunity to use these animals to 
study growth and homeostasis. The fruit fly is also highly amenable to genetic, 
biochemical and cell biological manipulations allowing easy experimental 
investigations. This chapter briefly discusses the mechanisms that are known to 
regulate timing, growth and homeostasis in Drosophila and parallels that exist 
between Drosophila and vertebrates.  
1.1 Life cycle of Drosophila melanogaster 
Life cycle of Drosophila starts as an egg that is produced by sexual 
reproduction involving two healthy adults. Drosophila eggs develop into first 
instar larvae that, after hatching, undergo two molting stages to give rise to 
second and third instar larvae. During the larval stages the larvae feed constantly 
and undergo a remarkable 150-200 fold growth. At the end of the feeding stage 
larvae start wandering out of the food and enter metamorphosis by forming 
pupae. The animals undergo metamorphosis inside the pupal case and eclose as 
adults, thereby completing the life cycle. Post eclosion adult flies need to reach 
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sexual maturity before they can reproduce. Timing of the transitions between the 
various developmental stages in Drosophila is sensitive to both internal and 
external factors (Tennessen and Thummel, 2011; Thummel, 2001). External 
factors like humidity, length of day light and temperature can all significantly 
effect developmental timing with temperature affecting timing most profoundly. 
Under lab culture conditions of 25OC embryonic development is completed in 
about 24 hours (Figure 1). First and second instar larval stages last about 24 
hours each, and the third instar stage lasts about 48 hours. Subsequently, the 
larvae wander for about 12 hours and enter pupal stage. Pupal stage then lasts 
about three and a half days and is followed by eclosion of adults. The entire 
developmental cycle is thereby completed in a total of 9 days from egg to adult. 
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Figure 1: A schematic showing the life cycle of Drosophila melanogaster  
A schematic of the Drosophila life cycle showing the various developmental stages and 
the estimated time spent at each stage. The duration of each stage shown here is for 
animals that are grown at 25OC. The three larval stages are demarcated by molting 
events at the end of each instar. First instar and second instar larval stages last about 24 
hours each. Third instar stage is about 48 hours long and the larvae spend another 12 
hours wandering before entering pupal stage. 
	  	   	  6	  
1.2 Regulation of developmental transitions in Drosophila melanogaster 
Internally, a number of hormonal and neuropeptidergic signals regulate 
the various developmental transitions (Figure 2 and 3). The most important 
among these signals is the insect steroid hormone ecdysone (E) (Yamanaka et 
al., 2013). E is produced primarily by the larval prothoracic glands (PGs), a pair 
of endocrine organs located in the ring gland, and is released into the 
hemolymph in response to multiple environmental cues that converge on the 
PGs to regulate developmental transitions (Yamanaka et al., 2013). Once 
released in the hemolymph, E is taken up by the peripheral tissues where it is 
converted to its active form 20-hydroxyecdysone (20E) by the action of a P450 
monooxygenase expressed in the non-endocrine tissues (Petryk et al., 2003). 
20E ultimately acts as the primary developmental hormonal signal that leads to 
manifestation of various physiological, morphological and behavioral changes by 
initiating necessary gene expression cascades (Thummel, 2001). Consistent with 
this understanding, ecdysone titers peak ahead of each of the developmental 
transitions and dictate progression from the embryonic stage to eclosion of an 
adult fly (Figure 2). The intensity of these peaks, along with additional regulatory 
mechanisms including, but not limited to, differential expression of receptor 
isoforms and primary ecdysone inducible factors, dictate the spatio-temporal 
effect of ecdysone signaling at the various developmental stages. While 
ecdysone is the primary effector of developmental transitions, production and 
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release of ecdysone from the PGs is regulated by mechanisms that integrate 
various environmental, metabolic and homeostatic cues that are conducive for 
healthy development (Yamanaka et al., 2013).  
 
Figure 2: A schematic representation of the ecdysone pulses that trigger 
each of the major developmental transitions in Drosophila 
The profile is depicted as 20E (the active form of ecdysone) equivalents in whole body 
homogenates (Riddiford, 1993). Dotted lines mark the major developmental transitions. 
From (Thummel, 2001). 
Among the various mechanisms that regulate the production and release 
of ecdysone in Drosophila, the role of the insect neuropeptide regulator, 
prothoracicotropic hormone (PTTH), is most well understood (Mcbrayer et al., 
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2007; Rewitz et al., 2009). PTTH is produced by a pair of bilaterally-symmetric 
peptidergic neurons in the larval brain called the PG neurons. The PG neurons 
innervate the Prothoracic glands (PGs) and are thought to regulate timing by 
regulating the release of PTTH that ultimately induces ecdysone biosynthesis by 
activating a MAP kinase pathway in the PGs (Mcbrayer et al., 2007; Rewitz et al., 
2009; Siegmund and Korge, 2001). The PTTH-producing PG neurons have been 
long believed to be the master regulators of timing that integrate and evaluate 
multiple developmental cues. However, this view may not present the complete 
picture of the regulatory network that dictates developmental transitions and has 
been challenged based on two observations. First, an increasing body of 
evidence shows that the only developmental cue that the PG neurons respond to 
is photoperiod (Mcbrayer et al., 2007; Truman and Riddiford, 1974). Second, 
ablation of the neurons or knocking down the PTTH receptor “torso” in the PGs 
do not block developmental progression but rather only delays developmental 
transitions (Mcbrayer et al., 2007; Rewitz et al., 2009). Moreover, this delay 
primarily affects the timing of entering metamorphosis while prior developmental 
transitions remain mostly un-affected. Therefore, it can be predicted that 
mechanisms, independent of the PG neurons and PTTH, exist to sense 
additional developmental parameters and ensure progression of developmental 
transitions.  
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The PGs themselves have been proposed to serve as a major regulatory 
node and have been shown to integrate tropic signals, particularly nutritional 
signals that relay the metabolic state of the larvae, to induce ecdysteroidogenesis 
(Figure 3) (Gibbens et al., 2011; Huang et al., 2008). A number of recent 
publicaitons point to Insulin-Insulin-like growth factor signaling (IIS) as a major 
regulator of ecdysone synthesis in the PGs (Caldwell et al., 2005; Colombani et 
al., 2005; Mirth et al., 2005). Since IIS is known to induce tissue growth in 
Drosophila larvae, it was proposed that IIS, via PI3K, regulates growth of the 
PGs allowing them to reach a mature stage competent for ecdysone production 
and release. This view is credible in light of the fact that the prothoracicotropic 
hormone purified from lepidopterans was an insulin family peptide and was later 
named bombyxin (Ishizaki and Suzuki, 1994). However, artificially inducing over-
growth of PG cells does not accelerate developmental transitions indicating that 
physical cellular growth may not be the mechanism by which IIS regulates 
ecdysone titers (Cáceres et al., 2011). An alternate hypothesis that has been 
proposed is that IIS integrates the nutritional status of the animal by cross 
communicating with the MAPK pathway in the PGs thereby making the PG cells 
competent to respond to PTTH and produce ecdysone (Yamanaka et al., 2013). 
Apart from PTTH and IIS, a number of other signaling pathways including TGF-β 
signaling, nitrous oxide signaling and TOR signaling can affect ecdysone 
production in the PGs. These signals allow integration of multiple physiological 
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inputs in the PGs when deciding the right time for transitioning to the next 
developmental state (Reviewed in (Yamanaka et al., 2013)). 
 
Figure 3: Regulation of ecdysone production and release in Drosophila 
(A) A schematic of the PG neurons that contralaterally innervated the PGs and 
stimulated ecdysone release. (B) Schematic of the various signaling pathways that has 
been shown to influence ecdysteroidogenesis in the Drosophila PGs (Yamanaka et al., 
2013). 
 
While juvenile-to-adult transitions in holometabolous insects like 
Drosophila seem quite different from mammals, significant parallels can be 
drawn in terms of mechanistic similarities in induction of hormonal cascades and 
physiological setups that induce these cascades. Similar to insects, vertebrates 
attain sexual maturity by undergoing juvenile-to-adult transition through puberty. 
The timing of pubertal transition in vertebrates is also regulated by a brain-
endocrine axis that is similar to insects. Pubertal transition is initiated by the 
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Kisspeptin-producing neurons in the brain that produce kisspeptin and directly 
stimulate the gonadotropin-releasing hormone (GnRH)-producing neurons 
resulting in the release of GnRH (Oakley et al.). GnRH subsequently signals to 
the pituitary gland through a G-protein coupled receptor and induces release of 
lutenizing hormone (LH) and follicle-stimulating hormone (FSH) (Ebling and 
Cronin, 2000). LH and FSH finally stimulate production of sex steroids in the 
gonads which leads to sexual maturity (LeMaire, 1989). This conservation in the 
hormonal regulation of developmental transitions along with the advantage of a 
short life cycle make insects an attractive model system to study the mechanisms 
involved in regulating developmental transitions and hormonal signaling. 
1.3 Mechanisms regulating growth in Drosophila melanogaster 
 Much like other higher animals the final size of the Drosophila adult is 
determined by the amount of growth achieved during juvenile stages. For flies 
the juvenile stage consists of the three larval instars during which the animal’s 
mass increases a remarkable 200 fold. At the end of the third instar stage, as 
metamorphosis begins, the larvae cease to grow and the mass of the larvae at 
this point determines the final body size of the adult (Tennessen and Thummel, 
2011). Therefore, the final body size of the adult is linked to the timing of entering 
metamorphosis. Under circumstances when food is not scarce and the larvae 
continue to grow at a normal rate, delayed entry into metamorphosis will lead to a 
larger animal, whereas precocious initiation of metamorphosis will lead to a 
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smaller animal. In addition to developmental timing, nutrient availability plays a 
major role in determining the rate of growth and therefore final body size 
(Tennessen and Thummel, 2011).  
 Nutrient availability in larvae is sensed by the larval fatbody (FB), a 
functional homologue of both adipose tissue and the mammalian liver, and is 
then linked to tissue growth through systemic hormonal signals (Colombani et al., 
2003; Géminard et al., 2009; Kim et al., 2008). The nutrient sensing mechanism 
of the FB primarily relies on amino acid transporters, like slimfast and minidiscs, 
which allow absorption of amino acids from the hemolymph (Colombani et al., 
2003; Martin et al., 2000). Inside FB cells, amino acids activate the highly 
conserved TOR pathway via poorly understood mechanisms involving Rag 
GTPases (Kim et al., 2008) leading to secretion of a yet unknown regulatory 
molecule from the FB that induces growth by primarily targeting the insulin 
insulin-like growth factor signaling (IIS) pathway (Géminard et al., 2009). The FB 
thus senses the nutritional state of the animal by amino acid levels via the TOR 
signaling pathway and remotely regulates growth by linking nutrient availability to 
insulin signaling (Figure 4). 
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Figure 4: Larval FB remotely regulates Dilp release in response to amino 
acid availability. 
A model showing the remote control of brain Dilp release by the FB. Amino acids, 
delivered by the gut into circulation, are taken up by the larval FB cells. In the FB cells 
amino acids activate the TOR pathway, which generates a secreted positive messenger. 
This messenger signals to the Drosophila insulin producing cells (IPCs) in the brain and 
induces Dilp release. From (Géminard et al., 2009). 
Insulin signaling (IIS) in Drosophila is mediated by Drosophila Insulin-like 
peptides, and the fly genome encodes 7 of these peptides (Dilp1-7). Three of 
these peptides, Dilp 2, 3, and 5, are expressed in two clusters of neurosecretory 
cells located in the larval brain (Brogiolo et al., 2001; Ikeya et al., 2002). These 
cells are analogous to vertebrate β-cells and release Dilps into circulation in 
response to nutrient availability (Géminard et al., 2009). Interestingly, despite 
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being expressed in the same cell, each of these Dilps are regulated differently by 
nutrients and may have independent functions with respect to growth and 
nutrient homeostasis. Nutrient availability affects Dilp 3 and 5 at the 
transcriptional level with starvation significantly down-regulating the mRNA level 
of these genes (Ikeya et al., 2002). On the contrary, Dilp2 is expressed all the 
time, and the peptides produced are stored in dense granules in the IPCs until 
nutritional signals perceived by the FB induce secretion of this peptide into the 
hemolymph (Géminard et al., 2009). Once in the hemolymph, Dilp peptides bind 
and activate the sole Drosophila insulin receptor (Inr) in the peripheral tissue 
which in turn, via a complex network of interactions with cellular nutrient sensors, 
growth promoting pathways and cellular homeostatic regulators, promotes 
cellular growth (Figure 5) (reviewed in (Teleman, 2010)). 
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Figure 5: Intracellular insulin signaling pathway in Drosophila 
Functional relationship between IIS and other intracellular signaling components is 
indicated. Arrows show activation, but may not necessarily indicate direct interaction. 
Bar-ended lines indicate inhibitory interaction. Broken lines indicate either indirect 
interactions or interactions that need further verification. Red lines indicate 
transcriptional regulation. From (Teleman, 2010). 
 
	  	   	  16	  
1.4 Drosophila as a model to study physiological homeostasis 
Homeostasis (Greek: “homois”, “similar” and “stasis”, “standing still”) is 
one of the most remarkable properties of complex multicellular organisms and 
refers to their ability to maintain a constant internal environment in response to 
changing environmental conditions like temperature, salt concentration and 
nutrient availability. Physiological homeostasis thus is critical for survival of 
multicellular organisms, and not surprisingly most organisms have evolved robust 
networks of multiple sensors, effectors and feedback mechanisms to maintain 
and regulate homeostasis. Deciphering how components of these networks 
function to achieve homeostasis is essential for understanding the underlying 
mechanisms behind complex diseases such as metabolic syndrome and 
diabetes. While a significant body of work has been generated using vertebrate 
models of homeostasis, understanding the genetic basis of the complex 
regulatory network and the functional interactions between the various pathways 
that regulate homeostasis can be very challenging to study in higher organisms. 
However, the fruit fly has emerged in recent years as an attractive model system 
to understand the genetic basis of homeostatic regulation (Baker and Thummel, 
2007; Léopold and Perrimon, 2007). These studies have also revealed surprising 
similarities in homeostatic mechanisms between vertebrates and insects.  
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1.5 Regulation of metabolic homeostasis in Drosophila melanogaster 
While the term homeostasis can encompass a wide range of physiological 
processes including regulation of cell number, temperature and salt and water 
content, for the purpose of this study we will focus on the regulation of metabolic 
homeostasis. Metabolic homeostasis in Drosophila is regulated by a number of 
players. First, a number of less understood nutrient and energy sensing 
mechanisms, including amino acid sensors like dRagA/B, Path and energy 
sensors like AMPK, detect the nutrient and energy state of the animals (Kim et 
al., 2008; Long, 2006; Pan and Hardie, 2002; Sancak et al., 2008). Most of these 
sensory mechanisms have been shown to converge on the TOR pathway, which 
regulates both cellular growth, and in case of Drosophila larvae, helps generate 
diffusible signals from metabolic tissues like the FB. These signals then induce 
the release of systemic metabolic regulators like Dilps that coordinate systemic 
metabolic homeostasis or can lead to induction of tissue growth (Géminard et al., 
2009; Sousa-Nunes et al., 2011). 
In Drosophila the Insulin-like growth factors play a dual role as regulators 
of both growth and nutrient homeostasis. Dilps, especially Dilp2, which is closest 
to human insulin in sequence similarity, play a vital role in regulating cellular 
nutrient uptake and consequently homeostasis of nutrients in circulation 
(Teleman, 2010). Consistently, knocking down dilp2 or ablating the IPCs leads to 
a diabetic phenotype similar to vertebrates, characterized by a higher 
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concentration of circulating sugar (Broughton et al., 2008; Rulifson et al., 2002). 
The physiological consequences of high circulating sugar concentration are still 
not understood. However, it must be noted that, unlike vertebrates high 
circulating sugar in larvae has not yet been shown to cause any tissue damage. 
Loss of IIS in the larvae also leads to increased accumulation of glycogen and 
obesity, characterized by higher triacylglycerol (TAG) content (Böhni et al., 1999; 
Broughton et al., 2005; Grönke et al., 2010; Tatar, 2001). Increase in total 
glycogen upon loss of IIS may be a unique characteristic of holometabolous 
insect larvae as Bombyxin, the insulin homologue in Bombyx mori, has also been 
shown to induce glycogen breakdown and mobilization in the major nutrient 
storage tissues (Satake et al., 1997). Apart from IIS, the Drosophila glucagon 
homologue AKH (adipokinetic hormone) also plays an important role in nutrient 
homeostasis. AKH has been proposed to be released in response to low 
circulating nutrient conditions and has been shown to induce nutrient mobilization 
from tissues like the FB (Kim and Rulifson, 2004; Lee and Park, 2004)(Figure 6). 
In addition to signals like Dilp and AKH that systemically regulate nutrient 
homeostasis, a considerable amount of cross talk between metabolically 
important tissues also exists in Drosophila. For instance, larval oenocytes, cells 
that have been shown to facilitate nutrient mobilization, have been proposed to 
interact closely with the FB to regulate nutrient mobilization upon starvation 
(Gutierrez et al., 2007). Similarly, signaling by microbial metabolites in the gut 
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has been shown to affect systemic insulin signaling via an unknown pathway 
(Shin et al., 2011). Taken together, these studies demonstrate that metabolic 
homeostasis requires a concerted interaction between various metabolic 
pathways and metabolic tissues in an animal (Figure 6). However, metabolic 
regulators discussed so far represent only a fraction of the robust network that 
would be necessary for metabolic homeostasis. Deciphering novel regulators of 
metabolism therefore is essential for obtaining a complete picture of systemic 
homeostatic networks and for understanding the mechanisms involved in 
metabolic disorders. In line with this goal, in Chapter 3 I describe our study 
exploring the role of TGF-β/Activin signaling in regulating metabolism and 
homeostasis. 
                     
Figure 6: A schematic showing the major regulators of nutrient 
homeostasis in Drosophila larvae 
Hormone names are shown in red, tissue names in blue. DILP, Drosophila insulin-like 
peptides; TAG: triacylglycerol. From (Léopold and Perrimon, 2007). 
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1.6 The TGF-β signaling paradigm  
The TGF-β superfamily forms the largest group of secreted polypeptide 
growth factors in the animal kingdom and, in vertebrates, consists of more than 
30 ligands (Schmierer and Hill, 2007). Based on similarities in sequence and 
signaling mechanism, these signaling molecules can be divided into two large 
subgroups that include the TGF-β/Activin and the bone morphogenetic protein 
(BMP) family. These ligands bind and activate a heteromeric receptor complex 
containing type I and type II serine/threonine kinases. The activated receptor 
complex then phosphorylates the R-Smad family of transcription factors. 
Canonical BMP signaling results in the phosphorylation of R-Smads1/5/8 while 
Activin/TGF-β ligands signal through R-Smads2/3. Phosphorylation of R-Smads 
facilitates their association with a common co-Smad in a heterotrimeric complex 
that is retained in the nucleus where it regulates transcription of target genes in 
association with a wide variety of cofactors. Additional layers of complexity are 
provided by extracellular molecules, like chordin, noggin and follistatin, that can 
bind and regulate ligand availability, and by inhibitory Smads that can negatively 
regulate activated R-Smads inside the cell (Balemans and Van Hul, 2002; Itoh 
and Dijke, 2007; Thompson et al., 2005). Moreover, a considerable amount of 
crosstalk exists between the TGF-β ligands and the various combinations of type 
I and type II receptors. Based on the receptor used, TGF-β ligands can have 
different physiological effects on target tissues (Feng and Derynck, 2005). 
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Figure 7: TGF-β signaling in vertebrates 
The signaling pathway is initiated when TGF-β ligands bind to the heterodimeric receptor 
complex consisting of a type I receptor and a type II receptor. Upon ligand binding the 
constitutively active type II receptor phosphorylates the type I receptor and activates it. 
Activated type I receptor then phosphorylates an intracellular R-Smad that, upon 
activation, binds an intracellular Co-Smad (SMAD4). The active R-Smad/Co-Samd 
complex translocates to the nucleus and regulates gene expression. From (Schmierer 
and Hill, 2007). 
NPC 
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1.7 TGF-β signaling in the Drosophila melanogaster 
Canonical TGF-β signaling is strikingly conserved in the fruit fly Drosophila 
melanogaster. However, Drosophila has fewer ligands and receptors and 
therefore provides a much simpler system to study (Figure 8). There are only 7 
ligands of which dActivin (dAct) and dawdle (daw) represent the TGF-β/Activin 
branch of TGF-β signaling (Figure 8 and 9) (Brummel et al., 1994; Parker et al., 
2004; 2006; Serpe and O'Connor, 2006). Of the remaining ligands, three are 
clear BMP homologues and two novel ligands are too divergent to be definitively 
assigned to a particular TGF-β subfamily (Parker et al., 2004). The TGF-β/Activin 
pathway in Drosophila is initiaited by ligand binding to the type I receptor, 
Baboon, that functions with either of the two type II receptors, Wit or Punt (Figure 
9) (Brummel et al., 1994; Serpe and O'Connor, 2006). There are three Baboon 
(Babo) isoforms in Drosophila that most likely bind different TGF-β/Activin ligands 
and signal through the single intracellular transducer dSmad2 (also called Smox) 
(Das et al., 1999; Jensen et al., 2009; Serpe and O'Connor, 2006; Shimmi et al., 
2005). BMP signaling on the other hand is mediated by the type I receptors Tkv 
or Sax in combination with Wit or Punt. For both BMP and TGF-β/Activin 
pathways, the product of the medea locus has been shown to function as the 
common co-Smad (Brummel et al., 1994; Letsou et al., 1995; Ruberte et al., 
1995; Shimmi et al., 2005). The relative simplicity of TGF-β signaling in the fly, 
along with the availability of powerful genetic approaches, makes Drosophila an 
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attractive system to study the role of TGF-β signaling in various physiological 
processes. 
 
Figure 8: A phylogenetic tree of the various components of the TGF-β 
superfamily 
A phylogenetic tree derived from alignment of protein sequences of the components of 
the TGF signaling superfamily. Mammalian proteins are shown in black whereas 
Drosophila homologues are shown in grey. Protein symbols are given with alternative 
names in parentheses. For the ligands, the putative, mature, fully processed forms were 
used to construct the tree. ACVR, activin receptor; ALK, activin receptor-like kinase; 
AMH, anti-Muellerian hormone; AMHR2, AMH receptor-2; BMP, bone morphogenetic 
protein; BMPR, BMP receptor; GDF, growth and differentiation factor; I-SMAD, inhibitory 
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SMAD; R-SMAD, receptor-regulated SMAD; TGF, transforming growth factor; TGFBR, 
TGF receptor. From (Schmierer and Hill, 2007). 
 
 
                                                
Figure 9: TGF-β/Activin signaling in Drosophila 
TGF-β/Activin signaling is mediated by the three known ligands, Daw, Myoglianin and 
Activin-β. The mechanism of signaling is similar to vertebrates where the ligand binds a 
heterodimeric receptor complex consisting of a type I receptor (Babo) and a type II 
receptor (Wit or Punt). Upon ligand binding the constitutively active type II receptor 
phosphorylates and activates Babo. Activated Babo then phosphorylates an intracellular 
R-Smad homologue Smox, which upon activation binds an intracellular Co-Smad 
homologue Medea. The Smox/Medea complex translocates to the nucleus and regulates 
gene expression. 
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My thesis work explores the role of novel players in regulation of 
developmental timing, growth and homeostasis in Drosophila melanogaster. 
Chapter 2 of my thesis shows how a developmental gap gene, giant, is involved 
in regulating developmental timing. Chapter 3 explores the role of Drosophila 
TGF-β ligand Daw in regulating metabolism, sugar and pH homeostasis and 
energy homeostasis in the larvae. Lastly chapter 4 shows the role of a pyrimidine 
salvage pathway enzyme, uracil phosphorybosiltransferase in regulating larval 
growth. 
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 CHAPTER 2 
The Drosophila gap gene giant regulates ecdysone production 
through specification of PTTH-producing PG neurons. 
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2.1 INTRODUCTION 
The giant (gt) locus, located on the Drosophila X chromosome, codes for a 
zinc finger transcription factor that is widely known for its role in specifying early 
anterior/posterior pattern in the blastoderm embryo (Capovilla et al., 1992; Eldon 
and Pirrotta, 1991; Reinitz and Levine, 1990; Stanojevic et al., 1991). Amorphic 
gt alleles lead to embryonic lethality due to the loss of posterior abdominal 
segments 5-7 and sometimes 8, as well as labral and labial structures in the 
head region (Gergen and Wieschaus, 1985; Mohler et al., 1989; Petschek et al., 
1987).  However, the original gt alleles were discovered and partially 
characterized as mutations that produced large third instar larvae as a result of 
developmental delay (Bridges, 1928). These mutants played an important role in 
the early history of Drosophila genetics because they also produced larger than 
normal polytene chromosomes that aided early cytogenetic studies (Bridges, 
1935).   
The viable gt alleles exhibit variable penetrance (~25% females, 13% 
males) that can be enhanced in females when placed over a deficiency, 
suggesting that they are hypomorphic mutations that enable some mutant larvae 
to survive past the early essential embryonic requirement for gt (Schwartz et al., 
1984). These larvae exhibit pronounced developmental delay especially during 
the third instar stage and pupate approximately 5 days later than wildtype 
(Schwartz et al., 1984). Post-embryonic development in holometabolous insects 
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is characterized by defined molting periods followed by metamorphosis. The 
precise timing of these events is regulated at a systemic level in response to 
multiple cues like nutritional status, body size, organ development and 
environmental conditions (Edgar, 2006; Menut et al., 2007; Mirth and Riddiford, 
2007; Nijhout, 2003). While these cues may regulate developmental timing in 
several ways, the primary mechanism involves production and secretion of the 
insect steroid hormone ecdysone.  In gt hypomorphic larvae, the protracted third 
instar stage appears to result from a delay in the rise of ecdysone titer that 
precedes the initiation of metamorphosis. Consistent with this view, feeding these 
animals 20-hydroxecdysone (20-E) reverts the delay phenotype leading to 
normal size larvae that pupate at the appropriate time (Schwartz et al., 1984).   
The molecular mechanism by which gt controls ecdysone production has 
been a long-standing mystery. In many insects, the regulation of ecdysone 
production in larvae involves two major components: a pair of bilaterally 
symmetric neurons (PG neurons) located in the cebral labrum portion of the 
brain, and the prothoracic gland, the endocrine organ that actually produces and 
secretes ecdysone (Gilbert et al., 2002). In Drosophila, the PG neurons directly 
innervate the prothoracic gland (Siegmund and Korge, 2001) and induce 
production and secretion of ecdysone by releasing an adenotropic peptide 
hormone called prothoracicotropic hormone (PTTH) (Mcbrayer et al., 2007). 
PTTH signals through the receptor tyrosine kinase Torso to activate a RAS/ERK 
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cascade that ultimately stimulates transcription of ecdysone biosynthetic 
enzymes (Rewitz et al., 2009). Intriguingly, attenuation of PTTH signaling delays 
the rise in ecdysone titer and the onset of pupation by approximately 5 days 
resulting in large pupae and adults, similar to those produced by gt hypomorphs 
(Mcbrayer et al., 2007; Rewitz et al., 2009). The similarity in phenotype between 
gt hypomorphs and attenuation of PTTH signaling prompted us to investigate the 
role of PTTH in the gt phenotype further. Here we report that rather than directly 
regulating PTTH production in the PG neurons, gt indirectly controls PTTH and 
subsequent ecdysone production by influencing the developmental fate of the 
PTTH-producing PG neurons. 
2.2 RESULTS 
2.2.1 Hypomorphic mutations in giant show stochastic elimination of ptth 
expression in PG neurons. 
The phenotypes seen in gt hypomorphic alleles (Schwartz et al., 1984), 
although less penetrant, are remarkably similar to those described for loss of the 
PTTH-producing PG neurons or PTTH signal transduction components 
(Mcbrayer et al., 2007; Rewitz et al., 2009). These include developmental delay 
and low ecdysone titers during the prolonged third instar stage, production of 
large larvae, pupa and adults, and the ability to rescue these phenotypes by 
feeding larvae 20-E  (Figure 10 A and B, (Mcbrayer et al., 2007; Rewitz et al., 
2009; Schwartz et al., 1984)). To examine if loss of gt affected the expression of 
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PTTH in the PG neurons, we carried out in situ hybridization using a ptth probe 
on brains prepared from wandering third instar hypomorphic gt alleles gt1 or gtE6.  
Similar in situ hybridization experiments with wild type CNSs show four distinct 
ptth-producing PG neurons, two in each brain lobe (Mcbrayer et al., 2007). 
However, gt hypomorphic alleles revealed varying degrees of abnormal ptth 
expression in different larvae and mutant backgrounds. The gt1 mutants display 
the most variability with approximately one third of the larvae showing either one 
or no cell expressing ptth (Figure 10C and D). Other gt1 larvae exhibit relatively 
normal ptth expression (Figure 10E). Individuals containing the gtE6 allele 
consistently exhibited expression within only one cell of the pair of bilateral 
PTTH-expressing neurons within each brain hemisphere instead of the usual two 
(Figure 10F). We conclude that the similarity in phenotype between ablation of 
PG neurons and the gt hypomorphic mutants and the semi-penetrant phenotype 
of the gt hypomorphic allele is likely caused by the partial loss of ptth expression 
in the PG neurons. 
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Figure 10: Hypomorphic giant mutants are phenotypically similar to PG 
neuron ablated flies and show variable loss of PTTH expression in the PG 
neurons 
(A and B) gt1 and gtE6  larvae exhibit a prolonged third instar stage in about 25% of 
females and 13% of males. This phenotype, although much less penetrant, is similar to 
PG neuron ablated larvae (ptth>Gal4/UAS-grim). This prolonged third instar stage gives 
rise to larvae and pupae that are significantly larger than yw control animals (pictures 
were taken at same magnification and settings and fused using Photoshop). (C) 
Consistently ptth expression, as observed by in situ hybridization, is lost from all four PG 
neurons in the developmentally delayed gt1 larvae. (D-E) Normally developing gt 
hypomorphic larvae show a variable stochastic loss of ptth expression ranging from one-
three of the four PG neurons. Many of them express ptth in all four PG neurons similar to 
wild type animals.  
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2.2.2 Gt is not expressed in PTTH-producing neurons or the prothoracic 
gland. 
Since gt encodes a zinc finger-containing DNA binding transcription factor, 
one possible explanation for loss of ptth expression in the PG neurons of gt 
hypomorphic mutants is that Gt directly controls ptth transcription. To address 
this possibility, we used immuno-staining to examine Gt expression in both larvae 
and embryos. We found no evidence for Gt expression in larval or embryonic PG 
neurons.  In the embryo we detected dynamic expression of Gt in various 
portions of the developing brain (Figure 11A,B and D).  At stage 14 we observed 
two prominent Gt-expressing neurons in the lateral portion of each brain 
hemisphere that could be either the PG neurons or perhaps their precursors  
(Figure 11B and C, yellow arrows).  To examine this issue, we attempted to 
double stain embryonic brains for Gt and PTTH using a transgenic line that 
expresses an HA-tagged form of PTTH (Mcbrayer et al., 2007).  However, 
embryonic expression of PTTH-HA in the PG neurons does not begin until 
approximately stage 17 -18, and at this time we no longer detect consistent Gt 
expression in the brain.  However, in a few rare embryos we observed 
simultaneous Gt and PTTH staining within the brain but they were in adjacent 
non-overlapping cells (Figure 11D, red arrowheads showing Gt expressing cells 
and green arrowheads showing the PG neurons). These results indicate that it is 
unlikely that Gt directly regulates ptth transcription in the PG neurons.  
	  	   	  33	  
 
 
Figure 11: Giant is expressed in the embryonic brain including two neurons 
adjacent to the PG neurons 
(A) Co-staining wild-type embryos with anti-Elav (a pan-neuronal marker) and anti-Gt 
show that Gt is expressed in the developing embryonic brain even at late embryonic 
stages. (B-C) At stage 14 there are two prominent Gt-expressing neurons in the lateral 
portion of each brain lobe, positioned ideally to be either the PG neurons themselves or 
precursors to PG neurons (B and C (red channel from B), yellow arrowheads). (D) To 
check if the PG neurons in the embryo express Gt, PTTH-HA expressing embryos were 
co-stained with anti-HA and anti-Gt antibodies. PTTH-HA expression is seen very late 
during embryogenesis by which time Gt expression fades. However, on rare occasions 
two Gt expressing cells (red arrowheads) could be seen right next to the PTTH-HA 
expressing PG neurons (green arrowheads). 
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2.2.3 gt1 affects the fate of PTTH-producing PG neurons 
In the absence of any evidence supporting a role for Gt in regulating ptth 
transcription, we sought to determine if loss of Gt affects the specification of PG 
neurons. Besides ptth, the only other described marker for PG neuron fate is the 
Feb211-Gal4 enhancer trap line (Siegmund and Korge, 2001) that contains an 
insertion into an unknown gene on chromosome 3.  Analysis of expression from 
this enhancer line in gt1 mutant larvae revealed a similar stochastic loss of GFP 
expression in different numbers of PG neurons as seen for ptth expression itself 
(Figure 12A and B). The all or none response observed for both ptth and 
Feb211-Gal4 expression in gt hypomorphs is consistent with a stochastic loss of 
PG neurons in these mutants.  
The gt1 mutation has been shown to be associated with two spontaneous 
insertions, one near the 5’ region of the gene and the other in the 3’ region 
(Mohler et al., 1989). We predict that these insertions likely affect gt expression 
levels during embryogenesis, and altered gt expression may affect the fating of 
different regions of the brain including precursors that give rise to the PG 
neurons. To examine this issue in more detail, we sought to determine if Gt 
expression is reduced or if fewer cells express Gt in gt1 mutant animals 
compared to wild type embryos. Figure 12 (C-F) shows a comparison between 
control and gt1 stage 13 embryos. We observe that under identical staining and 
exposure conditions, Gt staining intensity in the control embryo is stronger 
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compared to the gt1 embryo (Figure 12C and D). We also note a prominent 
cluster of approximately 5 bilateral posterior midline neurons that express Gt in 
stage 13 embryos (Figure 12E, yellow arrowheads). In equivalently staged gt1 
mutant embryos (Figure 12F), the number of cells in this cluster that express Gt 
is reduced to two to four cells (Figure 12F, yellow arrowheads).  Similarly, 
staining of a cluster of three cells positioned anteriorly on the midline axis (Figure 
12E and F, blue arrows) is also dramatically reduced in the gt1 sample.  
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Figure 12: gt1 affects expression of an independent PG neuron marker 
Feb211-GFP and may affect PG neuron development by expression 
threshold effect  
(A and B) In a gt1 background Feb211-GFP expression is lost in a stochastic manner 
identical to ptth in figure 1 indicating that the fate of the PG neurons may be affected and 
not just ptth expression. (C and D) A comparison of Gt immuno-staining intensity 
between control and gt1 embryos indicates that Gt expression is reduced in the gt1 
embryo (exposure time: C (1.693 sec) and D (1.754 sec). (E and F) At higher 
magnification, and upon increasing the exposure time for the gt1 embryo, the gt1 embryo 
in D show loss of Gt expression in some bilaterally symmetric Gt-expressing cells 
(yellow arrowheads). Loss of Gt is also seen in a cluster of three cells positioned 
anteriorly (blue arrows). 
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These results suggest that the fate of several neurons in the brain is likely 
affected in the gt1 mutant animals. Since we have no lineage tracers available to 
directly determine if the PG neurons are derived from earlier precursors that 
express Gt, we used an indirect assay to determine if PG neurons are mis-
specified in gt1 hypomorphs. Previous axon tracing experiments have revealed 
that the PG neurons are the only neurons that innervate the prothoracic gland 
(Siegmund and Korge, 2001). To determine if gt affects the fating of PG neurons, 
we examined cysteine string protein (Csp) distribution on ring gland cells.  As 
shown in Figure 13 (A-C) Csp co-localizes with PTTH in axon terminals and 
boutons on the surface of wildtype prothoracic gland cells as well as in gt1 mutant 
larvae that still show PTTH expression (Figure 13D-F). In contrast, 
developmentally delayed gt1 larvae in which PTTH expression is absent from all 
4 PG neurons, no Csp-containing boutons are observed on prothoracic gland 
cells (Figure 13G-I). In these same larvae however, Csp-containing axons and 
boutons are still seen within the corpus cardiacum and corpus allatum, two 
regions of the ring gland that are innervated by different sets of neurons (Figure 
13H, yellow arrowheads (Siegmund and Korge, 2001)). We conclude that loss of 
Gt affects the fate of the PG neurons since its absence leads to a loss of 
prothoracic gland innervation. 
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Figure 13: gt1 affects fate of the PTTH-producing PG neurons.  
gt1 and yw control larvae expressing PTTH-HA under the endogenous ptth promoter 
were co-stained with anti-HA and anti-CSP (cysteine string protein) antibodies. (A and 
D) PTTH-HA staining is clearly seen in the PG neurons, and sites of innervation on the 
prothoracic gland in the yw control larvae and in gt1; ptth-HA larvae that develop 
normally. (B, C, E and F) CSP co-localizes to the sites of innervation by the PG neurons 
on the prothoracic glands of these larvae. (G) gt1 larvae that manifest the ‘giant’ 
phenotype do not show any PTTH-HA staining either on the brain lobes where the PG 
neurons are located or on the prothoracic glands. (H and I) Csp staining is also absent 
on the prothoracic glands of these larvae indicating a loss of innervation by the PG 
neurons. However, Csp staining is still visible on the corpus cardiacum and the corpus 
allatum that are innervated by a different set of neurons than the PG neurons (H, yellow 
arrowheads). 
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2.2.4 PG neurons provide a tropic signal to the prothoracic gland. 
While working with the gt1 mutants we observed that gt1 mutant larvae 
exhibiting unilateral innervation of the prothoracic glands consistently caused 
asymmetrical growth in which the innervated gland was significantly larger than 
the non-innervated lobe (Figure 14).  DAPI staining revealed that the nuclei on 
the non-innervated side are much smaller compared to the innervated side 
(Figure 14B and C). This difference was consistently observed in all samples that 
failed to innervate one of the prothoracic glands indicating that cellular growth is 
likely reduced in absence of prothoracic gland innervation. Curiously, as 
previously reported (Mcbrayer et al., 2007) when both sides lacked innervation, 
the ring gland did not appear substantially smaller than wild type (compare 
Figure 13C and I).  However these glands are from developmentally delayed 
larvae in which the extra growth time likely enables them to “catch up” to the 
wildtype in terms of prothoracic gland size.  Ultimately we will need to examine 
PTTH null mutants to prove that PTTH, and not some other factor, is the tropic 
signal secreted from the PG neurons.  
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Figure 14: gt1 hypomorphs reveal that the PG neurons relay a tropic signal 
to the prothoracic glands that promotes growth  
(A and B) gt1; ptth-HA CNSs containing only one set of PG neurons (A, yellow 
arrowhead) mostly innervate only one of the prothoracic glands. The innervated 
prothoracic gland serves as an internal control to look for any growth promoting effect of 
the PG neurons. DAPI staining of these samples show that the prothoracic gland that is 
not innervated is consistently smaller than the control prothoracic gland indicating that 
the PG neurons provide a tropic signal to the prothoracic glands. The cells in the non-
innervated prothoracic gland have much smaller nuclei (B red arrowhead) indicating 
impaired DNA synthesis. (C) To quantify the difference in size, we determined nuclei 
diameter for 12 nuclei from one PG and considered the average of these measurements 
as a single data point representing PG size. PG size was similarly calculated for 
innervated and non-innervated PGs from three independent brain ring glands 
complexes. The mean of these measurements is plotted and show that PGs that are not 
innervated are significantly smaller (p-value = 0.005). Significance was calculated using 
a paired student t-test to negate the effect of variations in PG size between the three 
samples. 
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2.2.5 Residual PG neurons show enhanced axon misrouting in gt1 mutant 
larvae 
 In addition to the absence of prothoracic gland innervation in many gt1 
hypomorphic larvae, we noted that there is an enhanced frequency of axon 
misrouting in gt mutant larvae that still show ptth-HA expression in one or more 
of their PG neurons.  In wild type larvae, the polarized PG neurons in the left lobe 
of the brain send out their axons from the cell body across the central axis of the 
CNS to the right brain lobe. There the axon forms a loop with a left hand twist 
and then projects anteriorly to innervate the prothoracic gland cells on the right 
half of the ring gland (Figure 15A and B, and Siegmund & Korge, 2001).  
Similarly the neurons in the right lobe extend their axons into the left lobe and 
innervate the left half of the ring gland. This innervation pattern is most clearly 
revealed in gt1 mutant larvae retaining one pair of the bilateral PG neurons.  For 
example, in a gt1 mutant larva that retains the right PG neurons, there is 
innervation only within the left prothoracic gland (Figure 14A).  In wild type 
larvae, the axon tracts from each pair of PG neurons are almost parallel to each 
other at the base of the ring gland and rarely exhibit cross (in a single experiment 
only 1 out of 23 CNSs showed branching).  However, in the gt1 CNSs containing 
one or two PG neurons in only one brain lobe, we often see the axons branching 
at the base of the ring gland and innervating both prothoracic glands (Figure 
15C, yellow arrowhead). Interestingly we observed similar branching events in 
	  	   	  42	  
gt1 samples that have all the four PG neurons (Figure 15D and E, yellow 
arrowhead). This suggests that the cross innervations are not likely to be caused 
by a mechanism that tries to compensate for the lack of innervation on one side 
of the prothoracic gland.  Consistent with this view, we find that in certain cases 
such branching events caused excessive innervation of one of the prothoracic 
glands at the cost of the other (Figure 15D, red arrowheads). Approximately 24% 
of gt1 CNSs that had at least one PG neuron showed cross innervation events 
with clear branching at the base of the ring gland. These results suggest that gt is 
required not only for correct fate determination of the PG neurons, but also 
influences the projection of PG neurites to their target tissue. 
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Figure 15: PG neurons in gt1 hypomorphs exhibit an increased frequency of 
axon misrouting.  
(A) Anti-HA staining (red) of yw; ptth-HA CNS shows that axon projections from PG 
neurons follow a well defined path with the PG neurons in the left lobe of the brain 
innervating the right prothoracic gland and vice versa (modeled in B). (C) Similar staining 
of gt1; ptth-HA CNSs show that gt1 mutants containing one or two PG neurons in one of 
the brain lobes often show branching of axons at the base of the ring gland (yellow 
arrowhead). (D) Such branching is also observed in gt1; ptth-HA CNSs that retain all the 
four PG neurons and, in certain cases, leads to excessive innervation of one of the 
prothoracic glands at the cost of the other (red arrowheads). (E) An enlargement of the 
base of the ring gland in C clearly shows the branching (yellow arrowhead). (F) For a 
better understanding of the branching pattern a model of gt1 CNS showing axon 
branching is provided. While the model shows axons from only the red PG neurons 
cross innervating the PGs, it is possible for the green axon bundle or both the axon 
bundles to branch at the base of the PG. 
 
 
	  	   	  44	  
2.3 DISCUSSION 
Our work presented in this chapter shows that the hypomorphic gt1 
mutation leads to developmental delay and ecdysone deficiency by affecting 
development of the PTTH-producing PG neurons. The gap gene gt has been 
shown to have a complex and dynamic expression pattern during late embryonic 
stages using in situ hybridization (Eldon and Pirrotta, 1991). Our 
immunohistochemistry (IHC) staining against Gt in late embryos confirm this 
expression pattern. We observe that the primary staining of Gt is in an anterior 
medial position that is anatomically close to or overlapping with the pars 
intercerebralis (PI) and pars lateralis (PL) region of the brain. This part of the 
developing brain gives rise to a number of neurosecretory cells including several 
neurons that innervate the corpus cardiacum and corpora allatum, two other 
portions of the ring gland (de Velasco et al., 2007). The PI placode derives from 
neuroepithilium that expresses tailless and orthodenticle, two anteriorly 
expressed gap genes (Sprecher et al., 2007). The exact origin of the PG neurons 
has not been established, but they may be derived from two other placodes that 
reside more posterior to the PI region (de Velasco et al., 2007). Interestingly, we 
did observe a prominent cluster of bilateral posterior midline neurons that 
expressed Gt in stage 13 embryos indicating that gt may be expressed in 
neuronal precursors of the PG neurons. While we could not show co-expression 
of Gt and PTTH-HA in the same neuron in the developing brain, our observation 
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that Gt can be seen in a couple of neurons sitting next to the PG neurons in the 
brain supports the possibility that Gt is located at the right place to be able to 
influence development of the PG neurons. Whether Gt does so in a cell-
autonomous or cell-non-autonomous manner will require further fate mapping 
analysis of gt expressing cells. Nevertheless, these experiments add gt to the list 
of anteriorly expressed gap genes that affect the fate of the proto-cerebrum 
(Younossi-Hartenstein et al., 1997). 
At a molecular level, gt1 hypomorphic mutation is caused by two 
spontaneous insertions on either side of the giant coding region with one of the 
insertions located in the regulatory upstream region of gt (Mohler et al., 1989). gt1 
therefore is capable of affecting regulation of gt expression. A significant 
reduction in the level of Gt protein in late embryos, as seen with 
immunohistochemistry, confirms lower expression of gt in the gt1 mutants. Based 
on the reduced abundance of Gt in gt1 mutants and the expression pattern of gt, 
that includes precursory neurosecretory neurons, we conclude that gt1 affects PG 
neuron specification by affecting development of neuronal precursor cells 
through an expression threshold effect. Such a developmental expression 
threshold effect also explains the random stochastic loss of the PG neurons 
leading to the incomplete penetrance of the ‘giant’ phenotype. 
Prior to our study, it had been proposed that gt regulates developmental 
transitions and ecdysone production by affecting ecdysteroidogenesis genes 
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directly in the PGs. This conclusion was based on one study that showed 
presence of Gt in the embryonic PG using IHC, a conclusion drawn merely from 
the position of the Gt staining cells (Eldon and Pirrotta, 1991). The ring gland 
expression is intriguing since one possible way to restrict ptth expression to only 
the two neurons that innervate the prothoracic gland is by delivery of a required 
retrograde signal from the target tissue.  Such a mechanism is involved in 
regulating the peptidergic phenotype of the FMRF producing Tv neurons (Allan et 
al., 2003; Marques, 2003), and perhaps gt expression in the ring gland could play 
an analogous role in regulating a retrograde signal that controls ptth expression. 
However, in our experiments involving IHC of embryos and larval brains did not 
show any staining of the PG. We suspect that the previously-reported expression 
of Gt in the embryonic ring gland (Eldon and Pirrotta, 1991) was a misidentified 
portion of the dorsal brain. 
In Manduca sexta PTTH is believed to have a tropic effect on the larval 
prothoracic gland as it has been shown to induce general protein synthesis 
(Rybczynski and Gilbert, 1994).  Similar to Manduca sexta, prothoracic gland 
cells in Drosophila are mitotically quiescent during larval stages. Nevertheless, 
the gland cells exhibit substantial growth during the three larval stages and this 
growth is characterized by the formation of polytene chromosomes and an 
increase in size of the gland cells (Aggarwal and King, 1969). Our observation 
that lack of PG innervation by the PG neurons lead to smaller PG cells indicates 
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that Drosophila PTTH also have a growth-promoting role in the PGs. Ultimately 
we will need to examine PTTH null mutants to prove that PTTH, and not some 
other factor, is the tropic signal secreted from the PG neurons in Drosophila. 
However, the recent finding that PTTH signals through the Drosophila receptor 
tyrosine kinase (RTK) Torso is certainly consistent with the idea that PTTH is the 
tropic factor since the Torso signal is transduced through the canonical Ras-Raf-
ERK pathway (Rewitz et al., 2009) which is known to regulate cell proliferation in 
many systems (reviewed in (McCubrey et al., 2007)). 
Lastly, we reported that PG neurons present in gt1 mutants show an 
increased propensity of cross innervating the PGs. These results suggest that gt 
is required not only for correct fating of the PG neurons, but also influences the 
projection of PG neurites to their target tissue.  At present, we cannot distinguish 
if these axon guidance defects represent reduction in the expression of intrinsic 
factors within the PG neurons that respond to guidance cues or whether Gt 
affects the fate of not only the PG neurons themselves, but also surrounding 
neurons that might provide guidance cues.  Ultimately, lineage tracing 
experiments will be required to determine which neurons are descendent from 
Gt-expressing cells in order to address these issues. 
In summary, our demonstration that gt1 mutation affects the PPTH 
producing PG neurons resolves the long unanswered question as to how a 
hypomorphic mutation in a gap gene leads to developmental delay and ecdysone 
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deficiency. Our finding suggests that Giant may also play a crucial role in shaping 
the developing cortex. An extensive fate mapping study along with spatio-
temporal deletion of gt expressing cells in the developing embryo will throw more 
light on this new role of Giant during development. Lastly, we present a direct 
evidence for the role of PTTH signaling in regulating cell growth in the PGs, 
which may also affect ecdysone production and developmental timing. 
2.4 MATERIALS AND METHODS 
2.4.1 Drosophila stocks and husbandry 
The gt1 and gtE6 lines were obtained from the Bloomington Drosophila stock 
center. gt1; ptth-HA stocks were generated by standard genetic methods. 
Genomic ptth-HA lines (yw; ptth-HA) and the yw;Feb211-Gal4;UAS-GFP 
(Feb211-GFP) line were described previously (Mcbrayer et al., 2007; Siegmund 
and Korge, 2001). gt1;UAS-GFP;Feb211-Gal4 larvae were obtained by crossing 
Feb211-GFP males to gt1 females and selecting male larvae. Flies were raised at 
25OC on standard food in vials. 
2.4.2 Immunohistochemistry 
The following antibodies were used at the indicated dilutions for 
immunohistochemistry: rat anti-HA 3F10 (Roche) 1/500, rat anti-Gt (generous gift 
from Dr. Vincenzo Pirrotta) 1/500 and mouse anti-CSP (Iowa Hybridoma Bank) 
1/100. The Alexa series (Invitrogen) of secondary antibodies were used for 
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immunofluorescence at 1/500 dilution. CNSs from third instar wandering larvae 
were dissected out and fixed in 4% paraformaldehyde in PBS for 20 minutes at 
room temperature for anti-HA and anti-CSP staining. Antibody staining and 
washes of larval CNSs were conducted in 0.1% Triton-X100 in 1X PBS (PBST). 
Primary antibody treatments of CNSs were done at 4OC for 24 hours. Embryos 
were dechorionated in 50% bleach, fixed in 4% paraformaldehyde in PBS for 15 
minutes and all subsequent antibody reactions were in PBS + 0.1% Tween-20. 
Samples were mounted in 80% glycerol in PBS and visualized on a Zeiss 
Axioplan 2 with a CARV unit for confocal microscopy. 
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CHAPTER 3 
The Drosophila TGF-β /Activin ligand Dawdle independently 
regulates insulin signaling and mitochondrial metabolism in the 
larvae  
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3.1 INTRODUCTION 
Systemic homeostasis is a defining feature of multicellular organisms and 
is crucial for survival in diverse conditions such as starvation and fluctuations in 
temperature, pH and nutrient availability. Consequently, robust regulatory 
networks involving multiple sensors, feedback mechanisms and signalling 
pathways have evolved in most organisms to maintain homeostasis (Baker and 
Thummel, 2007; Léopold and Perrimon, 2007). Deciphering how components of 
these networks function to achieve homeostasis is essential for understanding 
biology and the underlying mechanisms behind multifaceted diseases like 
metabolic syndrome and diabetes. 
Insulin signaling is a key pathway that regulates nutrient homeostasis in 
higher organisms. Released from specialized insulin producing cells (β cells in 
vertebrates) in response to nutrient availability, insulin induces cellular nutrient 
uptake and storage/utilization. Insulin also interacts with other regulatory 
pathways including glucagon signaling, nutrient sensing in the brain and TOR 
signaling (Avruch et al., 2005; Fernandez and Torres-Alemán, 2012; Potter et al., 
2001). Apart from interactions mediating nutrient homeostasis, insulin levels can 
also indirectly affect pH homeostasis by up-regulating ketogenesis. Such cross-
regulations is essential for maintaining a robust homeostatic state and 
involvement of classical developmental pathways in regulating homeostasis has 
gained much attention recently. One such developmental pathway that has been 
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shown to affect multiple aspects of metabolism including nutrient and energy 
homeostasis is TGF-β signaling (Ballard et al., 2010; Zamani and Brown, 2011).  
A role for TGF-β signaling in regulating insulin signaling has been 
proposed based on a number of in vitro and in vivo studies. Several in vitro 
studies have shown that TGF-β ligand Activin-A can stimulate Ca2+ influx and 
insulin release from both rat and human β-cells in the presence of glucose (Florio 
et al., 2000; Totsuka et al., 1988). Yet prolonged exposure of cultured human 
islets cells to Activin-A antagonizes rather than stimulates insulin secretion and 
expression (Szabat et al., 2010). Activin-A also up-regulates pax-4 gene 
expression in cultured cells indicating a potential role of activin-A in regulating β-
cell replication and maturation (Brun, 2004; Ueda, 2000). Consistently, blocking 
activin signaling by either receptor deletion or by over-expression of a dominant 
negative receptor or inhibitory R-smad in the β-cells leads to hypoplastic islets 
and impaired glucose tolerance (Shiozaki et al., 1999; Smart et al., 2006; 
Yamaoka et al., 1998). Conversely, increasing activity of TGF-β superfamily 
ligands such as activins, myostatin and GDF11 by deleting their antagonist 
follistatin-like-3 (FSTL3) also affects β-cell differentiation and function, further 
confirming the role of TGF-β signaling in regulating insulin signaling (Mukherjee 
et al., 2007). Unlike Activin-A, Activin-B has been proposed to negatively regulate 
insulin release based on the phenotype of ALK7 (type I receptor that recognizes 
Activin-B and not Activin-A) mutants (Bertolino et al., 2008). While most of the 
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above-mentioned results involve either ligand gain-of-function or receptor 
deletion, loss-of-function studies using the ligands in question are either lacking 
or have failed to complement the corresponding gain-of-function studies (Bonomi 
et al., 2012; Li et al., 2009).  
In their study, Li et al. generated an Activin-A mutant by knocking in the 
Activin-B mature domain into the Activin-A locus. These mutants however did not 
develop any glucose intolerance or insulin resistance thereby questioning the in 
vivo role of Activin-A in insulin release in vertebrates. However, these mutants 
were much smaller and leaner than controls and these phenotypes could be 
rescued by growing the animals on a high-calorie diet. Further physiological and 
biochemical analysis of these mutants revealed characteristics that are 
associated with higher mitochondrial activity. Tissues from these mutants 
showed significantly higher expression of several mitochondrial genes and higher 
oxygen consumption. This effect of losing Activin-A on mitochondrial activity has 
significant pathophysiological implications, as mitochondrial dysfunction has 
been associated with many human diseases and disorders (Bayeva et al., 2013; 
Dromparis and Michelakis, 2013; Maléth et al., 2012; Mitchell et al., 2013; 
Watson et al., 2012; Zsurka and Kunz, 2013). Given the large number of TGF-β 
signaling components and redundancies in activity, parsing out the exact 
mechanisms by which TGF-β affects insulin signaling, metabolism and nutrient 
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and energy homeostasis using the vertebrate model system can be a challenging 
and time consuming. 
In comparison, Drosophila melanogaster is an attractive alternative 
containing a conserved and more concise repertoire of both TGF-β and insulin 
signaling components (Schmierer and Hill, 2007). In Drosophila, TGF-β/Activin 
signaling is mediated by three ligands, Activin-β (Actβ), Dawdle (Daw) and 
Myoglianin (Myo), that signal through a single type I receptor Baboon (Babo) and 
a single intracellular transducer dSmad2 or Smox. Insulin signaling in Drosophila 
is mediated by Insulin-like growth factors that have been shown to be functionally 
similar to insulin in vertebrates (Baker and Thummel, 2007; Géminard et al., 
2009; Rulifson et al., 2002; Teleman, 2010). Drosophila insulin-like peptides 
(DILPs) are produced primarily in a cluster of neurosecretory cells in the fly brain 
called the insulin producing cells (IPCs). These cells are functionally analogous 
to β-cells and produce 4 of the 7 Drosophila insulin-like peptides (DILP 1, 2, 3 
and 5). The IPCs regulate both growth and nutrient homeostasis by releasing 
these DILPs in response to food and conducive growth conditions (Géminard et 
al., 2009; Musselman et al., 2011). Availability of these conserved pathways, 
along with the amenability of the fly to genetic and experimental approaches, 
allowed us to investigate in detail the role of TGF-β signaling in regulating insulin 
signaling and metabolism in the fly. 
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In this study we show that TGF-β signaling mediated by the TGF-β/Activin 
ligand Daw regulates sugar homeostasis, pH balance and mitochondrial 
metabolism in Drosophila larvae. We show that canonical signaling by Daw 
regulates sugar homeostasis primarily by affecting release of DILPs from the 
IPCs. The effect of Daw on pH is mediated independent of IIS by Daw’s action on 
mitochondrial metabolism and production of metabolic acids in the larval fatbody. 
Interestingly, Daw affects both phenotypes in a dose-dependent manner, as 
demonstrated by both loss-of-function and over-expression/gain-of-function 
experiments, thereby providing evidence for a hormonal role of Daw in regulating 
systemic homeostasis. 
3.2 RESULTS 
3.2.1 Loss of dawdle (daw) leads to conditional lethality depending on 
growth conditions 
 We and others have previously shown that mutations in the locus coding 
for the Drosophila Activin-like ligand, Daw, lead to larval lethality and retardation 
in the outgrowth of motoneuron axons during embryogenesis (Parker et al., 2006; 
Serpe and O'Connor, 2006). Since the mutant motoneurons do eventually reach 
their muscle targets and form essentially functional synapses, the reasons for 
larval lethality remained unexplained. An opportunity to uncover the cause of daw 
mutant lethality arose when we noticed that the viability of null daw mutants 
depends on the food source (Figure 16). Growth on standard corn meal food 
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(CMF) resulted in developmental delay and larval lethality.  On this food daw11 
homozygotes showed multiphasic larval lethality with more than 90% of larvae 
dying before the third instar wandering stage. Moreover, mutant larvae that did 
reach the pupal stages (less than 10%) showed significant developmental delay 
compared to yw control larvae (Figure 16A), and the mutant pupae never 
reached the pharate stage (data not shown). Interestingly, both larval lethality 
and developmental delay were significantly/completely rescued when daw11 
homozygous larvae were grown on 60% yeast paste food (YPF) (Figure 16A and 
B). Moreover, when grown on YPF, a significant number of daw mutants eclosed 
as adults that were similar in size to control animals (Figure 17). Severe lethality 
on CMF was also observed for daw1/11 trans-heterozygotic larvae (Figure 16B). 
Since the daw1 and daw11 alleles were generated by imprecise excision of 
independent P element insertions we conclude that the food-dependent 
conditional lethality is specific to loss of daw and not caused by a genetic 
background effect. Both alleles are likely null since they delete most of the coding 
region of the gene including the translational start site (Gesualdi and Haerry, 
2007; Serpe and O'Connor, 2006).  
Interestingly, the daw lethal phenotype is dose-sensitive since daw1/+ and 
daw11/+ heterozygotes also showed significant larval lethality on CMF, although to 
a lesser extent than trans-heterozygotes (Figure 16C). Similar to daw mutants, 
loss of babo or smox, genes encoding the Daw receptor and R-Smad signal 
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transducer, respectively, also showed a food-dependent larval lethal phenotype 
(data not shown). The majority of either babo or smox mutant larva also failed to 
reach the pupal stage on CMF, but formed pre-pupae on YPF. Notably, unlike 
daw, null mutations in either myo or actβ, two other Drosophila Activin-like 
ligands, do not significantly affect pupariation rates on CMF food (data not 
shown). Thus the loss of larval viability on CMF for babo and smox mutants is 
primarily attributable to loss of daw signaling. 
 
Figure 16: daw mutants exhibit food dependent growth and viability  
(A) Developmental curves showing percentage of larvae that formed pupae and the time 
required to reach pupariation on cornmeal food (CMF) and yeast paste food (YPF). daw 
mutants (daw11) show significant developmental delay and larval lethality on CMF 
compared to yw controls. Growing the mutants on YPF completely/significantly rescues 
the phenotypes. (B) Lethality on CMF is observed for both homozygous and trans-
heterozygous daw mutants (daw11 and daw1/11). (C) daw heterozygotes also show 
significantly higher (p<0.001) lethality on CMF compared to w1118 wildtype controls. 
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Figure 17: daw mutants can eclose as healthy looking adults on YPF 
daw mutants when grown on YPF can reach adult stages and eclosed adults are similar 
in size to both w1118 wild-type and daw11/+ heterozygous controls. 
3.2.2 Daw is a key metabolic determinant that regulates both sugar 
homeostasis and pH balance 
 In an effort to explain the food-dependent lethality, we examined the 
steady-state levels of various key metabolites in daw mutant larvae grown on 
YPF and compared them to controls. We measured total triacylglycerol (TAG), 
glucose and glycogen stores of stage matched feeding daw mutant larvae and 
wildtype controls and found a significant increase in all three metabolites in the 
daw mutants (Figure 18 A-C). Elevated TAG and glycogen has previously been 
shown to be associated with loss of insulin-IGF signaling (IIS) in Drosophila. A 
significant increase in total TAG and glycogen content was observed in IPC-
ablated flies (Broughton et al., 2005; Teleman, 2010), and similar results were 
reported for flies that lacked dilp-2,3-5 or lacked the Drosophila Inr or the IRS 
homologue chico (Böhni et al., 1999; Grönke et al., 2010; Tatar, 2001). Our 
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observations suggested a role for Daw in regulating IIS in the Drosophila larva. 
Since IIS is also known to regulate circulating sugar concentration in larvae 
(Rulifson et al., 2002), we measured circulating sugar concentration of both 
feeding and 12 hour starved daw mutant and control larvae. We found a 
significant increase in circulating sugar levels in the daw mutants compared to 
both heterozygous and w1118 controls, consistent with a strong loss of IIS in daw 
mutants (Figure 18D). Interestingly, this “diabetic” phenotype was seen only in 
feeding animals and not in starved animals (Figure 19). A similar increase in 
circulating sugar concentration (about 40%) was also observed in smox null larva 
indicating that daw acts through the canonical Smad pathway to regulate IIS 
(Figure 19).  
To further evaluate whether daw might regulate other metabolic 
processes, we performed a small-molecule gas chromatography/mass 
spectrometry (GC/MS) analysis comparing the metabolite content of daw mutant 
larvae to controls. This analysis revealed a significant increase in multiple 
intracellular sugar metabolism and TCA cycle intermediates including pyruvate, 
citrate, 2-ketoglutarare, succinate, fumarate and malate, strongly implicating daw 
in the regulation of intracellular sugar/mitochondrial metabolism (Figure 18F). 
Interestingly, these metabolites are known to be present in high concentrations in 
Lepidopterans (Harrison, 2001; Wyatt, 1961), and a further increase in the 
concentration of these organic acids could lead to pH imbalance. We therefore 
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assayed for changes in internal pH of the daw mutants. Consistent with the 
increase in various metabolic acids, we find significant acidification of daw larval 
hemolymph compared to controls (Figure 18G). Overall, our data suggest that 
the Activin-like ligand Daw positively regulates IIS in larvae and protects against 
acidosis most likely by regulating the production of several metabolic acids that 
are intermediates in sugar metabolism.  
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Figure 18: daw regulates both sugar homeostasis and pH balance.  
(A-C) daw mutants show significantly higher TAG (A), glycogen (B) and glucose (C) 
content compared to controls. Metabolite contents were normalized to total soluble 
protein to account for differences in size of the animals. (D-E) Glucose + trehalose 
(Glu+TH) concentration of the hemolymph was measured for mutant and control feeding 
mid-third instar larvae. (D) daw mutants show a significant increase (~ 40 %) in 
circulating sugar concentration compared to both w1118 and daw1/+ controls. (I) Feeding 
smox mutants (smoxF4) also show a significant increase in circulating sugar 
concentration (~ 40 %) compared to yw controls. (F) A high-throughput GC/MS based 
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metabolomic analysis of daw1/11 and w1118 larvae show up-regulation of multiple sugar 
metabolism intermediates in the mutants. (G) Hemolymph pH of daw and smox mutants 
is significantly acidic (~pH 6.85) under conditions when w1118 and daw1/+ controls 
maintain a pH ranging between pH 7.2 and pH 7.4. 
 
 
Figure 19: daw is the primary TGF-β ligand that affects hemolymph sugar 
and does so only in feeding animals 
(A) daw mutant larvae when starved for 12 hours did not show any significant difference 
in circulating sugar concentration compared to heterozygous controls. (B) Feeding 
daw/Actβ double mutants showed an approximately 40% increase in circulating sugar 
concentration compared to matched controls. 
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3.2.3 High sugar content and acidity of CMF leads to lethality of daw 
mutants 
 Apart from YPF, a semi-defined food consisting of 5% yeast and 5% 
dextrose (5y5s) is also capable of completely rescuing viability of daw mutant 
larvae (Figure 20). We compared the major nutritional content of CMF, YPF and 
5y5s food to determine if nutritional differences could explain lethality on CMF 
(Figure 20A). We note that both YPF and 5y5s food are lower in total 
carbohydrate content. This difference, along with our observation that loss of daw 
affects sugar metabolism and IIS, led us to hypothesize that daw mutants may be 
sensitive to the high sugar content of CMF. Consistent with this notion, we found 
that when challenged with a high sugar diet (HSD), daw mutants showed a 
statistically significant increase in larval lethality (Figure 20B). 
Additionally, we examined the effect of acid in the food on the viability of 
daw mutants both because daw mutant larvae show internal acidosis and 
because CMF is more acidic (pH 4.3 compared to ~ pH 6.8 of 5y5s food) owing 
to the addition of propionic acid (PA) as a mold inhibitor. Acidic food (pH 4.3) 
indeed caused a significant decrease in the viability of daw mutants. Organic 
acids such as PA and acetic acid (AA) had a more profound effect on larval 
viability than inorganic acid (HCl) (Figure 20C). Interestingly, combining a high 
sugar diet with PA resulted in the most severe larval lethality, phenocopying the 
extent of lethality seen on CMF (less than 10% viability, Figure 20D). Acidic food 
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also led to significant developmental delay, with PA producing the strongest 
effect, followed by AA and HCl (Figure 20E).  
We hypothesized that the acidic food conditions led to larval lethality and 
developmental delay by aggravating the already acidic internal pH of the daw 
mutant larvae. Consistent with this view, we find that transferring daw and control 
mid L3s to acidic food conditions further lowers the hemolymph pH of mutants 
compared to non-acidic food (Figure 20F, dotted line shows pH of mutants on 
YPF). Interestingly, heterozygous mutants also showed a significant but 
intermediate drop in hemolymph pH compared to wildtype controls signifying a 
dose-dependent role of daw in regulating the acidosis phenotype, analogous to 
the CMF-induced larval lethality phenotype. Apart from high sugar and acidic 
conditions we tried a number of food conditions that mimicked CMF in nutritional 
content, or represented extremes of nutritional conditions, for any effect on 
viability of daw mutants. None of these conditions significantly increased daw 
lethality compared to wild-type controls (Figure 21). 
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Figure 20: High sugar content and Propionic acid (PA) in CMF kills daw 
mutants 
(A) A comparison of major nutritional content of CMF, YPF and 5% yeast+ 5% Dextrose 
(5y5s) food show a significantly higher carbohydrate content of CMF. (B) Viability of daw 
mutants is not significantly different from controls on 5y5s food. However, daw mutants 
show significantly higher lethality on food containing 15% sugar (5y15s). (C) Titrating the 
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pH of 5y5s food to pH 4.3 (same as CMF) leads to significant decrease in viability of daw 
mutants but not controls. Choice of acid to lower pH differentially affects larval viability 
with PA most severely reducing viability (~ 30 %). (D) Combining HSD with PA (pH 4.3) 
most severely decreases viability of daw mutants mimicking CMF (<10 % viability). (E) 
Acidic food condition also replicates delayed development of daw mutants as observed 
on CMF. PA once again most severely affects developmental timing. (F) 12 hour 
exposure to acidic environment is capable of impacting the internal pH of both daw 
heterozygotes and daw mutants (mutant pH on YPF or 5y5s food is shown with a dotted 
line) but not wild-type controls. PA induced acidity is more potent in reducing internal pH 
of daw mutants. 
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Figure 21: Viability of daw mutant larvae on various food conditions 
(A) Addition of PA to 5y5s food significantly increases lethality of both daw homozygous 
and trans-heterozygous mutants. Consistently, removing PA from CMF can significantly 
rescue lethality of daw mutants. (B) daw mutants did not show any significant change in 
viability on a range of food conditions mimicking either nutrient content of CMF or 
representing extremes of nutrient conditions. (C) Nutrient content of the various food 
conditions tested for daw viability. In green are the content in CMF for the corresponding 
class of nutrient. Red and dark-blue boxes show very low sugar and condition 
representing nutritionally poor food respectively. 
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3.2.4 daw dose-dependently regulates hemolymph sugar concentration 
and pH 
We tested if ectopic over-expression of daw can rescue the novel loss-of-
function phenotypes of daw described above. We found that over-expression of 
daw in the larval fat body using either the cg-Gal4 or fb-Gal4 driver completely 
rescues lethality of the mutants on CMF, enabling them to eclose as adults 
(Figure 22A, data not shown). Fat body over-expression of daw also causes a 
significant drop in circulating sugar concentration of daw mutants compared to 
controls (Figure 22B). Interestingly, excess daw causes circulating sugar 
concentration to drop below the normal range (~10 mg/ml compared to ~15mg/ml 
in feeding mid third instar larvae, Figure 18D,E and Figure 24E). A similar effect 
was observed for the hemolymph pH phenotype where over-expression of daw 
caused hemolymph pH of daw mutants to become significantly more basic than 
even the wildtype range (Figure 22C). These observations clearly show that Daw 
dose dependently regulates both circulating sugar concentration and hemolymph 
pH in Drosophila larvae. Consistent with dose-dependency, over-expressing daw 
in a much smaller number of cells, such as the ~ 14 larval IPCs (7 per brain 
hemisphere), rescues both diabetic and acidosis phenotypes but does not show 
an over-rescue effect (Figure 23). This result also highlights the ability of Daw to 
act as a systemic hormone in regulating both sugar balance and hemolymph pH. 
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Figure 22: Ectopic expression of daw can rescue metabolic phenotypes of 
daw nulls  
A UAS-daw construct was over-expressed in the daw mutant background using fatbody 
specific cg-Gal4 or fb-Gal4 drivers, and its ability to rescue lethality on CMF, circulating 
sugar concentration and hemolymph pH was assessed. Appropriate controls were daw 
mutants containing either the UAS-daw or Gal4 construct alone. (A) Over-expression of 
daw using either driver was able to completely rescue viability of daw mutants on CMF. 
(B) Ectopic over-expression of daw using either driver significantly rescues circulating 
sugar concentration. Notably, daw over-expression lowered circulation sugar 
concentration to about 9mg/ml compared to ~ 15 mg/ml observed in wild-type controls 
(refer Figure. 2D,E) (C) Ectopic over-expression of daw was also able to significantly 
rescue hemolymph pH. Similar to its effect on sugar, daw over-expression increased 
hemolymph pH to ~ 7.6, much higher compared to the wild-type range of pH 7.3 to 7.4 
(refer Figure 2G). 
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Figure 23: Over-expressing daw in the larval IPCs can rescue metabolic 
phenotypes of daw mutants 
(A) Over-expressing daw in the IPCs using a dilp2-Gal4 driver can rescue the diabetic 
phenotype of daw mutants. (B) daw over-expression in the IPCs of daw mutants can 
also rescue the pH phenotype significantly. 
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3.2.5 Daw positively regulates DILP release from the larval Insulin 
Producing Cells (IPCs) 
Metabolic phenotypes like elevated TAG, glucose, glycogen and elevated 
circulating sugar concentration, observed in the daw mutants, suggests a 
reduction of insulin signalling. To elucidate the mechanism by which daw may 
affect IIS, we examined various aspects of IIS such as dilp expression, Dilp 
release and signal reception in the daw mutants. We find that loss of daw does 
not affect expression levels of dilps 1, 2, 3 or 5 in the IPCs of feeding mid third 
instar larvae (Figure 24A). However, immuno-staining of feeding larval CNSs 
using anti-Dilp2 antibody shows significant accumulation of Dilp2 in the IPCs of 
mutant animals (Figure 24B and B’). In the absence of any change in expression 
levels, this result indicates a deficiency in Dilp release from the IPCs. To examine 
this issue further, we checked for the efficiency of Dilp5 release from IPCs using 
a starvation/re-feeding experiment. Starving mid third instar larvae showed a 
strong accumulation of Dilp5 in both test and control CNSs (Figure 24C). Re-
feeding for 4 hours on a nutritious media (2.5% yeast, 2.5% dextrose, 1% 
sucrose, 0.5% peptone and 0.5% yeast extract) induced control larvae to release 
nearly all Dilp5 peptide into circulation. However, daw mutants showed 
substantial retention of Dilp5 within the cell body upon refeeding, indicating a 
deficiency of Dilp release in mutant larvae in response to nutrients (Figure 24C).  
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If daw indeed regulates IIS upstream of the insulin receptor (Inr) by 
regulating Dilp release, increasing circulating Dilp titers in daw mutants should 
rescue the daw diabetic phenotype. Over-expressing dilp2 in a group of non-
insulin producing neuro-secretory cells using Kurs6-Gal4 has been shown 
previously to hasten developmental timing and produce smaller adults as 
expected for Dilp overproduction (Géminard et al., 2009). Using the same Kurs6-
Gal4 driver line we found that overexpression of dilp2 significantly reduces 
circulating sugar concentration in wildtype larvae (Figure 24D) and also 
significantly rescued the diabetic phenotype of daw null mutants (Figure 24E). 
These results show that the peripheral tissues in daw mutants are capable of 
responding to Dilps, and that loss of IIS in daw mutants is indeed largely caused 
by reduction in Dilp release into the hemolymph. 
 
 
	  	   	  73	  
 
Figure 24: Daw positively regulates DILP release from the IPCs 
(A) Expression level of dilp 1,2, 3 and 5 in dissected daw1/11 and control larval CNSs was 
measured using quantitative PCR and is reported as abundance relative to RPL23. (B) 
CNSs dissected from feeding control and mutant larvae was stained with anti-DILP2 
antibody (red). Samples were imaged by confocal microscopy with laser and scan 
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settings adjusted to the accumulation state of daw CNS so as to avoid saturation. Under 
identical staining and imaging conditions control CNSs do not show any staining for 
DILP2 indicating significant accumulation of DILP2 in the mutants. Elav staining (green) 
of the same samples serve as staining controls showing that staining intensity of the test 
and control samples are comparable. (B’) Quantified fluorescence intensity of DILP2 in 
the CNSs of daw mutant and control feeding larvae (n = 9 CNSs from 3 independent 
experiments for each plot) (C) CNSs dissected from 16 hour starved and 4 hour re-fed 
control and mutant larvae were stained with anti-DILP5 antibody (green). Under identical 
staining and imaging conditions DILP5 staining was much stronger in mutant re-fed 
CNSs than control animals. DILP5 staining in starved mutant and control animals was 
identical. (D) Increasing DILP2 titers in circulation of wild-type animals by over-
expressing dilp2 in non-insulin producing neuro-secretory cells (Kurs6-Gal4>dilp2) 
causes a significant decrease in circulating sugar concentration compared to matched 
controls. (E) Kurs6-Gal4>dilp2 had a similar effect on circulating sugar concentration in 
daw mutant larvae. 
3.2.6 Daw regulates acidosis by acting on large metabolic tissues like the 
larval fatbody 
daw mutants show significant accumulation of several organic acids that 
are intermediates of normal sugar metabolism. Therefore, we predicted that the 
acidosis observed in daw mutants is likely caused by a metabolic imbalance. 
Consistent with this notion, we find that expression of an activated type-I 
receptor, baboCA, in any large tissue like the gut, muscle or fat body, was able to 
significantly rescue the acidosis phenotype (Figure 25A). Interestingly, 
expressing baboCA in the fat body made the hemolymph pH of daw mutants 
significantly more basic than normal, as was observed for daw over-expression 
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(Figure 25A and Figure 25C). These results indicate that daw signaling likely 
regulates metabolic function in several large tissues which together contribute to 
overall pH balance in larval hemolymph. To determine if alterations in the organic 
acid levels are responsible for the acidosis observed in daw mutants, we 
compared daw11; fb-Gal4/+ controls and daw11; fb-Gal4>baboCA rescued animals 
for metabolite content using GC/MS analysis. The rescued animals had a 
significantly lower content of major organic acids compared to controls, indicating 
a direct correlation between acidosis and the level of these acids (Figure 25B). 
We therefore argue that daw signaling affects internal pH by altering metabolic 
accumulation of various organic acids including pyruvate, citrate, fumarate and 
malate. 
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Figure 25: Daw regulates pH balance by acting on the larval fatbody 
(A) Over-expression of a constitutively active type-I receptor, baboCA, in major metabolic 
tissues of daw mutants can significantly rescue acidosis observed in mutant controls. 
Notably, expressing baboCA in the fatbody mimics daw over-expression (Figure. 4C). (B) 
A GC/MS metabolomics analysis of mutant control and rescued larvae show significant 
down-regulation of multiple organic acids that are products of normal sugar metabolism. 
3.2.7 Loss of Daw affects mitochondrial gene expression and physiology 
in the fatbody 
We showed that loss of Daw leads to metabolic acidosis by causing 
accumulation of TCA cycle intermediates in major metabolic tissues like the FB. 
Since the acidosis phenotype is mediated by canonical TGF-β signaling we 
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decided to identify the transcriptional targets of Daw signaling to better 
understand how Daw regulates TCA cycle or mitochondrial metabolism. We 
focused on identifying targets of Daw in the FB as activating TGF-β signaling in 
the FB could rescue the acidosis phenotype of daw mutants. Gene expression 
changes in daw mutant FB compared to wildtype control were identified using 
Illumina next generation RNA sequencing. The sequencing results show that 
Daw primarily regulates genes that are involved in cellular metabolic processes 
(Figure 26A). A Gene Ontology (GO) class enrichment analysis of genes that 
were significantly deregulated in daw mutants (≥1.3 fold) showed that 37 out of 
38 GO classes for down-regulated genes and 66 out of 68 classes for up-
regulated genes belonged to cellular metabolic processes. This result shows that 
Daw is a major metabolic regulator and that effects of Daw loss-of-function on 
cellular metabolism cannot be attributed to any single metabolic gene or 
pathway. Notably, consistent with the role of Daw in accumulation of metabolic 
acids, GO classes involved in carboxylic acid and organic acid metabolic 
processes showed some of the most significant enrichments among deregulated 
genes in daw mutants (Figure 26A). 
Of the genes that were deregulated in daw mutants we found many that 
encodes for enzymes of the glycolysis and TCA cycle pathway (Figure 26B). 
While the effect of Daw on glycolytic genes was incoherent, with some enzymes 
(Hex-A, Eno) being up-regulated and others very strongly down-regulated 
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(Gapdh1, Ald and Pdk), loss of Daw was consistent in causing up-regulation of a 
number of TCA cycle enzymes (Figure 26B). Loss of Daw also led to significant 
up-regulation of a large number of genes that encode mitochondrial proteins of 
the oxidative phosphorylation apparatus (Table1). Since loss of Activin-A in 
mammals has been proposed to cause increased mitochondrial biogenesis we 
checked if up-regulation of mitochondrial genes in the daw mutants is caused by 
increased mitochondrial mass. We visualized mitochondria of daw mutant and 
control larval FBs using mitotracker staining (Figure 26C). While we did not see 
any increase in the amount of mitochondria in the mutant cells, we did observe 
obvious differences in mitochondrial morphology. In w1118 FB cells mitochondria 
are visible as a network of fine tubular structures that are most dense near the 
surface of the cell (Figure 26C). In comparison daw mutant cells had 
mitochondria that were highly clustered leading to a less dense but clumpy and 
fragmented mitochondrial network (Figure 26C). Over all these results show that 
Daw negatively regulates a large number mitochondrial metabolic genes and is a 
major regulator of mitochondrial activity and morphology. 
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Figure 26: Daw is a major regulator of metabolic genes and mitochondrial 
metabolism. 
(A) GO classes that were most significantly enriched in genes that were de-regulated in 
daw mutants. Up-regulated genes in daw mutants primarily affected oxidation-reduction, 
carboxylic acid metabolism and respiratory electron transport chain genes. (B) Glycolytic 
and TCA cycle enzymes that were significantly affected in the daw mutants. (C) 
Mitotracker staining of w1118 and daw1/11 FB cells. Loss of Daw causes significant 
morphological changes in the mitochondrial network marked by fragmented larger 
mitochondrion.  
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Table 1: Electron transport chain genes that are up-regulated in daw mutants. 
Gene ID Gene Name Function (electron transport chain) Fold change 
CG6030 ATPsyn-d ATP synthase, subunit d 1.3 
CG4412 ATPsyn-Cf6 ATP synthase coupling factor 6 1.5 
CG11154 ATPsyn-β ATP synthase, subunit β 1.4 
CG10664 CoIV Cytochrome c oxidase subunit IV 1.3 
CG11015 CoVb Cytochrome c oxidase subunit Vb 1.5 
CG7181 CoVIII Cytochrome c oxidase subunit VIII 1.3 
CG17903 Cyt-c-p Cytochrome c proximal 2.3 
CG2968 l(1)G0230 Hydrogen-exporting ATPase activity 1.4 
CG13240 l(2)35Di NADH dehydrogenase (ubiquinone) activity 1.5 
CG9762 l(3)neo18 NADH dehydrogenase (ubiquinone) activity 1.4 
CG3683 NDUFA8 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 8 1.5 
CG8844 Pdsw NADH dehydrogenase (ubiquinone) activity 1.5 
CG7361 RFeSP Rieske iron-sulfur protein 1.5 
CG3321 Predicted Hydrogen-exporting ATPase activity 1.3 
CG8680 Predicted NADH dehydrogenase (ubiquinone) activity 1.5 
CG9306 Predicted NADH dehydrogenase (ubiquinone) activity 1.4 
CG10320 Predicted NADH dehydrogenase (ubiquinone) activity 1.4 
CG18624 Predicted NADH dehydrogenase (ubiquinone) activity 1.6 
CG32230 Predicted NADH dehydrogenase (ubiquinone) activity 1.3 
CG3621 Predicted NADH dehydrogenase (ubiquinone) activity 1.5 
CG4769 Predicted Transferring electrons within CoQH2-cytochrome c reductase complex 1.4 
CG3560 Predicted Ubiquinol-cytochrome-c reductase activity 1.4 
CG3731 Predicted Ubiquinol-cytochrome-c reductase activity 1.4 
 
 
 
 
	  	   	  81	  
3.2.8 Daw regulates IIS and acidosis via independent mechanisms 
In vertebrates chronic loss of insulin signaling results in metabolic keto-
acidosis. In contrast, metabolic acidosis has also been proposed to cause insulin 
resistance (Cuthbert and Alberti, 1978; Mak, 2008). To define the cause and 
effect relationship in daw mutants between reduced insulin signaling and 
acidosis, we first asked if loss of IIS contributes to acidosis (Figure 27A). We 
found that over-expressing the potassium channel Ork1ΔC, to block insulin 
release in the larval IPCs, leads to a significant diabetic phenotype (Figure 27B), 
but it does not affect hemolymph pH (Figure 27C). Additionally, Kurs6-Gal4 
driven over-expression of dilp2, which significantly rescues the diabetic 
phenotype in daw mutants, did not affect hemolymph pH of the mutants (Figure 
27D). These results show that loss of IIS does not cause or contribute to the 
acidosis phenotype observed in the daw mutants. Next, we examined if 
expressing baboCA in the fat body of daw mutants, which is able to rescue the 
acidosis phenotype (Figure 25), is also able to rescue the diabetic phenotype of 
daw mutants. As shown in Figure 27E, fatbody specific expression of baboCA 
does not reduce the excess sugar levels in the hemolymph of daw mutants 
(Figure 27E). Taken together, these data indicate that acidosis does not 
contribute to loss of IIS, nor does impairment of IIS contribute to acidosis.  Thus, 
we conclude that daw regulates accumulation of metabolic acids and IIS through 
separate mechanisms.  
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Figure 27: Daw regulates sugar and pH homeostasis independently 
(A) Schematic showing the role of daw in regulating nutrient and pH homeostasis. 
Dotted lines represent possible interactions between the two prime phenotypes of loss of 
daw. (B) Over-expression of a potassium channel Ork1ΔC in the IPCs suppresses IIS 
and significantly up-regulates circulating sugar concentration in test animals compared 
to both wild-type and a genetically matched control. (C) Ork1ΔC over-expression in the 
IPCs did not affect the hemolymph pH of the diabetic animals. (D) Increasing DILP2 titer 
in circulation by over-expressing dilp2 with Kurs6-Gal4 did not affect hemolymph pH of 
daw mutant larvae. (E) Fatbody specific over-expression of baboCA failed to rescue 
hemolymph sugar concentration of the daw mutants. 
	  	   	  83	  
3.3 DISCUSSION 
Drosophila larvae spend much of their lives buried in food and therefore 
are constantly challenged by an environment that likely varies in hydration levels, 
pH, ionic strength, nutritional content and perhaps other factors, depending on 
the food type. Adapting to these challenges demands robust homeostatic 
mechanisms to cope with the potential variability.  Drosophila larvae therefore 
serve an apt model system to study regulatory networks that maintain systemic 
homeostasis. In this study, we demonstrate a central role of Drosophila TGF-
β/Activin signaling in regulating insulin signaling, metabolism, and pH balance, all 
of which are important for organismal homeostasis.  
3.3.1 Daw affects IIS by regulating insulin release through a non-cell-
autonomous process 
Similar to vertebrate insulin, Drosophila insulin-like peptides are produced 
and stored in dense granules in the larval IPCs and are released into the 
hemolymph in response to nutrient availability (Géminard et al., 2009; Rutter, 
2001). Apart from regulating Dilp release, nutrient availability also regulates 
transcription of certain dilps, since starvation has been shown to down-regulate 
dilp3 and dilp5 expression (Ikeya et al., 2002; Mukherjee et al., 2007). We did not 
observe any decrease in the steady state mRNA levels of dilp 1, 2, 3 or 5 in the 
daw mutants indicating that these mutants are neither starved nor are they 
defective in production of Dilps. However, daw mutants showed a significant 
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accumulation of Dilp2 in the IPCs even when food is abundant indicating a 
deficiency in food-induced Dilp release. Similarly, we show that the efficiency of 
Dilp5 release in response to nutrient availability is also compromised in daw 
mutants. These observations, coupled with the finding that ectopic expression of 
dilp2 in other neurosecretory cells is able to rescue the daw diabetic phenotype, 
indicate that in daw mutants, peripheral tissue is still responsive to Dilps, and that 
defective release of Dilps is the primary cause of the IIS defect. 
Our observation that TGF-β/Activin signaling impacts IIS in Drosophila 
reinforces a growing body of evidence suggesting that this regulatory interaction 
is a general function of TGF-β/Activin signaling across a diversity of species.  For 
example, recent work in C. elegans has documented a role for TGF-β signaling in 
mediating insulin release through transcriptional regulation of a potassium 
channel (exp-2) in the insulin producing cells (Park et al., 2012). However, such a 
cell-autonomous mechanism does not appear to be the case in Drosophila as 
neither smoxRNAi nor baboCA over-expression in the IPCs affected circulating 
sugar concentration in the wild-type or daw mutants, respectively (Figure 28A 
and B). Additionally, the Drosophila exp-2 homologue, shab, did not show any 
expression change in the daw mutant larval CNSs (Figure 28C). Previous studies 
have demonstrated that non-cell-autonomous regulation of Dilp release is 
operative in Drosophila and in some cases involves nutrient-induced signals from 
the fat body (Géminard et al., 2009; Rajan and Perrimon, 2012). Once again, 
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however, expressing baboCA in the fat body of daw mutants did not rescue the 
daw diabetic phenotype, suggesting that this tissue is not the source of the 
indirect Daw regulated signal that enhances Dilp release. Additional experiments 
are in progress to identify the relevant tissue or cell type involved in this relay.  
Activin/TGF-β family members have also been implicated in the regulation 
of insulin signaling in vertebrates. However, in these cases the molecular details 
are ill defined, in part due to the complexity and redundancy of the components 
of the signaling pathway, as well as the involvement of non-canonical signaling 
mechanisms. Numerous mouse knockouts as well as gain-of-function studies 
using various Activin signaling components reveal clear effects on pancreas 
development and β-cell number, in many cases leading to generation of adult 
animals with reduced glucose tolerance (Wiater and Vale, 2012). In addition, 
Smad3, a homolog of Drosophila Smox, has been shown to bind to the insulin 
promoter, and loss or knockdown of Smad3 leads to an increase in insulin 
transcription (Lin et al., 2009; Tan et al., 2011; Yadav et al., 2011). In contrast, 
we find that loss of daw in Drosophila does not alter the specification or numbers 
of IPCs in the brain, nor does it affect transcription of the IPC-expressed dilps. 
Intriguingly, there is evidence in mice that Activin family members can also 
modulate adult β-cell function at the level of insulin release. Both Activin A and B 
subunits are expressed in mature β-cells consistent with either autocrine or 
juxtacrine roles, but some data suggest that they affect insulin secretion in 
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opposite ways with Activin A promoting Ca2+ influx and insulin release but Activin 
B suppressing both (Bertolino et al., 2008; Florio et al., 2000; Totsuka et al., 
1988). While this notion has been challenged by another more recent study 
(Bonomi et al., 2012), it is intriguing to note in this regard that mutations in actβ, a 
second Drosophila Activin-like ligand that is strongly expressed in the IPCs, 
result in precocious development and smaller pupae and adults perhaps 
indicative of a gain in IIS (L. Moss-Taylor and M.B. O’Connor unpublished). 
Another relevant issue to note with respect to any role of Activin A or B in insulin 
release in vertebrates is the likely involvement of non-canonical signaling. 
Stimulation of isolated rodent β-cells with Activin A or B can influence Ca2+ influx 
and insulin release very rapidly (~1 to 5 minutes, respectively) and this short 
reaction time suggests involvement of a non-Smad signaling pathway in the 
process (Bertolino et al., 2008; Furukawa et al., 1995). In contrast, in Drosophila 
we show that the release of Dilps appears to be Smad dependent. Taken 
together, these examples illustrate that although the ability of TGF-β/Activin 
signaling to regulate IIS appears to be conserved across species, the exact 
mechanisms employed may vary. 
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Figure 28: Daw regulates DILP release cell non-autonomously 
(A) SmoxRNAi along with dicer2 over-expression in the IPCs was not able to induce a 
diabetic phenotype in w1118 larvae. (B) baboCA over-expression in the IPCs of daw 
mutants was not able to rescue the diabetic phenotype of daw mutants. (C) Expression 
level of shab larval CNSs of daw mutants and controls was measured using quantitative 
PCR. daw mutants did not show any significant difference in shab expression compared 
to controls. 
3.3.3 Acidosis: does Daw regulate systemic pH or is it metabolic acidosis? 
We showed that loss of daw causes significant acidification of the larval 
hemolymph, which if exacerbated by growth on low pH food leads to 
considerable larval lethality. The mechanisms influencing acid-base balance of 
the insect hemolymph involve a wide range of variables including CO2 exchange, 
metabolism, ion transport and buffering molecules (Harrison, 2001; Wyatt, 1961). 
While alterations in any of these processes can result in pH imbalance, we 
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believe that acidosis in daw mutants is likely caused by metabolic dysfunction 
based on the observation that activating TGF-β signaling in metabolic tissues can 
rescue the acidosis phenotype of the daw mutants. 
Much like in vertebrates, the insect renal system, comprising of the 
malpighian tubules, gut and anal pads, is a major regulator of hemolymph acid-
base balance. These tissues regulate pH primarily by mediating ion and acid-
base transport, and can effectively clear out inorganic acids like HCl from the 
hemolymph as demonstrated by acid injection and recovery experiments carried 
out in locusts (Harrison and Phillips, 1992; Phillips, 1981; Phillips et al., 1994; 
Thomson et al., 1988). However, expressing smox RNAi in the malpighian 
tubules did not induce acid sensitive lethality in wild-type animals indicating that 
the larval renal system is likely not impaired in the daw mutants (data not shown). 
More importantly, a role of daw in regulating acid-base balance solely through 
the renal system is refuted by the fact that expressing baboCA in the fat body or 
the muscle can significantly rescue the acidosis phenotype. This observation also 
makes it very unlikely that loss of daw is disrupting gas exchange through an 
affect on tracheal function. It is possible that alterations in buffering capacity 
might partially contribute to the daw acidosis since the fat body is the major 
source of hemolymph proteins (one of the major circulatory buffers (Harrison et 
al., 1990; Levenbook, 1950)) and we actually see a slight alkalinization of the 
hemolymph when we express baboCA in the fat body.  However, the significant 
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changes in the amount of metabolic acids in the daw mutants makes it more 
likely that acidosis in daw mutants is caused by metabolic dysfunction.  
In Lepidopterans, metabolites like succinate, citrate and organic phosphates are 
found in high concentrations in the hemolymph and are thought to play an 
important role in determining pH balance (Harrison, 2001; Wyatt, 1961). Most of 
these acids are produced by metabolic pathways, and loss of daw consistently 
leads to enhanced total body levels of major metabolic acids such as pyruvate, 
citrate, 2-ketoglutarate, succinate, fumarate and malate. This indicates that Daw 
likely globally regulates general cellular metabolism, and its loss leads to 
accumulation of these organic acids to excess levels such that they eventually 
overwhelm the various intrinsic buffering systems leading to acidosis. This also 
accounts for why expression of baboCA in any large tissue is able to partially 
rescue the acidosis phenotype. 
3.3.4 Daw regulates expression of mitochondrial metabolism genes and 
mitochondrial fusion 
Organic acids up-regulated in daw mutants are primarily TCA cycle 
intermediates. Since activating TGF-β signaling in the FB can rescue the 
concentration of these metabolites in the daw mutants, our data clearly indicates 
that Daw regulates peripheral cellular metabolism, particularly mitochondrial 
metabolism. Consistently, our deep sequencing result shows that Daw is a major 
regulator of cellular metabolic gene expression and expression level of multiple 
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TCA cycle and the electron transport chain enzymes go up in the daw mutants. 
Apart from TCA cycle enzymes multiple other genes that are involved in or are 
predicted to be involved in carboxylic acid and organic acid metabolic processes 
were also significantly up-regulated in the daw mutants. This up-regualtion of a 
whole suite of mitochondrial genes can predictably increase mitochondrial output, 
including output of TCA cycle intermediates, and explains why daw mutants 
accumulate a large amount of metabolic acids. Increased mitochondrial output 
would also require a steady supply of bio-fuels like free glucose or acetyl-CoA. 
However, we show that daw mutants are defective in IIS and therefore inefficient 
in cellular sugar uptake. Moreover, down-regulation of glycolytic enzymes like 
Hex-A, Gapdh-1 and Pdk makes it unlikely that glycolytic production of pyruvate 
and Acetyl-CoA fuels TCA cycle in the daw mutants. Rather, Acetyl-CoA is 
probably supplied by β-oxidation and ketogenesis pathways in the mutants, and 
consistent with this possibility we observed up-regulation of a number of β-
oxidation and ketogenesis enzymes in the daw mutants.  
Up-regulation of mitochondrial genes is also indicative of increased 
mitochondrial biogenesis as has been shown to be an outcome of losing Activin-
A in vertebrate models (Li et al., 2009). While our mitotracker staining did show 
larger mitochondrion in daw mutant FB, we observed that the density of 
mitochondrial network was thinner and fragmented in the mutants indicating 
defects in mitochondrial fusion (Chen, 2005). Mitochondrial fusion is a regulated 
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event that, along with mitochondrial fission, allows remodeling of the architecture 
of the mitochondrial network within the cytoplasm. Loss of mitochondrial fusion 
leads to formation of less tubular and spherical/clumped mitochondria much like 
what we observed in daw mutants (Chen, 2005). While this change in 
mitochondrial physiology is the most obvious outcome of defects in mitochondrial 
fusion, physiological impact of this defect are also significant (reviewed in (Chen, 
2005; Picard et al., 2013)). Two of the conserved and well-known regulators of 
mitochondrial fusion are Mitofusin 1 and 2 (Mfn1/2) and OPA1. Loss of these 
genes has been shown to cause a reduction in oxygen consumption caused by 
attenuation of electron transport rates in respiration complexes I, III and IV in 
mammalian cell cultures (Chen et al., 2005). Mfn-null and OPA1-RNAi cells also 
exhibit reversible inhibition of cell growth and loss of mitochondrial membrane 
potential (Chen et al., 2005). Consistently, despite an increase in expression of 
mitochondrial enzymes, daw mutants showed a significant reduction in ATP 
content indicating loss of mitochondrial activity (Figure 29). In line with the role of 
fusion in mitochondrial activity, artificially induced or naturally occurring mutations 
in Mfns and OPA1 has been implicated in developmental problems, 
neuropathies, obesity and vascular disease (Chen et al., 2003; Delettre et al., 
2002; Züchner et al., 2004). The fact that a higher order transcriptional regulators 
like Daw regulates mitochondrial fusion and thereby mitochondrial activity opens 
up the possibility of further genetic dissection of the process in Drosophila. 
	  	   	  92	  
Interestingly, expression level of the fly homologues of known regulator of 
mitochondrial fusion or fission like Mfns, OPA1 and DRP1 was not affected in the 
daw mutants. Therefore, it is likely that Daw regulates fusion by affecting 
expression of novel regulators of the process.  
  
Figure 29: Total ATP content of daw mutant larvae 
Total ATP content of daw mutant and control midthird instar larvae was measured and 
normalized to total protein content. 
3.3.5 Daw regulates IIS and acidosis via independent mechanisms 
Since IIS is an important metabolic regulator in both insects and 
vertebrates, and because chronic loss of insulin signaling in vertebrates often 
results in keto-acidosis, it was surprising to find that loss of IIS did not cause or 
contribute to the acidosis observed in daw mutants. Moreover, we found that 
chronic loss of IIS in wild-type Drosophila larvae also did not result in acidosis.  
We speculate that perhaps the differences in the manifestation of keto-acidosis 
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between vertebrates and Drosophila could be due to differences in how insulin 
signaling affects metabolic processes. In vertebrates loss of insulin eventually 
results in keto-acidosis because of increased fatty acid oxidation to meet energy 
demands. However in Drosophila and Bombyx larvae, loss of insulin actually 
leads to an increase in the storage of TAG suggesting that the modes of 
alternative energy production upon loss of IIS could be different in insect larvae 
and vertebrates (Böhni et al., 1999; Broughton et al., 2005; Satake et al., 1997; 
Tatar, 2001; Teleman, 2010).   
While we showed that loss of IIS is not responsible for the acidosis 
phenotype, we also entertained the notion that acidosis might affect insulin 
signaling since in vertebrates several reports have proposed that acidosis can 
lead to insulin resistance, perhaps by affecting various ligand-receptor 
interactions (Cuthbert and Alberti, 1978; Mak, 2008). However, we could 
completely rescue acidosis in daw mutants without ameliorating the diabetic 
phenotype, indicating that acidosis does not contribute to the diabetic phenotype 
observed in daw mutants. It is important to note that acidosis always correlates 
with the relative amount of metabolic acids. Since we could reduce the output of 
metabolic acids without affecting the diabetic phenotype, we can also conclude 
that Daw regulates accumulation of metabolic acids independent of IIS. 
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3.3.6 Hormone-like function of Daw 
We showed that expressing daw in any large, metabolically active, tissue 
is able to rescue the lethality of daw mutant larvae. In addition, we showed that 
Daw influences circulating sugar concentration and hemolymph pH in a dose-
dependent manner. These observations indicate that Daw is likely released into 
the hemolymph from tissues of origin and exerts its effect in an endocrine 
manner much like a hormone. Curiously, unlike most hormones, daw expression 
is not limited to one tissue or gland. Rather daw is expressed in a wide array of 
tissues including muscle, FB, gut, imaginal discs and surface glia of the CNS 
(Parker et al., 2006; Serpe and O'Connor, 2006). One possible purpose for such 
a wide distribution of a hormone like peptide could be that, being a metabolic 
regulator, daw expression is regulated by nutritional cues and its distribution in 
multiple tissues ensures integration of systemic metabolic status. 
3.3.7 Homeostasis and its significance in adapting to extreme conditions 
The ability to maintain physiological homeostasis is crucial for survival 
under conditions of environmental variability and the phenotypes of daw mutants 
we present here reflect the consequences of impaired sugar homeostasis and pH 
balance. We show that daw mutants manifest significantly higher lethality on a 
high sugar diet (HSD). Interestingly, HSD has been shown to induce peripheral 
insulin resistance in Drosophila larvae (Musselman et al., 2011; Pasco and 
Léopold, 2012) and such HSD-induced peripheral resistance in combination with 
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impaired insulin release already present in the daw mutants can lead to larval 
lethality. Alternatively, HSD could further elevate circulating sugar concentrations 
and cause lethality by damaging tissues. However, since circulating sugar in the 
larvae is primarily non-reducing trehalose, and since insects do not contain a 
capillary system, which is often the target of damage by high sugar in 
vertebrates, it is unlikely that hyper-trehalosemia alone can cause tissue damage 
in the larvae. 
Alterations in pH homeostasis however, can have wide spread 
physiological and behavioral consequences such as muscle degeneration, 
altered enzymatic activity and habitat and food choice (Harrison, 2001). 
Predictably, acidosis is expected to have a more severe impact on the viability of 
the daw mutants. Consistent with this prediction, aggravating the acidosis of daw 
mutants by exposing them to acidic food conditions leads to significantly higher 
lethality of the mutant larvae. Interestingly, in our feeding experiments, HCl 
acidified food was less detrimental to the growth of daw mutant larvae than food 
acidified with organic acids. This may indicate that the larval renal system is 
better able to cope with excess simple ions such as Cl− and H+ than larger 
organic acids like propionate and acetate. Consistently, food acidified with 
organic acids like PA and AA also had a significantly more severe effect on 
developmental timing and viability compared to HCl acidified food.  
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The mechanisms by which acidic food affects developmental timing 
remain an open question. However, one possible explanation for developmental 
delay might be alterations in hormonal signals involved in regulation of 
developmental timing, caused by low pH of the hemolymph. In support of this 
possibility, studies using honey bees and locusts have shown that changing 
partial pressure of CO2 affects pH balance and alters juvenile hormone levels 
(Bühler et al., 1983; Fuzeau-Braesch et al., 1982). Additionally, acidosis has 
been shown in vertebrates to affect secretion and activation of several hormones 
including corticosteroids, thyroid hormone and parathyroid hormone (Mitch, 2006; 
Wiederkehr et al., 2004).  
3.5 EXPERIMENTAL PROCEDURES 
3.5.1 Fly Strains and Food 
daw alleles daw11 and dawaact1 (referred in short as daw1) has been 
described previously, as have the smoxF4, baboFd4 and baboCA alleles (Brummel 
et al., 1999; Peterson et al., 2012; Serpe and O'Connor, 2006; Zheng et al., 
2003). Other fly lines used: UAS-daw (Serpe and O'Connor, 2006), UAS-dilp2 
(Brogiolo et al., 2001), UAS-Ork1ΔC and UAS-Ork1ΔNC (Bloomington stock 
center), UAS-smoxRNAi3B3 (Peterson et al., 2012), cg-Gal4 (Bloomington stock 
center, (Hennig et al., 2006)), fb-Gal4 (Neufeld lab.), mef2-Gal4 (Bloomington 
stock center), NCP1B1-Gal4 and Kurs6-Gal4 (Siegmund and Korge, 2001). A list 
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of recombinant fly lines generated during the course of this study is shown in 
Table 1. 
Table 1. Recombinant fly lines generated during the course of this study 
daw1, UAS-dilp2/CyoYFP 
daw11, UAS-
baboCA/CyoGFP 
daw11, fb-Gal4/CyoGFP 
daw11, cg-Gal4/CyoGFP daw11, mef2-Gal4/CyoGFP 
daw11, OK72-
Gal4/CyoGFP 
daw11, npc1b1-
Gal4/CyoGFP 
daw11, Kurs6-Gal4/CyoGFP 
daw11, dilp2-
Gal4/CyoGFP 
 
For all over-expression experiments a single Gal4 element was used to 
drive a single UAS construct. Controls contained either a single copy of the Gal4 
element (Gal4 control) or a single copy of the UAS element (UAS control). For 
example daw1/11, cg-Gal4>UAS-daw is an abbreviation for daw1,UAS-daw/ 
daw11,cg-Gal4. Corresponding controls are daw1,UAS-daw/+ and daw11,cg-
Gal4/+. 
Flies were raised on standard cornmeal food (CMF). Mutant and control 
larvae were grown on yeast paste food (YPF) or semi-defined food from the time 
of hatching onwards, unless mentioned otherwise.  
L1 larvae were collected 24 hours after egg collection (collections made 
daily from 11am to 2pm) and reared at 30-40 animals per plate/tube in a 12 hour 
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light/dark cycle. Experiments were performed 24 hours prior to when 25% of the 
larvae formed pupae. Time required for reaching 25% pupariation was 
determined by generating a developmental timing curve using the first egg 
collection of every collection cage. 
Analysis of nutrient content of CMF was done by Medallion labs 
(Minneapolis, MN). Contribution of yeast to nutrient content was calculated from 
nutrition facts per gram of yeast provided by the manufacturer (Saf-instant, 
Lesaffre Yeast Corporation). 
3.5.2 Metabolite and pH assays 
Triacylglycerol (TAG) assay: Samples were prepared by homogenizing 
3 mid third instar larvae per sample in 250 µl of PBT (PBS + 0.1 % tritonX-100). 
Homogenization was performed in microcentrifuge tubes using a plastic pestle. 
Subsequently, samples were sonicated for 4 seconds with a 0.5 sec pulse at 
20% amplitude setting. 10 µl of homogenate was mixed with 200 µl of triglyceride 
reagent and the mixture was incubated at room temperature for 15 minutes. 
Samples were then briefly centrifuged to get rid of any particulate material and 
supernatants were transferred to 1 ml disposable cuvettes. 800 µl of free glycerol 
reagent was added to each sample and incubated at room temperature for 15 
minutes to allow development of color. Spectrophotometric measurements were 
performed at 540 nm. TAG content was calculated from TAG standard curves 
generated with each experiment as per manufacturer’s instructions (Sigma TAG 
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standards). Protein estimation was performed using BCA kit using the sonicated 
samples and ratio of total TAG content to total protein content was reported as 
normalized TAG content. 
Glycogen assay: Samples were prepared by homogenizing 3-4 mid third 
instar larvae per sample in 100 µl of cold PBS. Samples were subsequently 
centrifuged at 5000 rpm for 1 min and supernatant was transferred to 0.2 ml PCR 
tubes. 10-20 µl of each sample was preserved for protein assay. Remaining 
supernatants were heat treated at 700C for 5 minutes using a thermo-cycler. 
Subsequently, samples were immediately chilled on ice. Protein aggregates were 
separated by centrifugation (13,000 rpm for 10 minutes at 40C) and supernatants 
were used for glycogen estimation. For estimation of total glucose + glycogen 
content 30 µl of the prepared supernatant was incubated with 100 µl of glucose 
oxidase/peroxidase reagent (Sigma Glucose assay kit, GAGO 20) containing 
amyloglycosidase (1 µl per ml of glucose reagent, Sigma, A1602-25MG) for 30 
minutes at 370C. In parallel 30 µl of supernatant was incubated with glucose 
oxidase/peroxydase reagent alone in identical conditions to estimate for total 
glucose content. At the end of the incubation period reactions were terminated by 
adding 100 µl of H2SO4 and left at room temperature for 5 minutes for color to 
develop. OD was measured at 555 nm and metabolite contents were calculated 
from glucose/glycogen standard curved generated along with every experiment. 
Total glycogen content was determined by subtracting total glucose content from 
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glucose+glycogen content. Measurements were normalized to total protein 
estimated with a BCA kit.  
Hemolymph glucose + trehalose concentration: For each sample 5-6 
mid third instar larvae were washed in PBS and dabbed on kim wipeTM. Larvae 
were then quickly ripped open on a piece of parafilm under the dissecting 
microscope. 1.5 to 2 µl of hemolymph was carefully collected from this heap of 
dissected animals using a P2 pipette and placed on the parafilm to form a small 
drop. 1 µl of hemolymph was subsequently pipetted out of this drop to 19 µl of 
trehalase buffer in 0.5 ml tubes, mixed by tapping and stored on ice while more 
samples are being collected. This two step pipetting prevents inadvertent 
pipetting errors caused by larval tissues clogging the pipette tip. The samples 
were then centrifuged briefly (3 minutes at 13,000 rpm) ad supernatants were 
transferred to 0.2 ml PCR tubes. Samples were heat treated at 700C for 5 
minutes in a thermocycler and immediately chilled on ice. Protein aggregates 
were separated by centrifugation at 13,000 rpm for 12 minutes at 40C. 
Supernatants were transferred to new tubes and used for sugar estimation. For 
sugar (glucose + trehalose) estimation 2 µl of sample was added to 28 µl of 
threhalase buffer containing x units/ml of porcine trehalase and the mixtures 
were incubated at 370C (water bath) for 16-18 hours to convert trehalose to 
glucose. Subsequently, total glucose concentration was measured using the 
sigma glucose oxidase kit as mentioned above. Standard curves were generated 
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with every experiment using 1 mg/ml of trehalose stock and were used to 
calculate sugar concentration in the hemolymph. 
pH assay: For hemolymph pH measurement, 3 µl hemolymph was 
extracted from a collection of 10-12 mid third instar animals (refer to hemolymph 
collection for sugar assay for more details), mixed with 2 µl pyranine dye 
(Invitrogen, 1.2 mM final concentration). Mixture was briefly centrifuged and 
absorbance spectrum of the supernatant was measured using a multichannel 
nanodrop spectrophotometer (NanoDrop 8000). The ratio of absorbance at 450 
nm and 405 nm was plotted against a standard curve to determine the pH. pH 
standards ranging between pH 6.6 and pH 7.6 by were prepared by titrating 50 
mM Tris with HCl. Samples were maintained on ice or 4 degree centigrade until 
measurements were made on the nanodrop in order to avoid any oxidation of 
phenolic compounds. 
3.5.3 Statistics 
All graphs and statistical analyses were generated using Graphpad 
prism4. For two-sample experiments standard student t-test was used for 
calculating significances. For multiple sample analyses, one-way or two-way 
anova followed by a post-hoc Tukey's HSD test was used. p-values are 
designated using the following convention: single asterisk means p-value ≤ 0.05, 
two p-value ≤ 0.01 and three p-value ≤ 0.001.  
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3.5.4 Antibodies and immunostaining 
Antibodies used: Rat anti-Dilp2 (1/500), mouse anti-Dilp5 (1/800) 
(Géminard et al., 2009), mouse anti-Elav (1/500) (9F8A9, DSHB), rat anti-
dFOXO (1/500) (gift from O. Puig lab) (Hennig et al., 2006). Antibody straining 
was performed as described elsewhere (Géminard et al., 2009). Samples were 
imaged using a confocal laser-scanning microscope (Zeiss LSM710).  
3.5.5 Fluorescence Quantification  
To quantify Dilp2 levels, confocal Z series of the IPCs were obtained using a 1 
µm step size and identical laser power and scan settings. Zeiss Zen software 
was used to generate multiple intensity projection images. Subsequently 
background signal was subtracted and fluorescence intensity was measured by 
drawing selections on the IPCs. Fluorescence intensity is presented as average 
of total selections made per sample.  
3.5.6 Quantitative PCR 
Tissues dissected from mid-third instar larvae were flash-frozen on dry-
ice. Total RNA was extracted using QIAGEN RNeasy Tissue Mini Kit according 
to the manufacturer’s protocol. RNA samples (5 µg per reaction) were reverse 
transcribed using SuperScript III (Invitrogen), and the generated cDNA was used 
for quantitative-PCR (Roche LightCycler 480 Real-Time PCR system). Rpl23 
was used as a reference gene for normalization. Three to six separate samples 
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were collected for each condition and triplicate measurements were conducted 
for each sample. Primers were designed specifically for qPCR using a web-
based software Primer3 (http://frodo.wi.mit.edu/). 
3.5.7 Mitotracker staining 
Larvae were dissected and inverted in Schneider’s media at RT. Samples 
were subsequently incubated in Schneider’s media containing mitotracker dye 
(MitoTracker Red CMXRos, Life Technologies) at a final concentration of 300 nM 
for 40 minutes with mild rocking. Samples were washed twice with 1X PBS for 10 
minutes each and fixed in 4% paraformaldehyde for 30 minutes at RT. 
Subsequently, samples were washed twice with PBT (1X PBS+1% tween) for 30 
minutes each with a 10 min incubation with DAPI in PBT in between. Samples 
were cleared in 40% glycerol before mounting in Vectashield mounting media. 
Final dissection was performed on microscope slides to mount fatbodies only. 
Imaging was done using confocal laser-scanning microscope (Zeiss LSM710) 
with a magnification of 100X. 
3.5.8 RNA sequencing 
 RNA sequencing of FB RNA was performed by Genewiz, Inc. Data 
analysis was done using the Galaxy tool set made available by the Minnesota 
Supercomputing Institute. 
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CHAPTER 4: 
Eukaryotic pyrimidine salvaging enzyme UPRT is active in 
Drosophila and limits specificity of tissue-specific RNA isolation 
by TU tagging. 
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4.1 INTRODUCTION 
Biosynthesis of pyrimidine bases is a critical part of cellular metabolism 
and growth, as these bases provide pyrimidine nucleosides that are important 
components of various biomolecules including DNA and RNA. Most multicellular 
organisms contain two pathways to generate pyrimidine nucleotides, a de-novo 
pathway that synthesizes pyrimidine bases from non-pyrimidine precursors and a 
salvage pathway that allows reutilization of pyrimidine bases from preformed 
pyrimidine nucleotides. Pyrimidine salvage pathway enzymes are vital for many 
microbes and most bacteria (Kim et al., 2009). However, the repertoire of 
enzymes involved in pyrimidine salvage can vary considerably between different 
species (Beck and O’Donovan, 2007). For instance members of the genus 
Pseudomonas have been shown to contain different pyrimidine salvaging 
enzymes depending on the species type. While Pseudomonas aeruginosa 
possesses a nonspecific ribonucleoside hydrolase enzyme, Pseudomonas 
mendocina does not. Likewise P. mendocina possesses cytidine deaminase and 
uridine phosphorylase enzymes and P. aeruginosa has neither cytidine 
deaminase nor uridine phosphorylase (Beck and O’Donovan, 2007). This species 
specific presence of these enzymes along with the fact that many pyrimidine 
analogs can have cytotoxic effects make these enzymes lucrative targets for the 
treatment of infectious diseases (Carter et al., 1997; Koyama et al., 2000). 
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The salvage pathway enzymes have also been targeted for treatment of 
cancer cells as many of these enzymes have been shown to be inactive or not 
present in humans. Treatments targeting the salvage pathway enzymes use 
these enzymes as suicide genes, which are responsible for metabolizing an 
otherwise harmless pyrimidine analog to a cytotoxic derivative within the target 
cells. The target cell could be either a parasite that naturally expresses the 
suicide gene or cancer cells that have been primed with the suicide gene (or a 
combination of genes to increase specificity). While suicide gene therapy using 
pyrimidine analogs like 5-fluorouracil (5-FU) has been used successfully in 
cancer chemotherapy for decades, these analogs can cause much harm to the 
host as well if the target gene is expressed and active in the host (Kim et al., 
2009). Therefore, an ideal suicide gene is one that is not active in the host, and 
the uracil salvage pathway enzyme uracil phosphoribosyltransferase (UPRT) has 
been proposed to be a good candidate (Carter et al., 1997; Villela et al., 2011).  
UPRT catalyzes the conversion of uracil base and 5’-phosphoribosyl-α-1’-
pyrophosphate (PRPP) to uridine monophosphate (UMP) and PPi (Figure 30A) 
(Carter et al., 1997). The enzyme thus salvages free uracil bases and converts 
them to a form that can be incorporated back into newly synthesized RNA 
(Figure 30A). UPRT derived from certain microbes like Toxoplasma gondii has 
been shown to be efficient in recognizing derivatives of uracil, including 5-FU, 
and can convert it to its cytotoxic forms F-UTP or F-dUTP. Incorporation of such 
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a microbial enzyme in cancer cells via an adenoviral delivery system thus has 
been shown to remarkably improve the efficiency of 5-FU as a chemotherapy 
agent (Hartkopf et al., 2013; Hasegawa et al., 2013). Interestingly, a recent study 
has shown that the human UPRT homologue, although conserved and 
expressed in most cells, is not enzymatically active in its purified form in vitro 
hereby making UPRT an ideal candidate for suicide gene therapy (Li et al., 
2007). However, it is not known if the enzyme would be active in vivo, especially 
under circumstances like embryonic growth or wound healing, when rapid cell 
proliferation demands rapid turnover of RNA synthesis and therefore a steady 
supply of UMP. 
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Figure 30: Role of UPRT as a salvage pathway and a comparison of protein 
sequence between higher and lower eukaryotes. 
(A) UPRT catalyzes conversion of uracil base to uridine monophosphate (UMP) thereby 
allowing salvage of uracil produced by RNA degradation. UMP can subsequently be 
incorporated back into newly synthesized RNA by the cells RNA synthesis machinery. 
(B) Multiple sequence alignment of the uracil-binding region of UPRT derived from lower 
eukaryotes (S. cerevisiar (Sc), T. gondii (Tg) and C. neoformans (Cn)) and higher 
eukaryotes (Zebrafish (Dr), Drosophila (Dm), Rat (Rn) and human (Hs)) is shown. In red 
are 7 amino acids present in microbes that are essential for forming a beta sheet 
necessary for proper folding of the uracil-binding site. Two conserved glycines, shown 
with an asterisk, are directly involved in urail binding and are missing or replaced in 
UPRT from higher eukaryotes. 
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Inactivity of the human UPRT enzyme has been attributed to its inability to 
bind uracil, its substrate (Figure 30B). A multiple sequence alignment of 62 
UPRT homologues from different organisms show that one proline and 2 glycines 
are critical for uracil binding in the uracil-binding site of UPRT. Human UPRT 
lacks the two glycines and in addition a Met conserved in the PRPP binding 
region of microbial UPRT is replaced with Ile or Thr (Li et al., 2007). Lastly, a 
stretch of seven amino acid residues present in prokaryotes (close to the uracil-
binding site) that forms a beta-sheet essential for generating a suitable uracil-
binding pocket is also missing in human UPRT (Figure 30B, Red). Interestingly, 
every change present in human UPRT were also present in enzymes from all 
higher eukaryotes, including C. elegans and Drosophila, indicating that the 
enzyme could be inactive in all higher eukaryotes (Li et al., 2007). 
                               
Figure 31: T. gonddi UPRT can incorporate uracil derivatives like 4-thio-
uracil (4TU) into cellular RNA. 
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Based on this premise that UPRT is inactive in higher eukaryotes, a 
promising cell-type specific RNA labeling technique called thio-uracil-tagging 
(TU-tagging) has also been proposed (Cleary et al., 2005; Miller et al., 2009). 
Cell-type specific RNA tagging is of particular interest in order to understand cell-
specific gene expressing changes that are critical for the functioning of 
multicellular organisms. The technique is even more important for research using 
small model organisms like Drosophila, C. elegans or zebrafish where dissection 
of small tissues for gene expression analysis can be challenging and in some 
cases impossible. TU-tagging utilizes the Toxoplasma gondii UPRT (Tg-UPRT) 
enzyme that is known to recognize uracil derivatives like 4-thio-uracil (4TU) and 
convert them to 4-thio-uridine monophosphate (4T-UMP) (Figure 31). In brief the 
technique involves expression of Tg-uprt in the cell type of interest followed by 
feeding of the experimental animal with 4TU. While 4TU is thereby delivered to 
all cells in the animal, conversion of 4TU to 4T-UMP takes place only in the cells 
that are expressing Tg-uprt. The 4T-UMP is subsequently incorporated in newly 
synthesized RNA in the target cells. Since naturally occurring RNA does not 
contain any thiol groups this technique results in labeling cell-type specific RNA 
with unique thiol groups. The thiolated RNA can subsequently be purified from 
total RNA extracted from the animals using chemical addition of biotin to the thiol 
groups and subsequent purification with streptavidin beads.  The efficiency and 
specificity of the technique depends on the extent of background incorporation in 
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the tissues that are not expressing Tg-uprt and the understanding that the 
endogenous UPRT enzyme in higher eukaryotes is inactive.  Thus 4TU-tagging 
is a promising cell-type specific RNA tagging and isolation technique. 
However, given the fact that a UPRT homologue is present in all 
organisms and that the catalytic site of the enzyme is conserved from 
prokaryotes to humans indicate that the enzyme may still have some function in 
higher eukaryotes (Li et al., 2007). In vivo the enzyme could be capable of 
converting uracil to UMP if a cofactor brings the substrate to the enzymatic site. If 
this machinery also recognizes 4TU, then specificity of the 4TU-tagging 
technique would be hampered. An active UPRT in higher eukaryotes would also 
mean that use of the microbial UPRT as a suicide gene therapy target needs to 
be re-considered carefully and more cautiously to avoid host tissue damage. 
Apart from salvaging uracil, the enzyme could also have a secondary biological 
function in higher eukaryotes that does not require the uracil-binding site. Such 
functionality could explain the necessity to conserve the enzyme through 
evolution (Figure 32). 
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Figure 32: A UPRT family tree based on sequence homology of conserved 
UPRT domains. 
Evolutionary tree of UPRT or UPRT-ase domain containing proteins from 62 organisms 
(Taken from (Li et al., 2007)). The red arrow shows UPRT of C. elegans. 
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In this chapter, I show that the Drosophila UPRT homologue (CG5537) 
can actively incorporate 4TU into RNA indicating that the enzyme is active in 
vivo. We also show that Drosophila UPRT is essential for larval growth as 
knocking out the gene leads to impaired larval growth and increased larval and 
pupal lethality. Lastly I show that partial knockdown of CG5537 using RNAi can 
be a viable option for improving the specificity of 4TU-tagging without affecting 
viability of the animals. 
4.2 RESULTS 
4.2.1 Drosophila Uracil phosphoribosyltransferase (Krishah) is 
enzymatically active in vivo. 
Eukaryotic uracil salvage pathway enzyme uracil phosphoribosyltransferase 
(UPRT) is considered enzymatically inactive in higher eukaryotes including 
Drosophila melanogaster. To test this premise we fed Drosophila S2 cells or 
larvae with 4TU and checked for incorporation of thiol groups in RNA extracted 
from these samples. We find that S2 cells were cable of efficiently incorporating 
4TU into RNA, and the extent of incorporation was directly proportional to the 
duration of 4TU feeding (Figure 33A). We could reduce this incorporation by 
about 60% by knocking down the Drosophila UPRT homologue krishah (kri) 
indicating that Kri is actively converting 4TU to 4TUMP in the S2 cells and 
leading to thiolation of cellular RNA (Figure 33A and B). The efficiency of kri 
knockdown was verified using qRT-PCR and kri-RNAi cells showed a 5-10 fold 
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reduction in kri mRNA levels (Figure 33C). Similar to S2 cells, knocking down kri 
in mid third instar larvae using a ubiquitous driver like da-Gal4 led to a severe 
reduction in 4TU incorporation (Figure 33D and E). These observations show 
that the Drosophila UPRT homologue Kri is active in both S2 cells and in the 
larvae. 
      
Figure 33: Drosophila UPRT homologue Kri can actively incorporate 4TU 
into cellular RNA. 
(A-C) Drosophila S2 cells can actively incorporate 4TU into cellular RNA. Knocking down 
kri can significantly impair this incorporation. The efficiency of kri knockdown was 
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verified using quantitative PCR (C). (D) Drosophila larvae can also incorporate 4TU into 
cellular RNA. This incorporation could also be strongly impaired by knocking down kri. 
(E) Once again efficiency of kri knockdown was verified using quantitative PCR. 
4.2.2 Generation of a kri mutant. 
Drosophila larvae grow a remarkable 150-200 fold during the three larval instars. 
Such a rapid growth demands a huge amount of biosynthesis of cellular material 
including proteins and therefore mRNA. It is therefore likely that an active uracil 
salvage pathway is essential for larval growth. To test this possibility we decided 
to make a kri mutant. The most effective method to generate a loss of function 
mutation in Drosophila is to perform an imprecise excision of a P-element that is 
located in or near the target gene and in the process create a deletion that takes 
out the gene of interest. Such a technique, however, was not possible to use for 
generating a kri mutant as kri is located in the promoter region of s6k which is an 
essential gene (Figure 34A). kri also overlaps with a third gene, mad2, that sits at 
the other end of the gene. Therefore deleting kri would have affected the 
expression level of s6k and mad2 and made characterization of loss of kri 
difficult. Hence, to generate a kri mutant we started with an available large 
deletion, mad2Δ, that deletes kri and portions of s6k and mad2 (Figure 34A). 
mad2∆ thus is a s6k, kri, mad2 triple mutant that has been shown to be larval 
lethal (Buffin et al., 2007). We first show that it is possible to rescue the triple 
mutant by inserting a large genomic DNA fragment, which supplements for all the 
three genes, on the second chromosome (mad2ΔRes) (Figure 34A and see Figure 
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35). For generating the kri mutant, a stop codon was introduced in the same 
genomic DNA in the kri exon to give rise to a nonsense mutation (Figure 34B). 
This genomic DNA was then inserted in chromosome 2 of mad2Δ mutants 
thereby rescuing them for s6k and mad2 only (Figure 34C). Insertion of the stop 
codon was achieved by modifying a novel recombineering technique developed 
for inserting small tags in genomic fragments and were performed by MaryJane 
O’Connor in the lab (Venken et al., 2008).  
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Figure 34: Methodology for generating a kri loss-of-function mutant. 
(A) Schematic of the w1118, mad2∆ and mad2∆Res animals is shown. mad2∆ contains a 
large deletion on chromosome 3 that deletes kri and portions of the flanking genes, s6k 
and mad2, giving rise to a s6k, kri, mad2 triple mutant. mad2∆Res animals are rescued 
mad2∆ animals in which a large genomic DNA containing s6k, kri and mad2 is inserted 
into the second chromosome. (B) A recombineering technique used to insert small tags 
into large genomic fragments. The same technique was used to introduce a small DNA 
fragment containing a stop codon into the kri locus of the same genomic DNA used in 
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mad2∆Res animals. (C) Schematic of a kri mutant which is essentially the same as the 
mad2∆Res animal but has a stop codon introduced in the kri locus of the rescue genomic 
DNA construct. 
4.2.3 Loss of kri leads to impaired larval growth and pupal lethality. 
The loss-of-function mutation in kri led to a larval/pupal lethality phenotype. Both 
kri mutants, one in which a stop codon was introduced at the 51st amino acid and 
the second at the 20th amino acid, failed to grow during larval stages and gave 
rise to wandering larvae that were thinner and smaller than both w1118 and 
mad2∆Res control animals (Figure 35A). These thin larvae formed thin pupae or 
pre-pupae that mostly failed to reach the pharate stage (Figure 35B). Propensity 
of the mutants and controls to form pupae, pharates and adults were also 
measured (Figure 35C). w1118 and mad2∆Res controls were not significantly 
different in their ability to form pupae. kri mutants, however, showed a significant 
reduction in the percentage of animals that reached the pupal stage (Figure 
35C). Similarly, while mad2∆Res control pupae were able to reach the pharate 
stage as frequently as the w1118 controls, kri mutant pupae almost completely 
failed to reach the pharate stage (~ 3% of pupae reached pharate stage) (Figure 
35C). We also looked at the ability of the control and mutant animals to survive 
untill adult stages. The mad2∆Res animals showed a significant decrease of about 
30% in the ability to survive to adult stages with most of the deaths occurring at 
the pharate stage (Figure 35C). The kri mutants however, were rarely able to 
survive to adult stages. Lastly, I checked if supplementing the kri mutants with an 
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active UPRT enzyme could rescue the phenotypes we observed. For these 
experiments, I over-expressed a codon-optimized Tg-uprt construct (uprt*, see 
next section) using a ubiquitous da-Gal4 driver in the kri mutant background. 
UPRT* caused only a minor improvement in growth of the kri mutants as 
reflected by a significant increase in the ability of the rescued animals to form 
pupae from larvae and pharate from pupae (Figure 35C). However, UPRT* failed 
to cause any rescue of survivability to adult stages. Since UPRT* can actively 
convert uracil to UMP, the failure of the enzyme to rescue viability and growth of 
the kri mutants shows that Kri may have an additional physiological role in higher 
eukaryotes.  
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Figure 35: Loss of Kri leads to impaired larval growth and a larval/pupal 
lethality phenotype. 
(A) Wandering third instar control and kri mutant larvae. kri mutants are much smaller 
and thinner than both wildtype and mad2∆Res controls. (B) Control and kri mutant pupae. 
kri mutants form small and thin pupae or pre-pupae that mostly die before reaching the 
pharate stage. (C) Quantification of the propensity of control, kri mutants and tg-UPRT 
rescued kri mutants to from pupae from larvae, pharate form pupae and adult from 
larvae. n = 5-10 measurements per genotype with 40 animals per measurement. 
Significances were calculated using two-way ANOVA with a Tuky’s post hock analysis to 
generate p values. 
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4.2.4 Potential improvement of specificity and efficiency of a cell-type 
specific RNA isolation technique using kri-RNAi. 
A cell-type specific RNA labeling and isolation technique using Tg-UPRT 
mediated 4TU incorporation has recently been proposed based on the premise 
that Drosophila UPRT is enzymatically inactive. However, the technique has not 
gained much popularity because of lack of efficiency in labeling and lack of 
specificity. I find that the Tg-uprt (referred to as uprt in Figure 36) construct used 
in previous studies is not translated efficiently in Drosophila larvae (Figure 29 A-
C). Since we do not have an antibody against Tg-UPRT, we over-expressed an 
N-terminally HA tagged Tg-UPRT construct, HA-uprt, in Drosophila motoneurons 
or whole animals and looked for HA-UPRT protein using immunohistochemistry 
(IHC) or Western blots. Quantitative PCR shows that UAS-HA-uprt was similar to 
UAS-uprt in terms of inducibility in the presence of a Gal4 driver (Figure 36A). 
However, when HA-uprt was expressed in motoneurons using a motoneuron-
specific OK371-Gal4 driver and the tissues were immunostained with anti-HA 
antibodies, we did not observe any staining (Figure 29B). This indicated that HA-
uprt mRNA was probably not translated efficiently, and the amount of protein was 
below detection level of IHC. When over-expressed using a strong pan-larval da-
Gal4 driver and the whole animal extract used to perform a Western blot, we 
could observe HA-UPRT as a band of 26 kDa, as expected (Figure 36C). 
However, we also observed multiple smaller bands in the test lane indicating 
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truncated protein products that had the N-terminal HA tag. Once again this 
indicated that HA-uprt mRNA is not translated efficiently. A bioinformatics 
analysis of the Tg-uprt sequence indicated that the Toxoplasma construct had at 
least 6 codons that were not recognized or very poorly recognized by Drosophila. 
We therefore synthesized the gene with these codons optimized for Drosophila 
and injected this codon-optimized construct, uprt*, to make UAS-uprt* lines. We 
also generated N-terminally HA tagged HA-uprt* constructs and injected them to 
generate UAS-HA-uprt* flies. When the HA-uprt* construct was expressed in S2 
cells and cell extract was used for Western blot, we could see a more prominent 
HA-UPRT* band on the blot and much reduced truncated products (Figure 36C). 
This showed that the new codon optimized uprt* construct can be translated 
more efficiently. I could also detect HA-UPRT* in S2 cells using IHC (Figure 
36D). We next tested if the new uprt* construct was translated into an 
enzymatically active product. For this, S2 cells were transfected with uprt* or 
vector alone constructs. The cells were fed 4TU and incorporation of 4TU in total 
RNA was measured. UPRT* was able to cause significantly higher incorporation 
of 4TU compared to background incorporation indicating that the UPRT* 
construct is efficiently translated and is enzymatically active (Figure 36E).  
A second concern with the Tg-UPRT mediated cell-type specific RNA 
labeling technique is lack of specificity. Our finding that the Drosophila UPRT 
homologue Kri is active in vivo and can efficiently incorporate 4TU may explain 
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why the technique has failed to achieve the level of specificity that is theoretically 
possible. Removing the endogenous UPRTase activity by knocking out kri would 
remedy this problem by eliminating background incorporation of 4TU. However, 
as we showed in the previous section, loss-of-function mutation in kri leads to 
larval growth defects and lethality making the kriST51orST20 mutants unusable for 
any functional study. Nevertheless, we observed that da-Gal4 driven kri-RNAi 
can significantly reduce 4TU incorporation and does not cause lethality. 
Therefore, we explored the possibility of using kri-RNAi in combination with uprt* 
over-expression to improve tissue specificity of RNA tagging. In order to be used 
together it is important that kri-RNAi does not target uprt* mRNA. The sequence 
of Tg-uprt is quite different from kri (29.52% identity), and codon optimization of 
Tg-uprt (to uprt*) caused the sequences to become further divergent (only 
24.94% identity). We therefore predicted that kri-RNAi will not target uprt* mRNA. 
We tested this in S2 treated with kri-RNAi by feeding 4TU for 6 hours either in the 
presence or absence of uprt*. When fed for 6 hours, background incorporation of 
4TU in S2 cells was similar to cells that were expressing uprt* (Figure 36F). In 
the presence of kri-RNAi, cells expressing uprt* showed a similar level of 4TU 
when compared to uprt* expressing cells in the absence of kri-RNAi. However, 
background incorporation of 4TU was reduced significantly. These results show 
that kri-RNAi can indeed be used along with uprt* over-expression to 
simultaneously reduce background incorporation of 4TU and cause UPRT* 
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mediated incorporation of 4TU. Notably, the fact that UPRT* can rescue the 
incorporation of 4TU in kri-RNAi treated cells validates the specificity of kri-RNAi 
and kri-RNAi-induced loss of 4TU incorporation. 
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Figure 36: Enhancing the efficiency and specificity of 4TU tagging in 
Drosophila. 
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(A) UAS-HA-UPRT and UAS-UPRT constructs containing the tg-UPRT and an N-
terminally HA-tagged version of the gene are highly inducible in the presence of a da-
Gal4 driver. (B) Expressing UAS-HA-UPRT in the motoneurons using an OK371-Gal4 
driver (expected expression pattern shown with UAS-GFP in the same sample) did not 
show any HA-UPRT peptide detectable using IHC. (C) tg-UPRT mRNA is not translated 
efficiently in Drosophila larvae and HA-UPRT peptide is seen as a series of 26kd and 
smaller bands on Western blot. However, a codon-optimized construct HA-UPRT*, when 
expressed in S2 cells was able to produce peptides that were primarily 26 kd in length. 
(D) HA-UPRT* peptide could also be detected in S2 cells using IHC. (E) UPRT* is 
enzymatically active and can efficiently incorporate 4TU in S2 cell RNA. (F) UPRT* can 
incorporate 4TU even in the presence of kri-RNAi and can significantly enhance the ratio 
of test to background incorporation of 4TU. 
4.3 DISCUSSION 
I studied the ability of the Drosophila UPRT homologue Krishah (CG5537) 
to convert 4TU into 4TUMP by assaying for incorporation of 4TU into cellular 
RNA in both S2 cells and Drosophila larvae. This work revealed that the 
endogenous enzyme is capable of incorporating 4TU into RNA in both S2 cells 
and larvae. Kri shares a high sequence similarity to human UPRT protein, which 
has been shown to be inactive in vitro and it has been proposed that this is most 
likely due to a non-functional uracil-binding site (Li et al., 2007). Since the 
sequence of the uracil-binding site of Kri is exactly same as humans (Li et al., 
2007), and since Kri can recognize a uracil derivative in vivo and allow 
incorporation of the compound into RNA, it is possible that Kri is able to bring its 
substrate to the catalytic site in vivo. This finding has important implications for 
cancer chemotherapy as microbial UPRT is considered a good target for suicide 
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gene therapy in treating cancer with a cytotoxic uracil derivative 5FU. Microbial 
UPRT has also been proposed as a drug target for treatment of infectious 
diseases like tuberculosis based on the understanding that human UPRT is 
inactive and is not essential. However, similar to Drosophila Kri, human UPRT 
may also be functional in vivo and future investigation of this possibility will be 
critical for justifying the use of uprt as a suicide gene for cancer chemotherapy or 
microbial infection management. Interestingly, while the activity and function of 
UPRT has been extensively studied in various microbes, activity of the enzyme in 
any higher eukaryote has not been reported before. Therefore, our observation 
that Drosophila UPRT is active in vivo is the very first evidence of the activity of 
this salvage pathway enzyme in any higher eukaryote. 
It has been proposed before, based on the fact that UPRT is conserved in 
higher eukaryotes despite being incapable of binding uracil, that UPRT in higher 
eukaryotes may have some unknown physiological function. My work with the kri 
mutant indicates a similar possibility. Loss of kri in Drosophila led to impaired 
larval growth and larval/pupal lethality. It is this lack of larval growth and 
formation of thinner larvae that prompted us to name this yet un-annotated gene 
‘krishah’ (kri), which in Sanskrit means ‘thin’. One possible explanation for this 
lack of larval growth in the kri mutants would be that the uracil salvage pathway 
is essential for growth particularly in the larvae. Drosophila larvae show a 
phenomenal 150-200 fold increase in mass during the larval stages. The larvae 
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therefore may need a very rapid turnover of mRNA to sustain this growth, and 
the de novo UMP synthesis pathway may not be sufficient to maintain a steady 
supply of UMP. Under these circumstances the uracil salvage pathway mediated 
by Kri may become essential. If this hypothesis is true, it can be predicted that 
the activity of UPRT in mammals may be important during biological processes 
that require fast cell proliferation like embryogenesis and wound healing. Such a 
possibility is worth exploring. While necessity to salvage uracil could be one of 
the reasons for lack of larval growth in the kri mutants, the fact that over-
expressing Tg-uprt in the kri mutants caused only a mild improvement in larval 
growth shows that kri most likely has other essential roles in larval growth. Tg-
UPRT can substitute only for the uracil-salvaging role of Kri in the larvae. 
However, being derived from an evolutionarily divergent source, Tg-UPRT is 
likely not capable of substituting for Kri for any, yet unknown, physiological role. 
A rescue of the kri mutants with over-expression of kri itself will be the best future 
experiment to perform for confirming any physiological role of Kri in larval growth. 
Reagents for such a rescue experiment are already being prepared, and the 
experiments will be performed soon.  
One of the reasons behind our interest in studying the enzymatic activity 
of Kri is the possibility of using an exogenously expressed UPRT to achieve cell-
type specific RNA tagging and isolation. This technique is essential for studying 
cell-type specific gene expression profiles and transcriptional responses to 
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signaling pathways like TGF-β signaling which we study in the lab. A recent study 
has explored this possibility and has shown that expressing Tg-uprt in a cell-type 
specific manner can allow incorporation of 4TU into cell specific RNA, facilitating 
cell specific RNA isolation (Cleary et al., 2005; Miller et al., 2009). The technique 
however, has not gained much popularity and issues with efficiency of 4TU 
incorporation and specificity of 4TU have been reported (unpublished). We find 
that the wildtype Tg-uprt construct used in previous studies contains codons that 
are not efficiently translated in Drosophila. This could be one of the reasons 
behind lack of efficiency in 4TU incorporation. We have generated a codon 
optimized Tg-uprt construct called uprt* and we have shown here that UPRT* 
can actively and efficiently incorporate 4TU. A comparative analysis of the ability 
of Tg-UPRT and UPRT* to incorporate 4TU in Drosophila cells has not be 
performed. However, Western blot and IHC experiments looking at the peptide 
product of N-terminally HA-tagged Tg-UPRT and UPRT* shows much more 
efficient translation of UPRT* in the Drosophila system. 
Lack of specificity with 4TU tagging can be attributed to the activity of the 
Drosophila UPRT homologue Kri. Kri shows significant ability to recognize 4TU 
and cause incorporation of the uracil derivative into cellular RNA from non-target 
tissues. I show that this background incorporation can be strongly reduced by 
knocking down kri. Since loss-of-function mutations in kri lead to larval lethality, a 
controlled knockdown of kri that reduces background but does not cause lethality 
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will be our next best choice at improving the specificity of the technique. This 
improvement may not be necessary for tagging RNA in larger tissues that would 
require a shorter duration of 4TU feeding and thereby keep background 
incorporation to a minimum. However, when tagging a very small number of 
cells, especially in tissues like the brain that are separated by a blood brain 
barrier, prolonged feeding becomes necessary to increase incorporation. Such 
prolonged feeding increases non-specific incorporation of 4TU, and previous 
attempts have shown that dissection of the small tissue becomes necessary to 
isolate cell-type specific RNA (Miller et al., 2009). For such experiments knocking 
down kri could significantly improve specificity and yield of cell-type specific 
tagged RNA. Knocking down kri may also avoid dissection of small tissues 
thereby allowing easy scale-up for isolation of RNA from small populations of 
cells.  
4.4 MATERIALS AND METHODS 
4.4.1 Drosophila stocks and husbandry 
w1118 and UAS-kri-RNAi (kk110071) line was obtained from VDRC. UAS-UPRT 
and UAS-HA-UPRT lines were generous gifts from Dr. Chris Doe’s lab. Mad2∆ 
line was a generous gift from Dr. Roger Karess’s lab. da-Gal4 was obtained from 
Bloomington Stock Center. Flies were raised on standard cornmeal food at 25OC 
and a 12 hour light dark cycle. For 4TU feeding experiments larvae were grown 
under axenic conditions. Embryos were sterilized using 50% bleach for 2 minutes 
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followed by a quick 70% ethanol wash and then transferred to autoclaved 
cornmeal food. Before feeding larvae were floated using filter sterilized 20% 
sucrose and transferred to autoclaved food containing 4TU. 
4.4.2 Immunohistochemistry 
Rat anti-HA 3F10 (Roche) antibodies were used at a 1/500 dilution. CNSs from 
third instar wandering larvae were dissected out and fixed in 4% 
paraformaldehyde in PBS for 20 minutes at room temperature for anti-HA and 
anti-CSP staining. Antibody staining and washes of larval CNSs were conducted 
in 0.1% Triton-X100 in 1X PBS (PBST). Primary antibody treatments of CNSs 
were done at 4ºC for 24 hours. S2 cells were fixed on glass culture slides as per 
standard protocol. 
 4.4.3 S2 cell culture and transfection 
S2 cells were cultured in standard cell culture plates with M3 media 
supplemented with Insect Media Supplement (IMS), 2% Fetal Calf Serum and 
penicillin/ streptomycin (PS) (growth media). Cells were maintained at 25 OC and 
passaged every 6 days at a density of 2 million cells per ml. All cell transfections 
were done using CellfectinII (Invitrogen). Freshly passaged cells growing in 
confluence (24 hours after passaging) were harvested, 3.2 million cells were 
plated in each well of a 6 well plate in 1.6 ml of M3+IMS media, and then allowed 
to attach to the bottom of the plate for 2 hours. Before transfection 1.2 microgram 
of DNA was mixed with 120 µl of M3+IMS media in a microcentrifuge tube and 8 
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µl of cellfectinII reagent was mixed with 120 µl of M3+IMS media in a separate 
tube. The tubes were incubated at RT for 15 minutes. Post incubation the 
solutions were mixed together and incubated at RT for another 5 minutes. At the 
end of this incubation the solution was added drop wise to the S2 cells. 8-16 
hours post transfection the medium was exchanged for M3+IMS+PS media, and 
cells grown for another 4 days before performing any experiment. For 4TU 
feeding post transfection, M3+IMS+PS media was exchanged with growth media 
containing 0.5 mM or 0.2 mM 4TU.  
4.4.4 Quantitative PCR 
Total RNA was extracted from S2 cells or whole larvae using QIAGEN RNeasy 
Tissue Mini Kit according to the manufacturer’s protocol. RNA samples (5 µg per 
reaction) were reverse-transcribed using SuperScript III (Invitrogen), and the 
generated cDNA was used for quantitative-PCR (Roche LightCycler 480 Real-
Time PCR system). Rpl23 was used as a reference gene for normalization. 
Three separate samples were collected for each condition and triplicate 
measurements were conducted for each sample. Primers were designed 
specifically for qPCR using Primer3 (http://frodo.wi.mit.edu/). 
4.4.4 4TU incorporation assay 
Incorporation of 4TU in RNA upon feeding with 4TU was assayed by chemically 
biotinylating thiol groups on RNA and probing for biotinylated RNA on a Northern 
blot using streptavidin HRP. Briefly, 20 µg of total RNA was incubated in 1X 
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biotinylation buffer (20mM tris and 1mM EDTA, pH 7.4) in a total volume of 166 
µl that included 40µl of Biotin-HPDP in DMF (1mg/ml stock). The reaction mixture 
was incubated in a 55 OC water bath for 20 minutes and then for 2 hour and 40 
minutes at RT, protected from light. Biotinylated RNA was extracted with acidic 
phenol (Ambion) to remove any free biotin reagent. Total RNA was precipitated 
from the aqueous phase by adding 1/10 th volume of 5 M NaCl and precipitating 
with 1:1 parts of isopropanol. The precipitate was centrifuged (maximum speed) 
for 10 minutes and the resultant pellet was washed once with 70% ethanol, dried, 
and re-suspended in 15 µl of RNAse free water. 1 µg of this RNA was run on a 
formaldehyde-agarose gel. RNA was transferred to a nylon membrane overnight 
using standard Northern blot technique. The RNA was then crosslinked to the 
nylon membrane using UV irradiation (auto setting, repeat once after flipping the 
blot) and blocked using 10X blocking solution (125mM NaCl, 17mM Na2HPO4, 
7.3mM NaH2PO4, and 1% SDS) by rocking at RT for 20 minutes. Subsequently 
the blot was incubated with streptavidin-HRP at 1/1500 dilution (1mg/ml stock) in 
10X blocking solution. The blot was washed twice with 1X blocking solution and 
twice with 1X assay buffer (10mM Tris, 10mM NaCl, 1m MgCl2, pH 9.5) before 
detecting with a standard ECL kit (Pierce) and photo-reactive film. Band 
intensities were measured using Image-J analysis software whenever applicable.  
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Appendix I 
Transcriptional targets of TGF-β signaling in larval tissues 
Daw specifically signals through a novel isoform of babo, baboc, which is 
expressed tissue specifically. Limited analysis of major tissues indicates that 
baboc is expressed strongly in tissues such as midgut and fatbody. Therefore, it 
is likely that daw regulates gene expression in a tissue specific manner and may 
be more active in regulating gene expression in tissues that are metabolically 
active and are involved in nutrient absorption. Identifying the transcriptional 
targets of TGF-β signaling in these tissues is vital for understanding the role of 
Daw in regulating metabolism. We decided to direct our endeavor towards finding 
the targets of Daw signaling in the larval fatbody primarily because we could 
rescue the acidosis and cellular metabolism phenotypes of daw mutants by 
activating TGF-β signaling in the fatbody only. To identify the transcriptional 
targets of Daw signaling in the fatbody I performed illumina RNA sequencing with 
total RNA extracted from fatbody dissected from w1118, daw1/+ and daw1/11 stage 
matched feeding mid third instar larvae. The table below shows genes that 
showed significant change in the mutants compared to either w1118 or daw1/+ 
controls. Apart from the deep sequencing experiment I performed a S2 cells 
based Daw stimulation assay to look for potential targets of TGF-β signaling. In 
these experiments S2 cells were stimulated with Daw and total RNA was 
extracted from the cells. This RNA was used to perform quantitative PCR to look 
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changes in expression of some 100 genes that were selected from a microarray 
dataset that I had performed previously. S2 cells that were not stimulated with 
Daw served as controls. This secondary screen showed strong upregulation of 
one gene, Dh31-R1, which is a diuretic hormone receptor, up on Daw 
stimulation. The screen also showed down-regulation of 5 genes up on Daw 
stimulation. Consistent with these genes being targets of TGF-β signaling, in my 
deep sequencing experiment Dh31-R1 showed a strong down-regulation in the 
daw mutants (Table X, shaded in pink). Additionally, two of the 5 genes (tobi and 
Dab) which were down-regulated on Daw stimulation showed strong up-
regulation in the daw mutants. These genes could therefore be strong candidates 
for being direct transcriptional targets of TGF-β signaling in Drosophila and could 
serve to identify the Smox-binding site in Drosophila that is still unknown.  
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Figure 37: Genes whose expression changed significantly in S2 cells up on 
stimulation with Daw. 
Fold change in the expression level of genes that responded to stimulation with Daw in 
S2 cells. Expression level relative to rpl23 was assayed using quantitative PCR. 
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Table 2: Genes that showed significant expression differences between w1118 
control and daw1/11 mutants.  
Gene Name W1118 daw1/11 log2 (Fold change) p Value 
Dpt 239.04 0.65 -8.52 0.0017 
CG5773 831.08 2.45 -8.41 5.00E-05 
CG4288 11.58 0.14 -6.37 0.00065 
CG3036 127.56 2.04 -5.97 5.00E-05 
CG3868 16.45 0.31 -5.71 0.00025 
CG31676 10.47 0.22 -5.55 0.00165 
DptB 370.95 8.31 -5.48 5.00E-05 
CG42329 91.28 2.08 -5.45 5.00E-05 
CG14762 8.89 0.32 -4.81 5.00E-05 
CG8654 44.94 1.72 -4.71 5.00E-05 
CG3239 3.68 0.15 -4.58 0.0004 
CG3513 101.27 4.71 -4.43 5.00E-05 
Gpo-1 79.82 4.32 -4.21 5.00E-05 
Hsp67Bb 78.54 4.30 -4.19 5.00E-05 
Odc1 27.72 1.53 -4.18 5.00E-05 
Dro 44.02 2.86 -3.95 0.0044 
CG18067 155.15 10.30 -3.91 5.00E-05 
CG31100 1.96 0.13 -3.91 0.0008 
CG42708 19.73 1.39 -3.83 5.00E-05 
r 16.58 1.23 -3.75 5.00E-05 
Rab23 2.09 0.16 -3.74 0.0026 
CG34034 5.31 0.42 -3.68 0.0048 
CG6426 18.93 1.49 -3.67 0.0004 
CG8160 995.23 81.25 -3.61 5.00E-05 
CG33926 12.76 1.06 -3.59 0.0012 
aay 148.70 12.44 -3.58 5.00E-05 
CG18278 1.75 0.16 -3.42 0.0028 
GstD2 36.96 3.59 -3.36 5.00E-05 
rdgC 1.89 0.19 -3.30 0.00085 
CG5966 1.45 0.15 -3.30 0.0042 
CG17032 15.09 1.59 -3.24 5.00E-05 
CG1213 3.52 0.37 -3.24 0.00095 
CG34436 145.24 16.86 -3.11 5.00E-05 
hebe 5.06 0.60 -3.07 0.00085 
Cyp6t1 2.98 0.36 -3.06 0.00345 
Cyt-b5-r 1009.56 123.57 -3.03 5.00E-05 
CG3292 12.92 1.76 -2.88 5.00E-05 
Myo28B1 3.14 0.45 -2.81 0.00035 
Drs 57.85 8.74 -2.73 0.0013 
CG9372 18.96 2.90 -2.71 0.0001 
CG2065 39.49 6.14 -2.68 5.00E-05 
CG13315 558.66 90.26 -2.63 5.00E-05 
CG9906 6.76 1.14 -2.57 0.0005 
CG6908 48.09 8.24 -2.55 5.00E-05 
CG4398 29.62 5.19 -2.51 5.00E-05 
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l(2)41Ab 7.10 1.26 -2.49 5.00E-05 
CG4607 3.64 0.69 -2.40 0.00315 
Pvf3 3.53 0.69 -2.36 0.00185 
CG8086 4.96 0.99 -2.32 0.0014 
Cyp9c1 48.61 9.80 -2.31 5.00E-05 
regucalcin 1232.29 250.27 -2.30 5.00E-05 
CG7384 20.99 4.30 -2.29 5.00E-05 
CG11425 82.24 17.17 -2.26 5.00E-05 
CG4562 4.50 0.94 -2.25 5.00E-05 
kcc 2.80 0.59 -2.25 0.00085 
CG15917 31.77 6.73 -2.24 0.0044 
Taf12L 22.48 4.77 -2.24 0.0038 
Tsp42Ep 379.50 80.90 -2.23 5.00E-05 
CG9220 3.98 0.86 -2.20 0.00415 
CG4021 11.64 2.53 -2.20 0.00085 
Myo61F 6.28 1.39 -2.18 5.00E-05 
CG34455 144.89 32.01 -2.18 5.00E-05 
CG6045 16.95 3.81 -2.15 5.00E-05 
CG2736 376.96 85.56 -2.14 5.00E-05 
CG6188 1995.59 458.25 -2.12 5.00E-05 
CG12692 5.48 1.27 -2.11 0.00315 
sug 43.61 10.21 -2.09 5.00E-05 
Gpdh 393.74 92.63 -2.09 5.00E-05 
CG31288 29.24 6.89 -2.09 5.00E-05 
CG1774 28.33 6.83 -2.05 5.00E-05 
roX1 13.38 3.23 -2.05 5.00E-05 
CG9396 55.33 13.80 -2.00 5.00E-05 
Fmo-1 80.42 20.34 -1.98 5.00E-05 
SP1173 32.37 8.19 -1.98 5.00E-05 
Gclm 45.49 11.56 -1.98 5.00E-05 
CG10916 72.54 18.43 -1.98 5.00E-05 
Dh31-R1 6.60 1.69 -1.96 5.00E-05 
CG4238 5.56 1.44 -1.95 0.0001 
CG32652 28.04 7.47 -1.91 5.00E-05 
CR32690 26.80 7.14 -1.91 0.0001 
CG5065 4.41 1.18 -1.90 0.0006 
Btk29A 8.90 2.40 -1.89 5.00E-05 
SpdS 182.74 49.64 -1.88 5.00E-05 
CG2955 11.74 3.21 -1.87 5.00E-05 
CG4797 8.88 2.43 -1.87 0.0003 
Cyp4p1 27.54 7.58 -1.86 5.00E-05 
CG18473 24.66 6.79 -1.86 5.00E-05 
CG15306 12.14 3.35 -1.86 5.00E-05 
Mst87F 36.42 10.06 -1.86 0.0022 
CG10841 6.10 1.69 -1.85 0.0001 
CG10924 73.78 20.46 -1.85 5.00E-05 
t 5.86 1.63 -1.85 0.0034 
CG6279 13.96 3.89 -1.84 0.00055 
CG17124 78.27 21.80 -1.84 5.00E-05 
fra 5.47 1.53 -1.84 5.00E-05 
CG8157 1090.65 306.39 -1.83 5.00E-05 
CG32548 12.88 3.63 -1.83 0.0001 
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fbp 639.43 180.29 -1.83 5.00E-05 
CG8851 4.28 1.21 -1.83 0.0034 
CG8565 13.22 3.74 -1.82 5.00E-05 
ssp5 5.68 1.61 -1.82 0.0006 
CG15040 2.91 0.83 -1.81 5.00E-05 
Mec2 43.92 12.58 -1.80 5.00E-05 
CR32658 24.74 7.09 -1.80 0.00015 
Dscam 2.19 0.63 -1.80 5.00E-05 
CG34434 28.46 8.18 -1.80 5.00E-05 
CG34168 41.88 12.04 -1.80 0.0013 
CG4907 3.20 0.92 -1.79 0.0034 
CG2267 7.34 2.13 -1.78 0.00075 
Hsp60B 6.49 1.89 -1.78 0.00025 
CR42767 22.29 6.50 -1.78 0.0009 
Cyp6g1 131.67 38.46 -1.78 5.00E-05 
CG12699 89.43 26.15 -1.77 5.00E-05 
AttA 60.86 17.81 -1.77 5.00E-05 
CR32661 18.06 5.30 -1.77 0.005 
Obp83cd 25.99 7.63 -1.77 0.00025 
CG17352 3.90 1.14 -1.77 0.0013 
CG3213 15.99 4.69 -1.77 5.00E-05 
Mst98Ca 19.96 5.88 -1.76 5.00E-05 
Men 511.49 150.71 -1.76 5.00E-05 
CG15128 8.16 2.41 -1.76 5.00E-05 
Klp59D 5.35 1.59 -1.75 0.00065 
TrxT 27.37 8.14 -1.75 5.00E-05 
CG18522 25.38 7.55 -1.75 5.00E-05 
CG32064 25.45 7.59 -1.75 5.00E-05 
CG9284 22.71 6.78 -1.74 0.00015 
CG31709 22.31 6.66 -1.74 5.00E-05 
Arp53D 7.49 2.24 -1.74 0.00465 
CG5840 37.37 11.23 -1.73 5.00E-05 
CG3330 13.65 4.11 -1.73 0.00025 
CG30148 170.03 51.38 -1.73 5.00E-05 
CG4802 100.87 30.62 -1.72 5.00E-05 
CG5790 4.88 1.48 -1.72 0.00125 
CG15208 7.80 2.37 -1.72 0.00345 
CG1324 13.94 4.25 -1.71 0.00015 
CG7229 4.82 1.48 -1.70 0.00185 
Porin2 9.45 2.91 -1.70 0.0043 
CG3323 4.94 1.52 -1.70 0.00085 
CG3875 10.34 3.20 -1.69 0.001 
Hsp68 53.38 16.60 -1.69 5.00E-05 
orb 5.12 1.59 -1.68 5.00E-05 
CG18266 6.30 1.96 -1.68 0.0018 
TTLL3B 5.10 1.59 -1.68 0.0002 
CG32063 20.44 6.37 -1.68 5.00E-05 
CG1288 15.13 4.73 -1.68 0.00055 
CG15086 3.19 1.00 -1.67 5.00E-05 
CG14718 7.63 2.40 -1.67 0.00015 
CG4691 11.41 3.59 -1.67 0.0011 
CG14540 8.52 2.71 -1.65 5.00E-05 
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Pkd2 5.61 1.79 -1.65 5.00E-05 
CG10252 29.44 9.38 -1.65 5.00E-05 
CG5762 14.62 4.66 -1.65 0.0015 
CG2750 1.88 0.60 -1.65 0.0012 
Atox1 114.84 36.65 -1.65 5.00E-05 
CG5111 5.20 1.66 -1.65 0.00325 
CG4439 21.55 6.89 -1.65 5.00E-05 
CG9920 31.98 10.23 -1.65 5.00E-05 
Poc1 7.74 2.48 -1.64 0.00105 
CG9389 6.46 2.07 -1.64 0.00065 
CG2861 8.52 2.73 -1.64 0.0003 
CG6304 8.74 2.80 -1.64 0.0015 
ocn 37.65 12.12 -1.63 5.00E-05 
CG7309 5.27 1.70 -1.63 0.0021 
CG42678 27.21 8.79 -1.63 5.00E-05 
CG7886 11.10 3.59 -1.63 5.00E-05 
CG4218 9.54 3.09 -1.63 0.00485 
SIP2 18.61 6.03 -1.63 5.00E-05 
loopin-1 30.42 9.86 -1.62 5.00E-05 
CG17098 6.62 2.15 -1.62 0.0003 
CG31025 8.74 2.83 -1.62 5.00E-05 
Hsc70-2 8.24 2.68 -1.62 0.0001 
CG1394 21.06 6.86 -1.62 0.0002 
CG7349 9.19 3.00 -1.62 5.00E-05 
CG6776 83.34 27.21 -1.61 5.00E-05 
CG1340 5.02 1.64 -1.61 0.00465 
CG7804 11.23 3.67 -1.61 0.0001 
CG13340 23.54 7.71 -1.61 5.00E-05 
CG6372 36.73 12.04 -1.61 5.00E-05 
CG3124 26.20 8.59 -1.61 5.00E-05 
CG31601 5.41 1.78 -1.61 0.00455 
CG42666 3.54 1.17 -1.60 0.002 
CG30376 11.89 3.94 -1.59 0.00525 
fan 12.09 4.01 -1.59 0.00585 
CG15109 21.11 7.01 -1.59 5.00E-05 
CG8219 4.03 1.34 -1.59 0.0014 
CG13991 2.02 0.67 -1.59 0.00115 
CG13597 7.72 2.58 -1.58 0.00155 
CG8564 7.59 2.54 -1.58 0.00065 
CG12861 17.06 5.70 -1.58 0.00025 
CG32703 4.49 1.50 -1.58 0.00015 
CG4836 32.86 11.03 -1.58 5.00E-05 
CG3927 15.46 5.22 -1.57 0.0002 
Cyp4d14 17.76 6.00 -1.57 5.00E-05 
Tub85D 26.04 8.80 -1.57 5.00E-05 
CG9133 20.82 7.03 -1.57 0.0007 
CG10859 6.69 2.27 -1.56 0.00025 
CG18135 242.81 82.78 -1.55 5.00E-05 
Idh 1051.71 358.73 -1.55 5.00E-05 
CG5043 6.61 2.27 -1.55 0.00155 
CG32081 7.12 2.44 -1.54 0.00275 
CG11089 430.81 148.25 -1.54 5.00E-05 
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ACXC 2.69 0.93 -1.54 0.0041 
PGRP-SD 280.36 96.86 -1.53 0.00025 
Ppm1 8.54 2.95 -1.53 0.00155 
CG13032 5.45 1.88 -1.53 0.00115 
AttC 203.20 70.29 -1.53 5.00E-05 
CG9975 25.66 8.90 -1.53 5.00E-05 
CG16782 9.61 3.34 -1.52 0.0038 
bol 11.43 4.00 -1.52 5.00E-05 
CG3964 5.78 2.02 -1.52 0.0001 
CG8526 4.80 1.68 -1.51 0.0053 
dj 13.59 4.77 -1.51 0.0004 
CG42820 5.03 1.77 -1.51 0.0019 
Hsp60C 14.92 5.24 -1.51 5.00E-05 
CG5538 17.93 6.30 -1.51 5.00E-05 
lea 5.15 1.81 -1.50 5.00E-05 
CG14355 4.92 1.74 -1.50 0.00025 
CG10623 14.21 5.05 -1.49 0.00015 
CG2893 12.61 4.49 -1.49 5.00E-05 
CG7813 4.68 1.67 -1.49 0.0024 
Cht3 1.78 0.63 -1.49 0.00305 
RpS19b 20.54 7.33 -1.49 0.00305 
CG33090 10.73 3.84 -1.48 5.00E-05 
sm 46.81 16.77 -1.48 5.00E-05 
CG11125 7.70 2.76 -1.48 0.00445 
CG3408 13.93 5.03 -1.47 5.00E-05 
nonA-l 7.03 2.54 -1.47 0.00015 
CG30015 2.79 1.01 -1.47 0.00095 
CG12179 2.52 0.91 -1.46 0.0019 
Cyp4d1 855.36 311.26 -1.46 5.00E-05 
CG7900 28.88 10.52 -1.46 5.00E-05 
CG6287 333.14 121.84 -1.45 5.00E-05 
mud 4.74 1.74 -1.44 5.00E-05 
srpk79D 2.81 1.03 -1.44 0.0024 
blot 4.45 1.65 -1.43 0.00085 
Pepck 1075.39 399.41 -1.43 5.00E-05 
CG15599 4.76 1.77 -1.43 0.0047 
Eaat1 40.88 15.24 -1.42 5.00E-05 
CG6752 2.57 0.96 -1.42 0.00105 
CG30187 100.47 37.56 -1.42 5.00E-05 
CG9279 4.26 1.61 -1.40 5.00E-05 
CG31029 8.47 3.21 -1.40 5.00E-05 
Treh 58.22 22.17 -1.39 5.00E-05 
CG13659 6.47 2.48 -1.38 0.0031 
CG17734 199.76 76.83 -1.38 5.00E-05 
CG12860 12.70 4.89 -1.38 0.0007 
Dhc98D 1.04 0.40 -1.38 0.00025 
RpL22-like 15.95 6.20 -1.36 0.00025 
CG1387 2.85 1.11 -1.36 0.00545 
CG10734 8.74 3.42 -1.36 0.0044 
Hsp26 46.81 18.33 -1.35 5.00E-05 
kuz 11.87 4.66 -1.35 5.00E-05 
CG31636 52.23 20.52 -1.35 5.00E-05 
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CG9344 46.51 18.29 -1.35 0.00375 
CG10512 234.74 92.48 -1.34 5.00E-05 
CG8136 6.66 2.62 -1.34 0.00435 
Rpt3R 7.60 3.00 -1.34 0.0056 
CG10960 93.99 37.35 -1.33 5.00E-05 
CG1347 18.62 7.41 -1.33 5.00E-05 
ana3 1.83 0.73 -1.32 0.00255 
exu 63.79 25.79 -1.31 5.00E-05 
scf 90.51 36.61 -1.31 5.00E-05 
CG6040 4.15 1.68 -1.31 5.00E-05 
CG14879 13.47 5.47 -1.30 5.00E-05 
Pdk 183.81 74.69 -1.30 5.00E-05 
CG10621 1171.47 477.51 -1.29 5.00E-05 
orb2 15.47 6.31 -1.29 5.00E-05 
ap 17.34 7.08 -1.29 5.00E-05 
Tob 4.32 1.77 -1.29 0.0021 
CG5987 6.63 2.73 -1.28 0.0007 
RpS5b 19.16 7.89 -1.28 0.0009 
dpr17 4.53 1.88 -1.27 0.00515 
Ih 19.70 8.19 -1.27 5.00E-05 
CG5660 3.79 1.58 -1.27 0.005 
CG14688 339.22 141.35 -1.26 5.00E-05 
CG15343 86.69 36.22 -1.26 5.00E-05 
fusl 14.27 5.97 -1.26 5.00E-05 
CG30460 9.38 3.93 -1.26 5.00E-05 
CG32444 164.43 68.87 -1.26 5.00E-05 
GstS1 603.83 253.51 -1.25 5.00E-05 
CG30151 42.28 17.78 -1.25 5.00E-05 
Klp3A 2.88 1.21 -1.25 0.00155 
CG9399 36.43 15.36 -1.25 5.00E-05 
hoe1 15.03 6.36 -1.24 5.00E-05 
CG5389 7.02 2.98 -1.24 0.00165 
Orct 20.99 8.91 -1.24 5.00E-05 
sle 6.93 2.95 -1.23 5.00E-05 
Ptpmeg 17.20 7.33 -1.23 5.00E-05 
l(2)08717 34.03 14.61 -1.22 5.00E-05 
CG6201 6.30 2.70 -1.22 0.00375 
Ance 59.46 25.53 -1.22 5.00E-05 
Nmd3 28.30 12.17 -1.22 5.00E-05 
CG17928 31.24 13.50 -1.21 5.00E-05 
Cyp310a1 96.37 41.85 -1.20 5.00E-05 
CG31324 11.74 5.14 -1.19 0.00065 
CG7860 37.58 16.49 -1.19 5.00E-05 
yellow-d 135.47 59.66 -1.18 0.00065 
GstE3 247.22 109.00 -1.18 5.00E-05 
Fim 23.72 10.51 -1.17 5.00E-05 
Stat92E 150.23 66.58 -1.17 5.00E-05 
CG13822 100.92 44.95 -1.17 5.00E-05 
CG4068 27.20 12.18 -1.16 5.00E-05 
Rbp4 9.36 4.23 -1.15 0.0028 
whd 47.00 21.29 -1.14 5.00E-05 
CG9664 65.95 29.90 -1.14 5.00E-05 
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CG5707 34.27 15.63 -1.13 5.00E-05 
CG11883 7.69 3.51 -1.13 0.0001 
CG2765 19.76 9.04 -1.13 5.00E-05 
CG4686 33.59 15.42 -1.12 5.00E-05 
CG4752 90.54 41.66 -1.12 5.00E-05 
CG3961 212.48 98.11 -1.11 5.00E-05 
CG8369 421.84 194.84 -1.11 5.00E-05 
Jheh3 187.14 86.78 -1.11 5.00E-05 
GstD4 72.66 33.72 -1.11 5.00E-05 
CG17350 35.69 16.58 -1.11 5.00E-05 
CG31414 34.26 15.99 -1.10 5.00E-05 
eIF4E-3 18.15 8.50 -1.10 0.00155 
Pof 17.58 8.24 -1.09 0.0001 
CG33099 56.71 26.63 -1.09 5.00E-05 
Pen 27.79 13.08 -1.09 5.00E-05 
CG5577 151.66 71.83 -1.08 5.00E-05 
alpha-Est5 24.20 11.50 -1.07 5.00E-05 
CG31988 18.67 8.89 -1.07 0.0017 
GIIIspla2 25.85 12.33 -1.07 0.0001 
CG33307 1481.95 710.88 -1.06 5.00E-05 
Jafrac1 285.69 137.06 -1.06 5.00E-05 
CG3714 31.67 15.20 -1.06 5.00E-05 
CG11897 5.00 2.40 -1.06 5.00E-05 
Spn42Db 48.44 23.29 -1.06 5.00E-05 
mthl3 23.83 11.46 -1.06 5.00E-05 
CG31523 17.23 8.31 -1.05 5.00E-05 
axo 15.08 7.31 -1.04 5.00E-05 
CG13868 148.07 71.94 -1.04 5.00E-05 
Pvr 28.79 14.06 -1.03 5.00E-05 
CG3842 73.80 36.21 -1.03 5.00E-05 
Ppat-Dpck 69.38 34.10 -1.02 5.00E-05 
polo 8.96 4.42 -1.02 0.00075 
CG10031 158.48 78.52 -1.01 5.00E-05 
Ady43A 8.57 4.25 -1.01 0.0016 
CG31373 29.07 14.41 -1.01 0.0033 
Fmo-2 57.17 28.36 -1.01 5.00E-05 
sPLA2 200.14 99.43 -1.01 0.0008 
Jheh1 59.78 29.80 -1.00 5.00E-05 
CG32191 29.02 14.47 -1.00 5.00E-05 
gb 10.68 5.33 -1.00 0.0001 
CG3226 56.77 28.39 -1.00 5.00E-05 
Obp99c 3093.55 1553.12 -0.99 5.00E-05 
Jupiter 16.85 8.48 -0.99 0.0005 
GstE8 39.13 19.86 -0.98 0.0008 
GstD1 2651.77 1350.57 -0.97 5.00E-05 
CG4893 34.69 17.71 -0.97 5.00E-05 
CG15293 713.05 365.12 -0.97 5.00E-05 
nmo 7.96 4.09 -0.96 0.00085 
CG9339 4.21 2.17 -0.96 0.00475 
GstE7 310.65 160.79 -0.95 5.00E-05 
Vago 133.21 69.18 -0.95 5.00E-05 
nimB4 46.00 23.96 -0.94 5.00E-05 
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CG3394 49.49 25.78 -0.94 5.00E-05 
CG8026 138.04 72.06 -0.94 5.00E-05 
CG4302 25.79 13.59 -0.92 0.0053 
Nhe2 5.16 2.73 -0.92 0.00095 
CG11284 75.83 40.20 -0.92 5.00E-05 
miple2 21.97 11.68 -0.91 0.0011 
l(1)G0255 166.49 88.52 -0.91 5.00E-05 
CG9444 61.14 32.79 -0.90 5.00E-05 
ssp3 6.03 3.24 -0.90 0.00025 
LRP1 21.24 11.43 -0.89 5.00E-05 
CG40191 108.20 58.44 -0.89 5.00E-05 
CG5567 29.40 15.97 -0.88 0.0001 
rl 45.73 24.85 -0.88 5.00E-05 
CG30344 12.81 6.97 -0.88 5.00E-05 
ade2 64.65 35.37 -0.87 5.00E-05 
vir-1 522.69 286.69 -0.87 5.00E-05 
CG14882 14.09 7.73 -0.87 0.00335 
ras 27.32 15.00 -0.87 0.0001 
CG11334 174.02 95.58 -0.86 5.00E-05 
Tsf1 1129.19 621.67 -0.86 5.00E-05 
CG31689 36.77 20.25 -0.86 5.00E-05 
CG32103 75.21 41.59 -0.85 5.00E-05 
ltd 63.21 35.02 -0.85 5.00E-05 
CG14997 85.47 47.57 -0.85 5.00E-05 
Spn6 40.44 22.51 -0.85 0.0001 
CG13641 452.33 251.98 -0.84 5.00E-05 
CG16743 465.53 259.91 -0.84 5.00E-05 
CG15093 418.69 233.95 -0.84 5.00E-05 
Tsp42Ek 312.47 174.64 -0.84 5.00E-05 
CG6574 36.34 20.38 -0.83 5.00E-05 
rogdi 12.31 6.90 -0.83 0.0008 
armi 4.79 2.69 -0.83 0.0034 
CG1532 116.66 65.46 -0.83 5.00E-05 
ade5 425.87 240.58 -0.82 5.00E-05 
CG14291 48.06 27.17 -0.82 5.00E-05 
Nc73EF 69.49 39.38 -0.82 5.00E-05 
PGRP-LB 18.19 10.38 -0.81 0.0051 
CG10254 9.99 5.70 -0.81 5.00E-05 
CG6199 277.47 158.89 -0.80 5.00E-05 
CG7692 7.05 4.04 -0.80 0.00075 
CG8788 91.54 52.48 -0.80 5.00E-05 
CG6654 8.73 5.01 -0.80 0.0042 
Yeti 244.65 140.75 -0.80 5.00E-05 
Unc-76 21.74 12.51 -0.80 5.00E-05 
CG9449 89.10 51.53 -0.79 5.00E-05 
Nha2 56.50 32.75 -0.79 5.00E-05 
CG1732 9.85 5.71 -0.79 0.00095 
CG4078 6.07 3.52 -0.79 0.0037 
CG34136 427.16 248.38 -0.78 5.00E-05 
CG6404 17.67 10.28 -0.78 0.0007 
fal 18.77 10.92 -0.78 0.00035 
pst 548.79 319.41 -0.78 5.00E-05 
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CG13185 3.12 1.82 -0.78 5.00E-05 
eIF4G2 13.66 7.98 -0.78 0.00225 
CG7737 9.58 5.62 -0.77 0.00375 
CG10171 75.41 44.33 -0.77 5.00E-05 
CG7255 367.45 216.03 -0.77 5.00E-05 
CG10527 628.73 369.87 -0.77 5.00E-05 
CG33493 911.57 536.69 -0.76 5.00E-05 
l(1)G0289 42.10 24.84 -0.76 5.00E-05 
Glt 536.86 318.94 -0.75 5.00E-05 
fry 11.20 6.66 -0.75 5.00E-05 
Sam-S 522.54 311.08 -0.75 5.00E-05 
Obp99a 629.57 375.13 -0.75 5.00E-05 
CG4572 58.97 35.42 -0.74 5.00E-05 
CG12262 355.57 213.69 -0.73 0.0001 
CG1662 38.14 22.93 -0.73 0.0001 
Tom70 14.82 8.94 -0.73 0.0008 
MRP 42.75 25.78 -0.73 5.00E-05 
CG9662 52.30 31.57 -0.73 0.0011 
CAH1 26.25 15.85 -0.73 0.00045 
CG2200 29.55 17.87 -0.73 0.00215 
oaf 15.36 9.40 -0.71 0.00455 
CG11737 18.69 11.44 -0.71 0.0006 
Tcp-1eta 48.43 29.74 -0.70 5.00E-05 
lap 36.01 22.15 -0.70 5.00E-05 
Ace 7.08 4.37 -0.70 0.00105 
Zip3 13.36 8.29 -0.69 0.0037 
CG10741 12.91 8.03 -0.69 0.00475 
Top2 11.67 7.27 -0.68 0.00025 
rept 14.46 9.01 -0.68 0.00525 
CG33494 139.45 87.05 -0.68 5.00E-05 
PGRP-SB1 323.17 201.81 -0.68 0.0012 
prominin-like 16.95 10.63 -0.67 5.00E-05 
att-ORFA 22.49 14.21 -0.66 0.0017 
CG7441 13.45 8.54 -0.66 0.00265 
Hsp60 154.89 98.30 -0.66 5.00E-05 
Tsp42Ed 29.24 18.62 -0.65 0.00555 
CG12825 342.71 219.20 -0.64 5.00E-05 
CAP 44.43 28.48 -0.64 0.0005 
CG3999 323.12 207.32 -0.64 5.00E-05 
CG8709 53.92 34.65 -0.64 5.00E-05 
DNaseII 364.94 234.73 -0.64 5.00E-05 
CG8368 15.96 10.27 -0.64 0.00125 
out 16.58 10.69 -0.63 0.00075 
CG2982 12.66 8.18 -0.63 0.0041 
mdy 147.45 95.55 -0.63 5.00E-05 
CG32626 218.56 141.83 -0.62 5.00E-05 
Tl 42.67 27.73 -0.62 5.00E-05 
CG10639 162.01 105.35 -0.62 5.00E-05 
CG32687 298.58 194.41 -0.62 5.00E-05 
CG5151 13.35 8.71 -0.62 0.002 
CG31778 202.16 132.51 -0.61 5.00E-05 
toc 7.11 4.66 -0.61 0.0045 
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CG33093 65.87 43.29 -0.61 0.00035 
Fer1HCH 280.32 184.51 -0.60 0.00155 
CG5991 61.08 40.22 -0.60 0.00015 
h 23.31 15.37 -0.60 0.0012 
SamDC 68.47 45.23 -0.60 0.00015 
CG6767 147.82 98.21 -0.59 0.0001 
Tif-IA 27.19 18.08 -0.59 0.00085 
nudC 41.19 27.40 -0.59 0.0009 
Ald 2630.16 1755.92 -0.58 0.0003 
Mical 5.99 4.01 -0.58 0.00425 
CG4882 24.63 16.54 -0.57 0.0052 
CG9616 239.42 160.74 -0.57 0.0004 
inx3 52.33 35.17 -0.57 0.0008 
nimB5 113.93 76.75 -0.57 5.00E-05 
Ubi-p63E 31.98 21.55 -0.57 0.00055 
Tps1 509.56 345.59 -0.56 0.0001 
CG8206 55.19 37.49 -0.56 0.0023 
CG6191 14.43 9.81 -0.56 0.00205 
CG10467 123.09 83.75 -0.56 5.00E-05 
prc 6.65 4.54 -0.55 0.00505 
CG34424 343.06 234.60 -0.55 0.00025 
KLHL18 71.23 48.80 -0.55 0.00025 
Ndg 35.36 24.24 -0.54 0.0003 
CG11811 37.86 25.96 -0.54 0.0018 
CG15814 25.51 17.54 -0.54 0.00415 
Cdc27 12.86 8.85 -0.54 0.0028 
Cct5 64.45 44.33 -0.54 0.00065 
CG9153 49.20 33.85 -0.54 0.00015 
ACXD 25.43 17.51 -0.54 0.00045 
Hn 537.26 371.54 -0.53 0.00015 
alphaTub84D 45.58 31.69 -0.52 0.00055 
CG9027 106.85 74.34 -0.52 0.00145 
CG10638 54.78 38.13 -0.52 0.00305 
CG7033 54.63 38.12 -0.52 0.0008 
p38c 59.45 41.54 -0.52 0.0023 
Uch 52.74 36.87 -0.52 0.0044 
Cyp4e2 263.88 186.40 -0.50 0.0004 
CG32803 103.54 73.18 -0.50 0.0022 
CG8258 41.09 29.05 -0.50 0.002 
CG5390 309.83 219.14 -0.50 0.00045 
CG3397 124.71 88.58 -0.49 0.00195 
Fpps 273.61 194.37 -0.49 0.0003 
Cyp4d2 40.63 28.94 -0.49 0.00505 
CG13654 22.71 16.22 -0.49 0.00345 
CG8449 75.14 53.69 -0.48 0.0027 
CG5525 53.08 37.94 -0.48 0.00205 
NTPase 51.00 36.48 -0.48 0.00425 
CG34215 1039.29 744.22 -0.48 0.00035 
CG17331 170.56 122.17 -0.48 0.00195 
Trc8 26.78 19.25 -0.48 0.004 
CG1516 541.96 389.64 -0.48 0.00285 
CG1468 962.19 692.17 -0.48 0.0011 
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Cctgamma 34.90 25.12 -0.47 0.00285 
CG4673 33.90 24.48 -0.47 0.00435 
skap 145.96 105.52 -0.47 0.0014 
CG4774 58.35 42.28 -0.46 0.0058 
CG6330 76.27 55.47 -0.46 0.00285 
CG9894 249.60 181.78 -0.46 0.0016 
CG33120 94.65 69.08 -0.45 0.00165 
CG16935 101.73 74.26 -0.45 0.0046 
Nsf2 29.25 21.36 -0.45 0.0054 
Itp-r83A 33.90 24.78 -0.45 0.00155 
CG32521 233.24 170.70 -0.45 0.00145 
CG3597 97.92 71.71 -0.45 0.00415 
gem 72.77 53.49 -0.44 0.00165 
gp210 14.59 10.79 -0.44 0.00525 
Droj2 114.60 84.91 -0.43 0.00245 
CG8029 72.61 54.16 -0.42 0.00375 
Vha100-1 70.73 52.76 -0.42 0.0027 
CG5590 308.03 229.81 -0.42 0.00235 
CG11594 287.04 214.76 -0.42 0.0028 
CG16718 57.00 42.67 -0.42 0.00345 
Idgf3 285.61 215.67 -0.41 0.00345 
CG17244 895.83 677.78 -0.40 0.00425 
CG11395 414.42 316.37 -0.39 0.00555 
CG14629 578.33 441.56 -0.39 0.0051 
awd 1806.62 2357.86 0.38 0.0061 
ATPsyn-d 509.60 665.72 0.39 0.0045 
Nurf-38 316.57 413.91 0.39 0.00545 
CG7461 148.52 195.73 0.40 0.0044 
CG7181 607.69 800.98 0.40 0.005 
CG31769 217.97 287.48 0.40 0.00405 
GRHR 70.69 93.26 0.40 0.0057 
growl 145.67 192.29 0.40 0.003 
CG32230 938.60 1239.71 0.40 0.00445 
CG3321 520.82 690.48 0.41 0.00345 
ced-6 97.83 129.79 0.41 0.004 
CG10664 649.57 862.13 0.41 0.003 
Xbp1 248.79 331.80 0.42 0.00265 
Ent2 57.97 77.33 0.42 0.0057 
Oat 804.93 1074.74 0.42 0.0051 
CG5010 148.25 198.13 0.42 0.004 
sec31 108.60 145.29 0.42 0.00275 
CG14767 62.92 84.22 0.42 0.0042 
prel 54.79 73.36 0.42 0.0056 
Pmm45A 95.25 127.64 0.42 0.0021 
Cyp1 655.39 881.47 0.43 0.00305 
CG2846 58.71 79.00 0.43 0.0061 
Atg8a 160.56 216.74 0.43 0.0024 
Pgm 284.52 384.62 0.43 0.00175 
fs(1)h 9.76 13.20 0.43 0.00575 
sesB 891.44 1206.25 0.44 0.0038 
CG17508 107.29 145.54 0.44 0.0029 
CG7834 484.92 658.59 0.44 0.00165 
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CG10962 1190.55 1617.30 0.44 0.0048 
Vha13 131.40 178.54 0.44 0.00465 
CG5315 93.04 126.46 0.44 0.00225 
arg 313.40 426.08 0.44 0.002 
Syb 160.65 218.57 0.44 0.0035 
porin 422.01 574.57 0.45 0.0014 
Sod2 136.89 186.65 0.45 0.0027 
ATPsyn- 1453.11 1982.70 0.45 0.00445 
spirit 109.29 149.13 0.45 0.00165 
Mtp 245.23 334.83 0.45 0.0016 
Surf4 270.20 369.56 0.45 0.001 
CG31548 117.17 160.36 0.45 0.00255 
l(2)37Cc 114.49 156.79 0.45 0.00165 
SdhC 128.19 175.91 0.46 0.0041 
CrebA 27.22 37.35 0.46 0.0021 
Prx5037 148.79 204.51 0.46 0.00135 
T3dh 115.82 159.37 0.46 0.0013 
for 89.62 123.40 0.46 0.0006 
CG9577 151.14 208.25 0.46 0.0023 
Vinc 25.73 35.51 0.46 0.00145 
Cyp28d1 201.58 278.55 0.47 0.00115 
l(3)neo18 151.48 209.44 0.47 0.0016 
CG6206 38.93 53.87 0.47 0.0016 
NP15.6 165.31 228.76 0.47 0.00365 
kdn 51.10 70.86 0.47 0.00145 
CG3560 401.67 557.18 0.47 0.00215 
Ucrh 377.60 524.08 0.47 0.00145 
CG14621 27.71 38.56 0.48 0.0057 
CG10672 88.60 123.33 0.48 0.00245 
Dcr-2 19.38 27.08 0.48 0.0052 
tud 60.30 84.30 0.48 0.0006 
CG10320 290.22 406.21 0.49 0.00375 
CG7320 216.14 302.53 0.49 0.00055 
l(1)G0230 539.05 754.97 0.49 0.00035 
CG1458 203.63 285.28 0.49 0.001 
CG3731 281.52 394.70 0.49 0.00075 
CG6910 517.60 726.68 0.49 0.00085 
CG33936 60.78 85.48 0.49 0.00055 
CG9467 25.59 36.00 0.49 0.002 
CG42593 24.07 33.88 0.49 0.0017 
CG32425 162.65 228.93 0.49 0.00065 
Sply 46.77 65.89 0.49 0.001 
CG6359 60.76 85.84 0.50 0.0011 
Tal 1019.23 1443.71 0.50 0.0005 
Hsc70-3 1360.11 1929.17 0.50 0.00475 
CG11357 17.31 24.56 0.50 0.0027 
CG15203 268.74 381.73 0.51 0.00075 
CG13887 152.58 216.78 0.51 0.0002 
lama 34.94 49.66 0.51 0.0006 
Cat 1672.69 2377.88 0.51 0.0033 
CG9306 140.58 199.99 0.51 0.00135 
CG9691 549.56 782.59 0.51 0.00025 
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CG2118 36.67 52.27 0.51 0.0008 
Hsromega 32.65 46.55 0.51 0.0048 
CG9436 35.19 50.23 0.51 0.0026 
CG9914 178.68 255.02 0.51 0.00015 
CG5002 31.58 45.11 0.51 0.00125 
tai 13.04 18.64 0.51 0.00025 
TRAM 395.74 565.83 0.52 0.0003 
CG10219 62.31 89.12 0.52 0.0038 
cu 49.86 71.33 0.52 0.0005 
Oatp74D 50.14 71.78 0.52 0.00035 
CG1105 79.88 114.45 0.52 0.00095 
Atg9 10.70 15.35 0.52 0.0057 
l(2)k09913 161.36 231.47 0.52 0.0001 
CG8726 28.95 41.57 0.52 0.0038 
CG1161 56.09 80.61 0.52 0.0015 
atl 71.65 102.98 0.52 0.0001 
CG9044 12.33 17.75 0.53 0.00145 
Egfr 35.10 50.65 0.53 0.00045 
CG4390 122.30 176.63 0.53 0.00035 
cdi 7.41 10.71 0.53 0.0012 
CG10660 20.58 29.75 0.53 0.003 
fru 11.18 16.17 0.53 0.0058 
CG30104 25.24 36.52 0.53 0.0017 
CG14715 244.75 354.19 0.53 0.00085 
CG4769 209.91 303.91 0.53 5.00E-05 
chic 461.36 668.11 0.53 0.00015 
CG6084 711.65 1032.24 0.54 0.00015 
schlank 59.72 86.65 0.54 0.00045 
CG7322 863.29 1253.61 0.54 0.0001 
CG8680 108.84 158.10 0.54 0.0019 
Rab7 82.33 119.63 0.54 0.0003 
Gie 44.57 64.77 0.54 0.003 
CG32000 31.39 45.76 0.54 0.00015 
alt 106.66 155.59 0.54 0.0001 
Las 30.23 44.11 0.55 0.00175 
Pdsw 203.85 297.86 0.55 0.00025 
CG15828 74.63 109.07 0.55 0.00015 
Atg13 14.46 21.14 0.55 0.001 
CG30492 46.36 67.77 0.55 0.0045 
Hydr2 63.02 92.31 0.55 0.00015 
CG14073 7.26 10.65 0.55 0.0028 
Pfrx 36.47 53.60 0.56 0.0002 
CG9319 49.20 72.36 0.56 0.00035 
Nedd8 95.24 140.10 0.56 0.0042 
CG7998 846.21 1244.82 0.56 0.0002 
Got2 783.44 1152.72 0.56 0.0003 
aralar1 68.91 101.52 0.56 0.0001 
l(2)35Di 127.91 188.48 0.56 0.00055 
CG18815 80.90 119.55 0.56 0.0001 
PH4alphaEFB 74.85 111.03 0.57 5.00E-05 
Lmpt 8.19 12.17 0.57 0.00495 
Pdi 3306.27 4915.83 0.57 0.0056 
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CG11015 294.92 438.62 0.57 5.00E-05 
Aats-val 31.55 46.95 0.57 5.00E-05 
RFeSP 261.63 389.50 0.57 0.0001 
CG3621 129.77 193.56 0.58 0.00075 
CG7430 190.56 284.41 0.58 0.0001 
Pde11 3.64 5.45 0.58 0.0055 
CG14200 5.53 8.29 0.58 0.0011 
CG40006 8.32 12.47 0.58 0.00515 
PMCA 33.96 50.95 0.59 5.00E-05 
CG13298 54.86 82.41 0.59 0.00065 
CG5059 52.74 79.24 0.59 0.0001 
Spn 3.91 5.88 0.59 0.00295 
CG12140 151.74 228.18 0.59 5.00E-05 
Acon 92.19 138.64 0.59 5.00E-05 
CG42258 15.07 22.74 0.59 0.00135 
LKR 88.66 133.81 0.59 5.00E-05 
vkg 263.62 398.27 0.60 0.00015 
CG16926 1597.43 2414.91 0.60 5.00E-05 
cpb 24.82 37.54 0.60 0.0006 
CG4335 155.06 234.66 0.60 5.00E-05 
Mitf 15.21 23.02 0.60 0.0005 
CG12272 11.54 17.47 0.60 0.00055 
CG3683 143.91 217.97 0.60 5.00E-05 
mnd 13.66 20.71 0.60 0.0009 
CG5599 23.23 35.22 0.60 0.0006 
ppl 704.36 1069.36 0.60 5.00E-05 
tobi 86.92 132.11 0.60 0.0001 
CG4729 123.80 188.17 0.60 5.00E-05 
CG15771 12.05 18.32 0.61 0.00135 
CG7149 28.20 42.91 0.61 0.0001 
Cyp4d8 51.30 78.07 0.61 5.00E-05 
flr 24.77 37.97 0.62 0.0002 
CG32529 5.64 8.65 0.62 0.0005 
CG3829 18.79 28.83 0.62 0.0002 
CG33144 5.93 9.11 0.62 0.00095 
ATPsyn-Cf6 657.43 1009.50 0.62 5.00E-05 
Hel89B 6.68 10.27 0.62 0.00025 
Spn77Ba 35.32 54.27 0.62 0.0001 
CG15369 903.73 1388.75 0.62 5.00E-05 
sda 5.00 7.69 0.62 0.00155 
Zyx102EF 38.36 59.16 0.62 5.00E-05 
Sps2 17.65 27.22 0.62 0.002 
CG6028 219.74 338.92 0.63 5.00E-05 
CG1702 55.82 86.14 0.63 0.0004 
CG17896 294.31 454.50 0.63 5.00E-05 
CG11309 165.99 256.60 0.63 5.00E-05 
CG33774 192.20 297.43 0.63 0.0046 
Cyp6a23 186.52 288.91 0.63 5.00E-05 
Trl 20.62 31.98 0.63 0.00025 
CG4630 12.48 19.38 0.63 0.00295 
alpha-Est3 11.72 18.20 0.63 0.0029 
CG12130 102.06 158.44 0.63 5.00E-05 
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CG18624 240.64 373.90 0.64 5.00E-05 
CG31075 3113.78 4842.14 0.64 0.00075 
CG12581 11.42 17.76 0.64 0.0004 
mfas 24.93 38.78 0.64 5.00E-05 
Cct1 99.46 154.72 0.64 5.00E-05 
CG6067 131.21 204.25 0.64 5.00E-05 
CG30359 276.34 430.92 0.64 5.00E-05 
CG11652 27.71 43.31 0.64 0.00015 
eIF-2 277.93 434.56 0.64 5.00E-05 
CG14196 40.69 63.69 0.65 5.00E-05 
stv 11.39 17.84 0.65 0.00025 
galectin 66.08 103.50 0.65 5.00E-05 
Mnt 11.80 18.48 0.65 0.0002 
PKD 31.13 48.85 0.65 5.00E-05 
LanA 90.59 142.25 0.65 5.00E-05 
CG9331 1076.32 1690.29 0.65 5.00E-05 
CG42351 364.81 573.69 0.65 5.00E-05 
CG9547 129.20 203.32 0.65 5.00E-05 
CG2254 337.06 531.31 0.66 5.00E-05 
Acox57D-d 41.62 65.63 0.66 5.00E-05 
SdhB 125.42 197.83 0.66 5.00E-05 
SCAP 23.38 36.96 0.66 5.00E-05 
CG30091 63.90 101.28 0.66 5.00E-05 
CG9953 57.14 90.73 0.67 5.00E-05 
CG3267 34.68 55.26 0.67 5.00E-05 
wnd 4.75 7.58 0.67 0.00225 
CG10824 21.17 33.82 0.68 0.0059 
CG7220 9.27 14.80 0.68 0.00315 
dob 43.76 69.97 0.68 5.00E-05 
Ets98B 13.96 22.39 0.68 5.00E-05 
CG33460 37.91 60.85 0.68 0.00025 
Gp150 45.46 72.96 0.68 5.00E-05 
CG10026 103.41 166.01 0.68 5.00E-05 
CG32486 9.88 15.87 0.68 0.0004 
CG9238 87.33 140.31 0.68 5.00E-05 
CG1021 7.92 12.72 0.68 0.0006 
CG15438 19.28 31.01 0.69 0.0003 
Reg-2 845.94 1361.77 0.69 5.00E-05 
ClC-a 14.09 22.70 0.69 5.00E-05 
Eno 892.63 1443.08 0.69 5.00E-05 
ox 425.87 688.68 0.69 0.0001 
CG5205 7.97 12.89 0.69 5.00E-05 
Cyp6v1 21.79 35.26 0.69 0.0001 
CG1968 11.06 17.95 0.70 0.0018 
scu 511.47 831.90 0.70 5.00E-05 
by 5.47 8.91 0.70 0.00235 
LanB1 53.36 86.94 0.70 5.00E-05 
Lsd-2 536.59 875.32 0.71 5.00E-05 
CG3061 44.23 72.16 0.71 5.00E-05 
bmm 21.90 35.72 0.71 5.00E-05 
CG32699 12.74 20.84 0.71 5.00E-05 
CR42862 129.76 212.35 0.71 5.00E-05 
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CG6325 6.71 10.98 0.71 0.00065 
Gli 7.73 12.67 0.71 5.00E-05 
dl 9.20 15.09 0.71 0.0004 
SelG 45.51 74.78 0.72 0.0001 
C3G 5.76 9.48 0.72 0.0001 
CG32850 9.58 15.76 0.72 0.0008 
CG5532 57.63 94.90 0.72 0.00015 
Acsl 92.96 153.10 0.72 5.00E-05 
CG30069 4.39 7.24 0.72 5.00E-05 
Spn42Dc 39.91 65.91 0.72 5.00E-05 
Oda 293.72 485.95 0.73 5.00E-05 
CG15658 9.89 16.36 0.73 0.00215 
Pu 9.97 16.54 0.73 0.00175 
Rala 18.30 30.39 0.73 5.00E-05 
ImpL2 33.72 56.18 0.74 5.00E-05 
CG6115 98.67 164.41 0.74 5.00E-05 
GstE6 24.55 40.95 0.74 0.00215 
grass 103.17 172.11 0.74 5.00E-05 
CG8586 43.45 72.51 0.74 5.00E-05 
CG32068 157.38 262.91 0.74 5.00E-05 
hfw 18.92 31.66 0.74 5.00E-05 
IP3K2 9.59 16.05 0.74 0.00015 
CG30273 25.71 43.15 0.75 0.00405 
CG5362 1322.49 2220.43 0.75 5.00E-05 
CG1291 32.01 53.75 0.75 5.00E-05 
Thor 354.04 594.87 0.75 5.00E-05 
su(r) 133.33 224.28 0.75 5.00E-05 
4GalNAcTA 20.78 34.99 0.75 5.00E-05 
kraken 33.21 55.92 0.75 5.00E-05 
CG14787 47.34 79.78 0.75 5.00E-05 
CG7878 9.70 16.36 0.75 0.00035 
CG1275 33.59 56.69 0.75 5.00E-05 
CG2083 3.48 5.88 0.76 0.00015 
CG34417 21.92 37.08 0.76 0.0002 
CG6543 812.56 1375.99 0.76 5.00E-05 
CG32666 4.69 7.95 0.76 0.00035 
Ac13E 3.24 5.51 0.76 0.0003 
Cyp9b1 57.82 98.32 0.77 5.00E-05 
CG2493 102.44 174.42 0.77 5.00E-05 
smp-30 242.44 413.22 0.77 5.00E-05 
CG30288 56.25 96.08 0.77 5.00E-05 
CG31674 14.01 24.07 0.78 0.0008 
fu12 27.85 47.94 0.78 5.00E-05 
CG2862 307.03 528.73 0.78 5.00E-05 
Hex-A 40.14 69.17 0.79 5.00E-05 
Sp7 35.19 60.88 0.79 5.00E-05 
Gs1l 13.96 24.21 0.79 0.00365 
CG9629 188.55 328.41 0.80 5.00E-05 
CG14872 61.68 107.43 0.80 5.00E-05 
CG9542 148.00 258.50 0.80 5.00E-05 
Dhfr 28.53 49.90 0.81 0.0016 
CG14225 20.07 35.12 0.81 5.00E-05 
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Fdh 252.21 441.27 0.81 5.00E-05 
CG6770 813.42 1425.07 0.81 5.00E-05 
CG6746 63.62 111.60 0.81 5.00E-05 
CG1943 21.82 38.36 0.81 5.00E-05 
cp309 6.54 11.51 0.81 5.00E-05 
alpha-Est8 13.15 23.18 0.82 5.00E-05 
if 11.45 20.21 0.82 5.00E-05 
CG5044 93.59 165.63 0.82 5.00E-05 
CG3603 111.38 197.47 0.83 5.00E-05 
CG2991 15.63 27.78 0.83 5.00E-05 
CG5261 168.65 299.96 0.83 5.00E-05 
Msp-300 5.39 9.60 0.83 5.00E-05 
casp 29.37 52.25 0.83 5.00E-05 
CG8475 27.12 48.32 0.83 5.00E-05 
eIF2B-epsilon 13.74 24.49 0.83 0.00525 
CG17597 95.64 170.58 0.83 5.00E-05 
CG12025 38.34 68.43 0.84 5.00E-05 
CG32407 75.75 135.45 0.84 5.00E-05 
CG30269 25.51 45.65 0.84 0.00475 
mav 4.15 7.42 0.84 0.0046 
CG2911 12.45 22.34 0.84 0.00495 
CG2444 201.92 362.55 0.84 5.00E-05 
CG42806 45.29 81.69 0.85 0.00115 
CD98hc 60.51 109.23 0.85 5.00E-05 
bor 25.28 45.72 0.85 5.00E-05 
CG11474 44.79 81.44 0.86 5.00E-05 
scrib 5.58 10.17 0.87 5.00E-05 
CG13004 13.35 24.35 0.87 5.00E-05 
CG42694 12.56 23.00 0.87 5.00E-05 
CG30431 35.96 65.91 0.87 5.00E-05 
CG11791 9.14 16.77 0.88 0.0014 
Lac 25.90 48.02 0.89 5.00E-05 
MSBP 140.96 261.44 0.89 5.00E-05 
CG32369 15.46 28.74 0.89 5.00E-05 
Aats-thr 68.18 126.90 0.90 5.00E-05 
CG6912 143.08 266.76 0.90 5.00E-05 
Ate1 19.26 36.03 0.90 5.00E-05 
CG42846 754.20 1411.23 0.90 5.00E-05 
Acer 78.18 146.48 0.91 5.00E-05 
Spn43Ab 437.52 821.61 0.91 5.00E-05 
CG3609 176.01 330.79 0.91 5.00E-05 
tok 23.72 44.75 0.92 5.00E-05 
HspB8 149.56 282.24 0.92 5.00E-05 
Tsp42Eq 10.77 20.34 0.92 0.0022 
Thd1 12.52 23.75 0.92 5.00E-05 
CG12159 20.87 39.61 0.92 0.00035 
CG1969 17.34 33.09 0.93 5.00E-05 
Ance-4 178.24 340.47 0.93 5.00E-05 
PyK 286.60 547.79 0.93 5.00E-05 
mRpL28 59.37 113.75 0.94 5.00E-05 
ry 25.76 49.38 0.94 5.00E-05 
v 138.56 268.00 0.95 5.00E-05 
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Kr 99.32 192.23 0.95 5.00E-05 
CG34437 71.06 138.03 0.96 5.00E-05 
CG31937 67.48 131.28 0.96 5.00E-05 
ATPCL 471.67 919.22 0.96 5.00E-05 
bnl 2.54 4.97 0.97 0.0011 
CG1637 83.31 163.05 0.97 5.00E-05 
CG5999 41.98 82.23 0.97 5.00E-05 
CG10932 178.01 349.69 0.97 5.00E-05 
yellow-f2 33.20 65.25 0.98 5.00E-05 
CG18812 6.90 13.61 0.98 0.0002 
CG1307 16.66 32.90 0.98 0.0002 
Socs36E 3.63 7.19 0.98 0.00015 
CG31793 8.18 16.28 0.99 5.00E-05 
CG1092 37.20 74.01 0.99 5.00E-05 
Ncc69 4.29 8.55 0.99 5.00E-05 
ScpX 188.00 374.48 0.99 5.00E-05 
CG32412 35.49 70.80 1.00 5.00E-05 
Mlc2 8.26 16.51 1.00 5.00E-05 
CG3270 40.19 80.35 1.00 5.00E-05 
CG9536 41.40 82.91 1.00 5.00E-05 
CG10376 5.23 10.48 1.00 0.00065 
CG6357 5.77 11.59 1.01 0.0046 
Lip4 57.51 116.31 1.02 5.00E-05 
Act57B 25.45 51.50 1.02 5.00E-05 
CG8501 11.88 24.05 1.02 0.0015 
CG18343 92.75 188.03 1.02 5.00E-05 
Aats-his 91.15 185.48 1.02 5.00E-05 
CG5793 596.58 1215.06 1.03 5.00E-05 
Ugt35a 48.76 99.38 1.03 5.00E-05 
cbt 48.18 98.44 1.03 5.00E-05 
CG4592 27.75 56.81 1.03 5.00E-05 
Est-6 19.13 39.49 1.05 5.00E-05 
Cyp9b2 264.00 548.09 1.05 5.00E-05 
CG14375 99.08 205.86 1.05 5.00E-05 
CG6834 41.05 85.31 1.06 5.00E-05 
Herp 66.89 139.37 1.06 5.00E-05 
up 6.54 13.66 1.06 0.00095 
CG3168 13.75 28.80 1.07 5.00E-05 
CG9989 6.62 13.89 1.07 0.00465 
Ser 1.39 2.93 1.08 0.00205 
CG14131 5.98 12.66 1.08 0.00035 
rho-4 3.49 7.43 1.09 0.00485 
CG3775 57.84 123.18 1.09 5.00E-05 
CG16713 689.44 1468.57 1.09 5.00E-05 
CG6805 7.20 15.36 1.09 0.0001 
Spec2 5.95 12.74 1.10 0.00025 
CG12883 28.05 60.32 1.10 5.00E-05 
CG32115 27.79 59.87 1.11 5.00E-05 
Odc2 18.02 39.46 1.13 5.00E-05 
CG31974 14.36 31.46 1.13 5.00E-05 
CG6503 137.01 300.35 1.13 5.00E-05 
JhI-1 7.38 16.24 1.14 5.00E-05 
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CG8745 242.13 534.70 1.14 5.00E-05 
Mhc 5.09 11.24 1.14 5.00E-05 
retm 9.02 19.95 1.15 5.00E-05 
CG18249 16.86 37.36 1.15 5.00E-05 
CG11241 96.13 213.36 1.15 5.00E-05 
CG8249 12.28 27.38 1.16 5.00E-05 
CG2064 17.60 39.31 1.16 5.00E-05 
CG3770 18.60 41.63 1.16 5.00E-05 
CG4594 54.79 122.63 1.16 5.00E-05 
GM130 19.44 43.52 1.16 5.00E-05 
Prm 4.16 9.32 1.16 5.00E-05 
Glycogenin 14.58 32.81 1.17 5.00E-05 
CG9380 2.27 5.12 1.17 0.00445 
FucTB 11.50 25.93 1.17 5.00E-05 
Mlc1 7.07 16.00 1.18 0.00555 
CG16712 4239.41 9600.83 1.18 5.00E-05 
Cyt-c-p 196.81 447.29 1.18 5.00E-05 
Pect 90.25 206.41 1.19 5.00E-05 
CG13751 60.27 138.41 1.20 0.0003 
GstD10 494.55 1137.03 1.20 5.00E-05 
CG33691 4.95 11.42 1.21 5.00E-05 
htt 3.89 9.00 1.21 5.00E-05 
CG18347 18.75 43.41 1.21 5.00E-05 
Nplp2 15518.10 35937.90 1.21 5.00E-05 
CG4793 16.41 38.18 1.22 5.00E-05 
CG33123 25.22 58.80 1.22 5.00E-05 
scyl 31.36 73.21 1.22 5.00E-05 
Yp3 347.88 814.03 1.23 5.00E-05 
CG1600 113.75 266.48 1.23 5.00E-05 
wts 5.30 12.41 1.23 5.00E-05 
CG9674 14.76 34.83 1.24 5.00E-05 
CG9231 14.14 33.48 1.24 5.00E-05 
CG5953 1.78 4.23 1.25 0.0017 
CG7224 398.74 948.39 1.25 5.00E-05 
CG17681 5.45 13.32 1.29 0.00175 
Ect3 70.22 172.71 1.30 5.00E-05 
CG32280 66.97 164.88 1.30 5.00E-05 
CG8034 11.91 29.32 1.30 5.00E-05 
CG3568 3.65 9.02 1.31 0.0023 
CG32335 7.88 19.56 1.31 0.0005 
trbl 15.90 39.67 1.32 5.00E-05 
CG1640 73.01 182.62 1.32 5.00E-05 
shf 6.04 15.14 1.33 5.00E-05 
CG42345 2.28 5.71 1.33 0.00035 
kek1 6.54 16.46 1.33 5.00E-05 
CG11198 137.92 349.10 1.34 5.00E-05 
CG11784 30.58 77.42 1.34 0.00025 
Ahcy89E 9.40 23.81 1.34 5.00E-05 
CG33785 8.40 21.33 1.34 5.00E-05 
Got1 149.36 379.73 1.35 5.00E-05 
LpR2 1.15 2.94 1.35 0.00275 
iPLA2-VIA 24.44 62.62 1.36 5.00E-05 
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RhoGDI 26.22 67.26 1.36 5.00E-05 
Sodh-1 113.67 292.11 1.36 5.00E-05 
pyd3 41.85 108.74 1.38 5.00E-05 
Aats-ile 34.09 89.10 1.39 5.00E-05 
CG18619 10.29 26.94 1.39 0.0055 
CG11313 44.93 118.68 1.40 5.00E-05 
CG33459 30.68 81.63 1.41 5.00E-05 
Act5C 637.59 1713.69 1.43 5.00E-05 
kal-1 49.16 132.17 1.43 5.00E-05 
Acf1 1.07 2.90 1.43 0.00065 
veil 3.82 10.37 1.44 5.00E-05 
CG13962 452.80 1233.00 1.45 5.00E-05 
lig3 10.50 28.61 1.45 5.00E-05 
CG7763 230.37 628.20 1.45 5.00E-05 
Aats-asn 104.60 285.69 1.45 5.00E-05 
btsz 2.06 5.64 1.45 5.00E-05 
CG16758 189.14 520.26 1.46 5.00E-05 
Zw 51.77 143.42 1.47 5.00E-05 
CG2611 67.67 187.71 1.47 5.00E-05 
CG5704 4.58 12.81 1.49 0.00305 
oys 33.43 93.93 1.49 5.00E-05 
ppa 1.72 4.85 1.50 0.0008 
JhI-26 75.34 212.97 1.50 5.00E-05 
GstD7 125.00 353.44 1.50 5.00E-05 
Tsp42El 23.68 67.26 1.51 5.00E-05 
CG8229 24.79 70.49 1.51 5.00E-05 
CG34348 65.74 188.01 1.52 5.00E-05 
Kaz1-ORFB 73.42 211.87 1.53 5.00E-05 
CG3902 718.98 2077.11 1.53 5.00E-05 
Ubi-p5E 13.12 38.31 1.55 5.00E-05 
CG17816 1.60 4.75 1.57 0.00265 
CG12224 12.75 37.94 1.57 5.00E-05 
stg 1.51 4.51 1.58 0.0019 
CG11882 4.21 12.58 1.58 0.0043 
CG9837 72.61 219.41 1.60 5.00E-05 
Gs1 124.13 376.13 1.60 5.00E-05 
lectin-28C 115.06 349.35 1.60 5.00E-05 
CG2964 1.80 5.48 1.60 0.0041 
Eip63F-1 2.11 6.42 1.60 0.00035 
spir 3.54 10.78 1.61 5.00E-05 
CG6830 1.30 3.97 1.61 0.0041 
CG33226 15.54 47.80 1.62 0.0034 
Dif 5.62 17.32 1.62 5.00E-05 
CG10444 15.79 48.80 1.63 5.00E-05 
Ipp 2.82 8.83 1.65 0.00475 
CG1607 1.89 5.93 1.65 0.0005 
CG31248 25.82 81.44 1.66 5.00E-05 
CG33199 42.26 134.10 1.67 5.00E-05 
CG2017 29.23 93.02 1.67 5.00E-05 
CG17278 14.61 46.97 1.69 5.00E-05 
Sodh-2 141.58 455.79 1.69 5.00E-05 
Ac78C 0.88 2.84 1.69 0.0002 
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Alas 59.77 198.72 1.73 5.00E-05 
Cyp9f2 10.10 33.70 1.74 5.00E-05 
Hex-C 5.54 18.53 1.74 5.00E-05 
CG5288 81.05 272.10 1.75 5.00E-05 
CG9505 9.12 30.74 1.75 5.00E-05 
p24-2 6.45 21.76 1.75 0.0009 
Epac 1.71 5.89 1.79 5.00E-05 
CG17221 12.62 43.64 1.79 5.00E-05 
CG3700 12.69 44.07 1.80 5.00E-05 
Sip1 3.10 10.75 1.80 0.0005 
Dgp-1 35.46 123.30 1.80 5.00E-05 
slow 5.69 20.15 1.82 5.00E-05 
Hexo1 2.25 8.03 1.83 0.0006 
CG7433 1.51 5.47 1.86 0.0022 
Tina-1 109.71 400.53 1.87 5.00E-05 
Zasp52 4.24 15.54 1.87 5.00E-05 
CG9119 38.98 142.79 1.87 5.00E-05 
CG42868 128.98 474.35 1.88 5.00E-05 
CG5618 2.73 10.06 1.88 0.0001 
dnr1 1.33 5.03 1.92 0.0005 
alpha-Est1 52.33 200.11 1.93 5.00E-05 
daw 44.22 171.90 1.96 5.00E-05 
Cyp4p3 4.79 18.63 1.96 5.00E-05 
CG13936 3.75 14.60 1.96 5.00E-05 
CG1140 73.24 287.66 1.97 5.00E-05 
MtnA 92.47 364.25 1.98 5.00E-05 
CG4250 9.35 37.97 2.02 0.0004 
CG33510 4.33 17.85 2.04 5.00E-05 
CG18622 1.94 8.10 2.06 0.00585 
bgm 226.62 950.01 2.07 5.00E-05 
Hmgs 23.28 97.59 2.07 0.0002 
TepI 6.89 28.91 2.07 5.00E-05 
CG4259 9.41 39.97 2.09 5.00E-05 
Cpr11A 2.70 11.80 2.13 0.0008 
CG34232 5.63 24.66 2.13 0.00065 
CG3921 0.38 1.71 2.19 5.00E-05 
CG2641 9.97 47.58 2.25 5.00E-05 
CG9928 6.39 31.46 2.30 0.00455 
jp 0.30 1.51 2.33 0.00335 
CG6812 0.78 3.93 2.34 0.0041 
CG34054 10.93 55.40 2.34 5.00E-05 
CG9512 65.23 331.82 2.35 5.00E-05 
nrv3 0.67 3.41 2.35 0.00455 
Cyp6d5 20.60 106.08 2.36 5.00E-05 
CG11370 1.66 8.54 2.37 0.0024 
CG14400 23.51 122.31 2.38 5.00E-05 
Cyp309a1 30.65 167.14 2.45 5.00E-05 
CG18431 0.95 5.21 2.46 0.0013 
Dab 0.23 1.30 2.50 0.00125 
CG9766 1.00 5.71 2.51 0.00525 
Cyp6d2 2.63 15.47 2.56 0.0001 
JhI-21 10.81 64.37 2.57 5.00E-05 
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CG5321 24.97 152.49 2.61 5.00E-05 
Inos 27.34 168.36 2.62 5.00E-05 
Tsp96F 1.01 6.26 2.64 5.00E-05 
CG4928 0.78 4.92 2.65 0.00065 
l(2)01289 2.00 12.63 2.66 5.00E-05 
CG10764 1.77 11.26 2.67 0.0003 
CG32647 2.47 15.72 2.67 5.00E-05 
CG32352 0.14 0.91 2.68 0.00455 
Cyp12a4 11.34 72.78 2.68 5.00E-05 
dally 1.80 12.10 2.75 5.00E-05 
pncr009:3L 5.45 36.61 2.75 5.00E-05 
melt 0.34 2.37 2.80 0.0046 
CG33225 9.95 69.75 2.81 5.00E-05 
asparagine-synthetase 178.17 1266.13 2.83 5.00E-05 
CG15861 1.79 12.77 2.83 0.0008 
CG14292 3.07 21.94 2.84 0.0034 
Rbp6 0.29 2.16 2.92 0.00155 
CG10814 1.65 12.78 2.96 5.00E-05 
v(2)k05816 0.58 4.64 2.99 5.00E-05 
CG14964 0.10 0.78 2.99 0.00485 
CG11961 1.68 14.37 3.10 5.00E-05 
GstD3 78.75 678.89 3.11 5.00E-05 
CG17549 31.46 281.79 3.16 5.00E-05 
Muc11A 3.81 35.15 3.21 5.00E-05 
CadN 1.19 11.10 3.23 5.00E-05 
dgo 0.12 1.17 3.23 0.00255 
CG2663 0.13 1.26 3.26 0.0052 
CG12974 0.27 2.60 3.27 0.00395 
CG12520 1.16 11.22 3.27 0.00045 
CG1358 0.07 0.68 3.30 0.00075 
CG8665 50.87 533.87 3.39 5.00E-05 
CG13077 0.86 9.48 3.47 0.0005 
Tsp42Eg 10.69 118.23 3.47 5.00E-05 
CG30438 0.17 1.90 3.51 0.00095 
CG42335 0.52 5.92 3.51 0.00115 
NaPi-T 0.57 6.56 3.51 0.00045 
CG16727 0.82 9.53 3.54 0.0003 
CG11892 1.88 22.36 3.57 5.00E-05 
CG33511 0.27 3.23 3.59 0.0037 
W 0.17 2.18 3.65 0.00025 
Or83b 0.92 11.79 3.68 5.00E-05 
Ipod 0.86 11.23 3.70 0.0015 
Npc2f 41.49 560.92 3.76 5.00E-05 
CG32284 0.88 12.06 3.77 0.00265 
dpr12 0.20 2.80 3.82 0.00025 
CG11236 2.68 38.23 3.83 5.00E-05 
Mur18B 3.53 51.35 3.86 5.00E-05 
Scp2 4.48 65.84 3.88 5.00E-05 
CG10514 1.66 24.69 3.90 5.00E-05 
CG42390 0.56 8.66 3.95 5.00E-05 
CG6125 0.31 4.72 3.95 0.0024 
Tehao 0.28 4.45 3.97 5.00E-05 
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CG14669 0.21 3.45 4.02 0.0054 
Cyp12d1-p 0.20 3.64 4.17 0.0009 
Mipp1 0.42 7.68 4.18 0.0002 
CG15406 0.52 9.56 4.21 0.00245 
CG5697 0.20 4.13 4.37 0.0043 
Rhp 0.26 6.05 4.56 0.0043 
CG42807 7.21 183.39 4.67 5.00E-05 
CG9259 1.13 31.47 4.80 5.00E-05 
kar 8.52 248.33 4.87 5.00E-05 
CG5853 3.19 94.92 4.90 5.00E-05 
CG42256 0.01 0.35 5.21 0.00015 
Uro 1.62 62.58 5.27 5.00E-05 
Cyp6a2 1.11 43.43 5.29 5.00E-05 
TepIV 21.06 943.37 5.49 5.00E-05 
Glut1 0.49 24.15 5.63 5.00E-05 
Sox21a 0.21 10.39 5.64 5.00E-05 
CG4716 5.62 287.76 5.68 5.00E-05 
CG8539 0.21 11.00 5.73 0.00045 
CG10073 0.22 12.27 5.82 5.00E-05 
CG42784 0.03 1.88 5.84 0.00395 
CG18088 0.05 32.37 9.24 0.00555 
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Appendix II 
Metabolomic analysis of daw mutant, control and rescued animals 
Table 3: Metabolites that changed significantly in daw mutants 
Metabolite w1118 daw1/+ daw1/11 p Value (w
1118 
vs daw1/11) 
p Value (daw1/+ 
vs daw1/11) 
2-KETOGLUTARIC ACID 165.03 227.88 731.41 6.84304E-07 2.3088E-06 
FUMARIC ACID 1094.78 2120.88 4391.50 4.57759E-12 6.93251E-10 
KYNURENIC ACID 6.73 2.69 23.24 2.89739E-07 4.3031E-09 
PYRUVIC ACID 47.20 50.91 152.00 9.4797E-08 2.02032E-07 
2-HYDROXYGLUTARATE 170.83 254.95 459.58 0.000518535 0.013292859 
LACTIC ACID 108.80 127.19 286.43 1.61058E-05 0.000125954 
PROLINE 259.63 355.80 654.81 4.23399E-05 0.00044123 
MALEIC ACIDD 10.94 8.79 27.52 0.042996267 0.007334776 
SUCCINIC ACID 417.66 548.13 908.66 9.08981E-05 0.000995913 
MALIC ACID 678.70 1107.54 1350.83 4.04794E-07 0.003442133 
PHOSPHOGLYCEROL 18348.18 26150.13 33752.32 6.00909E-06 0.003010881 
SARCOSINE 249.96 148.00 452.48 0.009411255 0.000319751 
GLUTAMIC ACID 1232.52 1730.63 2220.60 0.001308593 0.034461765 
GLUCOSE-1-PHOSPHATE 503.10 665.75 901.69 0.000248519 0.005738014 
GLUCOSE-6-PHOSPHATE 1036.26 1303.71 1819.48 0.000488572 0.005079255 
ALANINE 59.77 43.78 91.30 0.004365965 9.83012E-05 
THREONINE 445.01 451.77 670.52 0.001140642 0.001322886 
N-ACETYLGLUTAMATE 5.53 5.15 7.56 0.009520861 0.005961834 
CHLOROGENIC ACID 8.04 8.22 10.33 0.029237344 0.025451283 
SERINE 1329.05 1332.89 1070.75 0.038814879 0.014492513 
2-METHYLCITRATE 20.77 23.01 13.41 0.001231365 6.46623E-05 
UREA 468.52 425.21 293.29 0.017772342 0.039009571 
ADENOSINE 56.10 46.88 35.05 0.006407944 0.006543595 
SORBITOL 502.24 319.96 242.16 0.016528562 0.012549088 
TRYPTOPHAN 2981.49 3076.08 1430.40 1.67651E-05 1.90177E-05 
PHOSPHOETHANOLAMINE 389.90 227.78 165.95 0.000310896 0.011857815 
TYROSINE 1578.20 1567.60 655.08 2.86271E-07 1.18003E-07 
MANNITOL 115.47 80.01 46.58 9.37004E-07 5.01032E-05 
RIBITOL/XYLITOL 43.69 22.12 16.60 1.68726E-06 0.001140791 
METHIONINE 748.48 627.50 248.57 4.84584E-06 0.00029275 
ORNITHINE 2778.49 1756.96 669.53 3.60723E-08 3.79136E-07 
HOMOSERINE 516.41 73.75 99.05 5.16287E-09 0.006127233 
2-AMINOADIPIC ACID 141.31 95.55 27.10 8.26712E-06 2.83578E-07 
HOMOCYSTEINE 143.75 74.31 20.30 7.1423E-05 2.21825E-05 
PANTOTHENIC ACID 49.83 47.79 3.84 4.27548E-08 9.57413E-14 
URIC ACID 2710.83 536.01 88.74 1.09577E-05 2.73697E-06 
P.S: Values shown are normalized to total mass of the samples in mg. Orange: 
metabolies that were up-regulated, Purple: metabolites that were down-regulated. n = 8 
samples per genotype with each sample containing 15 mid third instar larvae. 
	  	   	  175	  
Table 4: Metabolites that changed significantly in FB-Gal4>baboCA rescued 
animals. 
Metabolite daw
11; UAS-
baboCA/+ 
daw11; FB-
Gal4>baboCA p Value 
FUMARIC ACID 1886.56 341.47 3.32307E-11 
2-KETOGLUTARIC ACID 206.96 49.92 7.81026E-09 
2-HYDROXYGLUTARATE 87.72 21.97 1.50896E-07 
MALIC ACID 1405.20 385.31 1.57752E-12 
PYRUVIC ACID 364.60 113.63 3.13668E-07 
PHOSPHOGLYCEROL 3314.64 1209.84 1.05466E-10 
SEDOHEPTULOSE-7-P 742.05 279.29 3.55323E-06 
HOMOSERINE 101.49 39.04 0.000481617 
LACTIC ACID 79.81 32.98 1.13081E-05 
GLUCONIC ACID 2.39 1.04 0.000625109 
SUCCINIC ACID 284.59 154.08 6.4534E-07 
PROLINE 294.18 188.93 0.034875365 
CITRIC ACID 298.45 202.02 8.06185E-07 
GLYCEROL 446.50 302.42 0.000480892 
ISOCITRIC ACID 41.32 28.19 0.036800303 
GLUTAMIC ACID 505.32 357.26 0.000545458 
URIC ACID 47.77 33.86 0.032087711 
1-MONOPALMITOLYLGLYCEROL 5.54 4.07 0.002802307 
THREONINE 1424.67 1078.76 6.36175E-05 
GLUCOSE-6-PHOSPHATE 380.35 293.79 0.032640246 
PHOSPHATE 1528.38 1314.62 0.001464929 
LYSINE 3459.28 3841.44 0.03647346 
MANNITOL 20.69 25.87 0.03588341 
2-PHOSPHOGLYCERATE 2.65 3.34 0.034457672 
UREA 894.30 1132.65 0.030001039 
B-ALANINE 2201.86 2804.23 0.000397703 
GLYCERIC ACID 3.33 4.64 5.74706E-05 
4-AMINOBUTYRATE 60.36 85.67 0.014917927 
URACIL 15.25 22.12 0.045411202 
DHAP 4.04 6.10 0.004575078 
ADENOSINE 11.52 17.45 0.035677386 
GLYCINE 164.09 264.88 3.90927E-05 
PHOSPHOETHANOLAMINE 53.57 87.23 2.26782E-05 
3-PHOSPHOGLYCERATE 54.44 95.09 0.000117853 
TRYPTOPHAN 448.06 958.17 0.000217579 
PHENYLALANINE 206.79 527.19 4.12385E-06 
TYROSINE 188.14 550.50 3.84241E-09 
PANTOTHENIC ACID 2.55 8.16 2.09619E-06 
ORNITHINE 189.86 656.00 0.000392143 
2-AMINOADIPIC ACID 17.27 80.96 3.78091E-05 
METHIONINE 103.26 1176.98 6.36852E-09 
HOMOCYSTEINE 3.36 46.07 1.55419E-07 
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P.S: Values shown are normalized to total mass of the samples in mg. Orange: 
metabolites that were up-regulated, Purple: metabolites that were down-regulated. n = 8 
samples per genotype with each sample containing 15 mid third instar larvae. 
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Appendix III 
Smox is required for dFOXO nuclear localization in starved larval fatbody 
 
Figure 38: Smox is required for dFOXO nuclear localization 
To test the role of TGF-β signaling in dFOXO nuclear localization Smox-RNAi or babo 
null clones were generated in larval fatbody. The larvae were grown to mid third instar 
stages and starved to induce nuclear localization of dFOXO. Fatbody were subsequently 
stained with anti-dFOXO (Red) antibodies and localization in the clones were compared 
to surrounding control cells. Cones were identified as GFP positive cells. (A-A’) dFOXO 
nuclear localization is inhibited in fatbody cells expressing a Smox-RNAi construct 
generated in our laboratory. (B-B’) dFOXO nuclear localization is inhibited in fatbody 
cells expressing a Smox-RNAi construct generated by VDRC. (C-C’) dFOXO nuclear 
localization is not affected in fatbody cells that are mutant for the type-I receptor Babo. 
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Appendix IV 
 
 
